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Background: Evolving treatment options for people with cancer mean that increased 
numbers survive after diagnosis and enter a period where they perceive themselves 
as cancer free. Unfortunately, some experience a cancer recurrence, which can be at 
an advanced stage. Their prior treatment experience may influence their approach to 
this recurrence. New treatments are available to people in this illness stage. This 
experience is not well understood.  
 
Aim: To describe the experience of advanced cancer recurrence in people who have 
perceived themselves to be cancer free. 
 
Methods: A constructivist grounded theory approach. Qualitative interviews (n = 15) 
with people living a minimum of 2 or more years cancer free, with an advanced 
incurable cancer recurrence. Constant comparative method was used with theoretical 
sampling. Initial coding and focused coding enabled the development of final 
concepts. Concepts were substantiated using focused narrative synthesis literature 
review. 
 
Results: An inductively-developed understanding of three interactive concepts: 
Reluctant Acceptance, Seeking Life Through Continuous Treatment, and Hope in the 
Face of an Uncertain Future. These describe the experience from diagnosis of 
advanced cancer recurrence, with initial anger and sadness that the cancer is no 
longer curable. This shifts to a state of reluctant acceptance, which is a catalyst to 
seeking life through continuous treatment. Seeking life through continuous treatment 
creates hope in the face of an uncertain future, which then influences seeking life 
through continuous treatment. 
 
Conclusion: The experience of advanced cancer recurrence within the context of 
newly evolving treatment options leads to seeking treatment for advanced-stage 
cancer that is understood to be incurable but treatable. Seeking life through 
continuous treatment and hope in the face of an uncertain future are interactively 
linked to each other, creating a state of personal equilibrium for this population. This 
study illuminates the ways in which advanced cancer and treatment are perceived by 
this population. It provides direction for future research, which should focus on testing 
the model in a variety of settings, and developing understanding about the 
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Chapter 1: Introduction to Thesis 
1.1 Introduction 
Cancer remains the number one cause of death in the United States (U.S.) for 
people over the age of 60 (American Cancer Society, 2016b, p. 59). But while 
cancer continues to kill people, treatment options have successfully extended 
patients’ survival rates. Immunotherapy and focused treatments have resulted 
in a larger number of people living with cancer with high risk for recurrence 
(Miller et al., 2016).  
Defining this population as ‘survivor’ or ‘in survivorship’ is a point of 
controversy, as these terms do not adequately capture the specific population 
or location and trajectory of their disease (Dirven, van de Poll-Franse, 
Aaronson, & Reijneveld, 2015). The focus of this thesis is to understand the 
experience of advanced cancer recurrence in people who believed 
themselves to be cancer free.  
This chapter provides an introduction to the motivation for completing this 
study as well as historical context for the concepts of cancer survivors and 
cancer survivorship and the culture of United States (U.S.) health care. This 
research contributes to the broader discussion around the controversy that 
exists between healthcare providers and people with cancer using these terms 
of survivor and survivorship as the sole means for defining this population. 
Defining this population as survivor ignores the cultural and contextual 
influence of people with cancer in the U.S.   
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1.2 Motivation for This Study 
As an oncology nurse working with newly diagnosed patients or patients with 
recurrent disease, I have found that their primary concern is to understand 
their prognosis and potential for cure. Patients are given 5-year survival 
statistics, which may give the impression that if they survive 5-years without a 
recurrence they will be cured of their cancer disease (Deimling, Sterns, 
Bowman, & Kahana, 2007). Additionally, in the U.S., professional and 
advocacy organizations have added to the confusion regarding prognosis by 
defining anyone diagnosed with cancer as a ‘survivor’ (Hewitt, Greenfield, & 
Stovall, 2006). As discussed above, this overarching definition of survivor fails 
to provide a clear description of the target population and a more restricted 
definition for the purpose of research is needed (Dirven et al., 2015). 
My position in the Division of Nursing Research has included training nurses 
to provide survivorship care and develop Survivorship Care Plans (SCPs) to 
meet the Commission on Cancer requirements to maintain accreditation. 
Focusing on long-term effects of cancer and cancer treatments, the potential 
for recurrence with advanced disease was not discussed even for those with a 
significant risk for recurrence. Although in my current position I do not provide 
direct care to cancer patients I have wondered what the response might be for 
people with cancer who experience a cancer recurrence. 
This study aimed to explore the experience of advanced cancer recurrence in 
people who believed themselves to be cancer free. This central aim was 
supported by the following 4 questions:  
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1. What does prognosis or 5-year survival mean to people with 
cancer? 
2. How do people with cancer understand risks for recurrence? 
3. What do the terms cancer survivor, or cancer survivorship mean, 
when patients are seeking treatment, are actively receiving 
treatment, are in remission, or are dealing with recurrence?  
4. How do people diagnosed with cancer recurrence after perceiving 
themselves to be cured understand this experience?  
1.3 Contextual Positioning of This Work 
The healthcare system within the United States is funded by four primary 
organizations: Federal government-supported Medicare for people over 65 
years old, Medicaid system for low-income earners without access to 
employer-related insurance, Veterans Administration health care for U.S. 
veterans, and the American Indian Health Care coverage for Americans with 
greater than 1/16th American Indian ancestry. All others must be able to 
purchase private pay insurance through their employer or pay for it 
themselves through independent health insurance plans. This study began as 
the Affordable Care Act was in place, which offered multiple insurance plans 
at a lower cost that included different levels of coverage and deductibles 
depending on amount of coverage desired. This is important to understand, as 
it impacts patients’ ability to seek cancer treatments regardless of their 
disease stage. Drug companies market their drugs directly to the population 
through television and radio advertisements, which further influence patient 
requests for medications and influences health care planning between 
patients and their physicians. Although this access to care will change in the 
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future as the U.S. struggles to continue to provide this level of care to paying 
patients, this was the environment in which this research took place.  
This environment of cancer care is different than experienced in other 
countries. In the United Kingdom as in Australia, universal publicly funded 
health care provides free care to its population and has tight controls on what 
treatments are possible (Jefford et al., 2013). The potential to allow patients to 
receive treatments without evidence to back their use in specific situations is 
seemingly less likely in publicly funded programs.  
1.4 Cancer and Prognosis 
Cancer remains the number one cause of death in the U.S. for people over 
the age of sixty (American Cancer Society, 2016b). The estimated number of 
new cancer cases in the United States in 2016 was 1.685 million for all cancer 
sites, and there were 595,690 estimated deaths from cancer that year (p. 1). 
Although survival rates may be increasing, the American Cancer Society 
(2016b) cautions that they cannot be applied to all people with cancer, as 
‘treatment, other illnesses, and biological or behavioural differences’ (p. 3) will 
impact individual survival. 
Survival is described based on 5-year relative survival rates calculated by the 
percentage of people who are living 5 years after a cancer diagnosis 
(American Cancer Society, 2016b). The number of those survivors who are 
cured, on treatment, or experiencing recurrence is not reflected in that 
number, as that number is evidencing the people living after a cancer 
diagnosis but does not specify where in the trajectory they are. Recurrence or 
cure is relative to disease, stage, and other comorbidities that influence 
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disease progression, and disease can recur well beyond the five-year mark 
after diagnosis (Folkesson et al., 2005). The five-year statistics reported in the 
Cancer Facts and Figures (2016a) are developed using the trends reported in 
the nine oldest reports from the Surveillance, Epidemiology and End Results 
Program (SEER). Therefore these data were based on people diagnosed with 
cancer from 1975 through 2012 and a methodology of projecting for 4 years 
ahead for new cancer cases and deaths. This report provides some insight 
into the complicated analysis done in an attempt to anticipate cancer 
occurrence and deaths and the need for better methods to understand 
survival, recurrence, and death in cancer epidemiology. Probabilities are 
calculated based on the average experiences in the general population and 
are not able to include individual risk factors that impact the development of 
cancer and recurrence. In light of what is known about individual factors that 
increase a person’s risk for developing cancer or influence cancer recurrence, 
this methodology seems unreliable (Goldman, 1984; Kelly et al., 2013). It 
contributes to the overall confusion people with cancer experience related to 
prognosis and risks for recurrence. 
This confusion around what recurrence means and how people with cancer 
experience advanced recurrence was amplified at the onset of my study by 
limited research focusing on this particular population. At the time of this 
writing, more research is beginning to focus on the experience of cancer 
recurrence. A meta-ethnography published subsequent to my literature review 
looked at patients’ experience with cancer recurrence (Wanat, Boulton, & 
Watson, 2016). The 17 articles chosen described the experience from 
primarily breast and ovarian cancer participants living with advanced 
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recurrence. This meta-ethnography helped to highlight the limited amount of 
research around a deeper understanding of this growing population 
experiencing advanced cancer recurrence in light of the changes in the 
evolving treatment context.  
1.5 Cancer Recurrence 
There are growing numbers of people living with cancer as well as people who 
have had cancer, received treatment, and continue to face a risk for 
recurrence. There is less known about cancer recurrence as compared to 
initial diagnosis but there are data reporting that 1 in 6 people with cancer will 
recur with advanced disease (Ng & Travis, 2008, p. 1). However, one cannot 
predict who they will be. There is data that describes potential five-year 
survival based on disease type, stage, treatment choice, age, and 
socioeconomic status (Cossetti, Tyldesley, Speers, Zheng, & Gelmon, 2015; 
Hooning et al., 2006; Soerjomataram, Louwman, Ribot, Roukema, & 
Coebergh, 2008). For instance, in breast cancer survivors with higher-stage 
disease and grade there is an increased hazard rate of relapse (HRR) related 
to higher percentage of HER2 positive and ER-Negative/HER2-negative 
subtypes which are more-aggressive types of breast cancer (Cossetti et al., 
2015). Woman diagnosed at a younger age and premenopausal women have 
worse early rates of recurrence compared to postmenopausal women who are 
older at diagnosis (Cortesi et al., 2012; Kneubil et al., 2013). Late recurrence 
in ER-positive women with breast cancer can occur even after 10 years and 
there is a spike in early recurrence rates within five years post diagnosis and 
treatment in ER-negative breast cancer patients (Cossetti et al., 2015).  
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People with colon-rectal carcinoma experience cancer recurrence dependent 
also on stage and type of treatment they received as their initial treatment 
(Camma et al., 2000; Compton, 2002; Glimelius, Gronberg, Jarhult, Wallgren, 
& Cavallin-Stahl, 2003). A study done to evaluate the overall survival rates 
and local recurrence rates found that radiation prior to surgical resection 
provided an increase in overall survival rate and the local recurrence rate 
benefited from 26% local recurrence without radiation prior to surgery to 9% 
recurrence in those who had been radiated prior to surgery (Folkesson et al., 
2005, p. 5645). Distant metastases for these patients though did not change 
regardless of radiation and 34% did develop distant metastases as far out as 
12 years post-surgery (p. 5646).  
The numbers of cancer survivors are growing and as of January 2017 these 
accounted for 5% of the population in the U.S. (Mayer, Nasso, & Earp, 2017, 
p. E11). This may be related to the growing numbers of people being 
diagnosed with cancer as the population is aging and living longer and 
therefore at higher risk for developing cancer (American Cancer Society, 
2016b; de Moor et al., 2013; Gilbert, Miller, Hollenbeck, Montie, & Wei, 2008; 
Mayer et al., 2017). Sixty-four percent (64%) of all survivors are five or more 
years post diagnosis (de Moor et al., 2013, p. 561). Recent improvements in 
cancer treatment and earlier diagnoses of cancer that improve outcomes of 
treatments all support the growing numbers of cancer survivors, but cancer-
related deaths have continued to account for over a half million deaths each 
year in the United States (American Cancer Society, 2016b; Deimling, 
Bowman, & Wagner, 2007; Lobb et al., 2015). From first diagnosis to death, 
people with cancer are facing recurrence and living and dying from cancer 
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with little research focused on the specific phase of advanced recurrence (de 
Moor et al., 2013; Ferrell, Munevar, & Sun, 2011). In the United States, these 
people who have been diagnosed with cancer across all stages of the disease 
trajectory are all referred to as cancer survivors regardless of their disease 
status (National Academy of Sciences, 2005; National Coalition of Cancer 
Survivors [NCCS], 2018). 
1.6 Complexity of the Term Survivor 
The term ‘cancer survivor’ is used broadly in the literature to advocate for the 
needs of all people from the time of a cancer diagnosis, during treatment, 
across the trajectory of their lives until the time of death (Jefford et al., 2013; 
Khan, Rose, & Evans, 2012; Mayer et al., 2017; Morgan, 2009). The term 
cancer survivor was introduced by Fitzhugh Mullan, a physician who was also 
diagnosed with cancer, and the term cancer survivor was promoted by the 
National Coalition of Cancer Survivors (NCCS) in 1986. The goal of the NCCS 
was to support people who had cancer and believed a more optimistic label 
that evoked a positive outcome, and encompassed a developing concept of 
being a cancer survivor as opposed to early terms like cancer victim or cancer 
patient (Bell & Ristovski-Slijepcevic, 2013; Deimling, Bowman, & Wagner, 
2007; Morgan, 2009). The NCCS (2018), which as an advocacy group was 
recognising the growing numbers of cancer survivors, was seeking federal 
funding increases for survivorship research and care. This interest in research 
funding as well as education of clinicians grew into the survivorship movement 
which followed the growing efforts in the U.S. to cure cancer (Khan, Harrison, 
Rose, Ward, & Evans, 2012). The ‘war on cancer’ was the term used to 
identify the increased national investment in cancer care promoting earlier 
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diagnosis, new treatments, and the search to ‘cure’ cancer (Sporn, 1996). The 
literal meaning of surviving is related to living through a traumatic event and 
coming out the other side, but with an expectation that the threat is past and 
survivorship is permanent (Surbone, Annunziata, Santoro, Tirelli, & Tralongo, 
2013). Julia Rowland (2008), as the director of the Office for Cancer 
Survivorship at the National Cancer Institute in the U.S. stated that being free 
of disease does not mean the individual is free from cancer. People are living 
longer after having cancer and professionals in health care recognise that 
identifying clinical practice concerns and research on this population is 
needed (Bell & Ristovski-Slijepcevic, 2013; Feuerstein, 2007; Mayer et al., 
2017; Surbone & Tralongo, 2016).  
The NCCS defines this experience of being a survivor as on a lifespan 
continuum: 
An individual is considered a cancer survivor from the time of 
diagnosis, through the balance of his or her life. Family members, 
friends, and caregivers (carers) are also impacted by the survivorship 
experience and are therefore included in this definition (Hewitt et al., 
2006, p. 29).  
Therefore, anyone who has been diagnosed with cancer and is living with 
cancer is a survivor. This concept of cancer survivor is related to having 
experienced the trauma of a cancer diagnosis and the physiological and 
psychological aspects these people share, which label them as a cancer 
survivor (Bell & Ristovski-Slijepcevic, 2013; Deimling, Bowman, et al., 2007; 
Mayer et al., 2017). Dr. Mullan (1985) described the concept of cancer 
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survivors as related to the phase of cancer survivorship extending from 
diagnosis, the experience of treatment, then to an extended phase following 
treatment, and finally a permanent phase which was considered as being 
cured. The use of the term survivor is complex and the term itself does not 
provide any insight into who this person who has experienced a cancer 
diagnosis is. The term survivor is not helpful and may be used to describe 
someone who has had an early-stage cancer, was treated and cured but also 
used to describe someone with advanced recurrence who will not have an 
option for cure. Referring to everyone who has ever been diagnosed with 
cancer as a survivor is not useful and prevents research from describing 
clearly who the population is that the research is being applied too. What does 
survivor really mean? 
1.7 Meaning of Survivorship 
The term survivorship is meant to include understanding the clinical needs, 
advocacy, educational needs, and research related to all people living with 
cancer (Bell & Ristovski-Slijepcevic, 2013; Mayer et al., 2017). The term 
survivorship relates to the very broad needs of people with cancer as across 
phases of prevention, screening, rehabilitation, symptom management, 
palliative care, and end-of-life care (Mayer et al., 2017; Morgan, 2009). The 
terms cancer survivor and cancer survivorship are often used interchangeably 
but the concept of cancer survivorship was developed to provide an inclusive 
term that defines the population of survivors with a generic set of needs. 
Literature has however documented that there is great diversity in needs for 
all people living with cancer (Doyle, 2008; Hewitt et al., 2006; Khan, Rose, et 
al., 2012; Morgan, 2009; Mullan, 1985). 
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The problem with these concepts is the belief that this label or set of generic 
needs fits all people who have cancer. Research around the acceptance of 
the term cancer survivor by the people who have experienced cancer has 
shown that this term is not universally accepted (Feuerstein, 2007; Khan, 
Rose, et al., 2012; Mayer et al., 2017; Surbone & Tralongo, 2016). Many 
people who have experienced cancer recognise its impact on their lives but 
would rather not be defined by that experience (Surbone et al., 2013). 
Feuerstein (2007) called for an evidence-based definition but also 
acknowledged that one definition may not be possible. Doyle (2008) described 
cancer survivorship as ‘unique to the individual but has some universality’ (p. 
499). Rather than focusing on identifying one definition Khan, Rose, & Evans 
(2012), highlight the importance of the fight against cancer rather than defining 
the outcome of the fight. Many people who have had cancer do not support 
this term that suggests they will not face cancer again, when they are aware 
that they had advanced disease at diagnosis, and do not believe they are 
cured (Khan, Rose, et al., 2012). Once diagnosed, whether cancer free or not, 
the fight is never ending. This is especially relevant in the current context of 
evolving treatment options. The term can alienate people who do not feel 
included and may be experiencing multiple side effects, continuing disease or 
cancer recurrence, and have difficulty in being called a survivor or feeling 
optimistic (Mayer et al., 2017; Surbone & Tralongo, 2016).  
Understanding the concepts of survivor and survivorship as described by early 
researchers helps provide an understanding of the development of these 
terms and an attempt to define the needs of people who have experienced 
cancer under a single general label (Doyle, 2008; Mullan, 1985). Doyle (2008) 
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described a model of cancer survivorship that includes the attributes and 
consequences of a cancer diagnosis and includes the positive and negative 
aspects. These attributes have consequences related to the four domains of 
quality of life, physical wellbeing, psychological wellbeing, social wellbeing, 
and spiritual wellbeing. The diagnosis of cancer and the uncertainty that 
follows can be a life-changing experience that may have both positive and 
negative effects on the person with cancer. Although Doyle refers to this as 
’an individual experience with universality’ (p. 505) these attributes are broadly 
supported by earlier work of Mullan (1985) and continue to be part of the 
survivorship discussion today (Doyle, 2008, p. 505; Mayer et al., 2017; Mullan, 
1985; Surbone & Tralongo, 2016).  
People with cancer do experience general phases related to where they are in 
the continuum process from diagnosis with cancer through an acute phase 
related to diagnosis and treatment, and an extended phase that follows 
treatment (Mullan, 1985). This post treatment period includes remission and 
relapse or a permanent phase that is termed ‘long-term survivorship’, which 
includes late effects of disease or treatments and a continued risk for second 
cancers or distant metastasis. So there is a sense of the universality of 
phases of the continuum, but the point of the terms being used remains 
confusing and only seems to muddy the water.  
Certain cancer diseases have a greater potential for long-term survival than 
others; for instance the long-term survival rate for thyroid cancer and germinal 
testicular cancer are greater than 90% (Surbone & Tralongo, 2016, p. 3373). 
This is in sharp contrast to other cancer diseases such as pancreatic cancer 
 13 
or lung cancer, which have a much lower chance of long-term survival. It is 
important to note that none of these descriptions of phases of survivorship 
include the final phase of end of life (Doyle, 2008; Miller, Merry, & Miller, 2008; 
Mullan, 1985; Surbone & Tralongo, 2016), which correlates with the literal 
meaning of survivor or survivorship implying that permanent cure is achieved. 
The early years of the evolving survivorship movement created language to 
the point of the choice of those words advocating for a future where a cancer 
diagnosis did not mean death.  
As researchers have begun to conduct qualitative studies to understand how 
the individual experiences cancer, new perspectives on defining this 
experience have been revealed (Khan, Rose, et al., 2012; Surbone et al., 
2013). The many meanings around the concepts of survivor and survivorship 
have been described by multiple researchers (Mayer et al., 2017; Miller et al., 
2008; Mullan, 1985; Surbone et al., 2013). The lack of clarity remains a barrier 
in the clinical and biomedical research of survivors and survivorship today 
(Surbone & Tralongo, 2016). There is a need to categorise the specific context 
of the population of people with cancer being studied to improve the 
understanding of prognostic indicators around recurrence as well as other 
needs of long-term cancer survivors (Bell & Ristovski-Slijepcevic, 2013; 
Surbone & Tralongo, 2016). There is a need for research to explore very 
distinct phases beyond a cancer diagnosis, beyond a generic label, or single 
umbrella that focuses on the universality of this shared experience (Doyle, 
2008, p. 502; Mayer et al., 2017; Surbone & Tralongo, 2016).  
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This early history of the cancer survivorship movement is provided to help 
establish the importance of describing this study’s specific population and the 
perspectives of people with cancer who thought they were cured, but now 
experience recurrence of advanced disease. Although supporting people with 
cancer with optimism and hope is important, there may be better ways to 
provide care and support needed. Understanding how a specific disease, 
individual risk factors, and prognosis with different diseases impacts advanced 
recurrence can provide information for a specific population that is not well 
understood (Mayer et al., 2017; Surbone & Tralongo, 2016).  
1.8 The Research Focus  
The problem for this research is focused on describing a period of time that is 
experienced by people with cancer along the continuum of living with cancer. 
This study aims to capture a specific moment in the disease trajectory of 
people with cancer who experience advanced cancer recurrence after 
perceiving themselves as cancer free at a time when treatment options are 
evolving for people with advanced cancer. It will provide meaning and insight 
into this specific moment of time marked by evolving treatment options, and 
give insights into factors this population is focused on. Therefore, 
understanding the experience from the participants’ voice is important and 
finding a method that allows an interactive process to develop their meaning 
of this experience is needed.  
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1.9 The Aims of This Study 
The aims of this study are twofold: 
1. to describe the experience of people with cancer who have been 
cancer free for an extended period and believe themselves to be 
cured and recur with a diagnosis of advanced cancer, and 
2. to develop a conceptual model that will provide a deeper 
understanding of this specific experience of advanced cancer 
recurrence in people who perceived themselves to be cancer free in 
a context of evolving treatment options, and guide future research. 
1.10 Thesis Outline 
The structure of the thesis is outlined below. 
Chapter 2: Methodology/Methods describe, the methodology of the study and 
the rationale for choosing a qualitative approach for this research. It describes 
the method chosen and also elaborates on the constructivist grounded theory 
approach and clarifies the reasons for a delayed literature review. It provides a 
description of the general process used per constructivist grounded theory to 
develop the subcategories, categories, and conceptualisation of the 
conceptual model 
Chapter 3: Findings describes the findings related to the participant interviews 
and the conceptualisation of the meaning of advanced cancer recurrence in 
people who perceived themselves as cancer free. As this is a constructivist 
grounded theory method, data analysis occurs simultaneously with data 
collection. The newly developed conceptual model is introduced in preparation 
for the next chapter using a diagram that visualises the conceptual process.  
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Chapter 4: Literature Review offers a review and synthesis of the literature in 
relation to the concepts identified within the conceptual framework developing 
from the constructivist grounded theory method. This is a focused review to 
substantiate the developing conceptual model related to this specific 
population of people experiencing advanced cancer recurrence after believing 
themselves to be cured.  
Chapter 5: Discussion/Conclusion describes the conceptual model as 
substantiated by the literature review. Related concepts provide support for 
the conceptual model of Reluctant Acceptance of Living with Advanced 
Cancer Recurrence. A diagram of the conceptual model is provided. Strengths 
and limitations of the study, as well as implications and recommendations for 
future research, are included. A conclusion is presented to provide final 
thoughts related to the study’s contributions to the fields of palliative care and 
cancer survivorship. 
1.11 Summary 
Significant improvements have been achieved in cancer treatments which 
have resulted in the rising number of survivors and prolonged lifespan 
trajectory. These advances have impacted the person living with cancer’s 
perceptions of late-stage cancer and recurrence as well as treatment 
decisions. Greater understanding is needed about this specific point along the 
disease trajectory in order to advance understanding and improve the quality 
of care for patients living with cancer and their families. Additionally, defining 
the population of people who believed themselves to be cancer free and then 
recur with advanced disease will help future researchers accurately describe 
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the population of focus without depending on data referring to a generic set of 
people with very different trajectories for their future.  
This chapter has identified the confusion associated with the meaning and use 
of the terms cancer survivor or survivorship (Bell & Ristovski-Slijepcevic, 
2013; Feuerstein, 2007; Surbone & Tralongo, 2016). In an effort to clarify the 
exact population that this research is focused on, the term cancer survivor is 




Chapter 2: Methodology and Methods 
2.1 Introduction 
This chapter describes the methodology and methods selected to answer the 
research question: What is the experience of people with cancer when they 
are diagnosed with advanced cancer recurrence after a period of time where 
they considered themselves to be cancer free? 
As indicated by Bryman (2008) and Lincoln, Lynham, & Guba (2011) using a 
particular methodology helps to frame the study and supports the research 
data-gathering and -analysis to achieve meaning and significance. A 
qualitative constructivist grounded theory methodology was adopted, and is 
justified and explored within this chapter, including a rationale for delaying the 
substantive literature review until after data collection and analysis. 
Two things were especially important in the planning of this study’s method: 
1. the ability to allow the participants’ voices to be heard in relation to 
this experience of having believed they were disease free and 
subsequently having advanced cancer recurrence; and 
2. the development of a conceptual model that represents the 
participants’ experience with advanced cancer recurrence after 
having believed they were cancer free.   
2.2 Methodological Overview 
Planning and conducting a research study to explore patients’ experiences 
with advanced cancer recurrence after having believed they were cancer free 
requires a thoughtful selection of research method. The various approaches of 
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qualitative or quantitative methods bring about different perspectives and 
produce different knowledge about a topic of study (Seale, 1999; Whittemore, 
Chase, & Mandle, 2001). Establishing the specific approach to be followed 
allows the study to be systematically developed and maintains the 
transparency of the process, all the while supporting trustworthiness and 
credibility, which then ensures truthfulness of the study (Bryman, 2008; Caelli, 
Ray, & Mill, 2003; Whittemore et al., 2001).  
2.3 Paradigms That Guided This Inquiry 
In research, there are key paradigms that guide the method of inquiry and the 
methodology supported by the researcher (Polit & Hungler, 1991; Seale, 
1999). Paradigms are ‘sets of beliefs and practices, shared by communities of 
researchers which regulate inquiry within disciplines’ (Weaver & Olson, 2006, 
p. 459). Paradigms guide a researcher’s approach to science (Denzin & 
Lincoln, 2000) and are sets of ‘philosophical underpinnings from which 
specific research approaches flow’ (Weaver & Olson, 2006, p. 459) (e.g. 
qualitative or quantitative methods).  
Paradigms consist of the following: ontology, epistemology, and methodology 
(Denzin & Lincoln, 2000; Lincoln, Lynham, & Guba, 2011), which are 
explained below, and raise the following set of questions:  
1. Ontology: What is the relationship between the researcher and 
knowledge? And how is that knowledge justified?  
2. Epistemology: What is the nature of knowledge or reality?  
3. Methodology: How should the inquirer go about choosing a 
research design? 
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Table 1 Paradigms of Research, below draws on five paradigms of research 
described in Denzin & Lincoln et al. (2011), and aims to establish the 
relationship between different paradigms of research, and the objectives of 
this proposed research (p. 100). Denzin & Lincoln list a number of general 
descriptors for each paradigm for researchers to use to provide a framework 
for choosing the epistemological stance that best supports the aim of this 
study: positivism, post-positivism, critical theories, constructivism or 
interpretivism and participatory (Gibson, 2017; Lincoln et al., 2011; Tuli, 2010). 
The methodology chosen by a researcher is determined by the researcher’s 
position within these paradigms (Guba & Lincoln, 1994; Lincoln et al., 2011; 
Tuli, 2010).  
Positivism applies natural science to the study of social reality. The positivist 
paradigm offers a ‘scientific explanation’ (Tuli, 2010, p. 99) of behaviour, 
which is the product of empirical information that exists independent of human 
construction. Positivists maintain that knowledge is objective and is best 
described in experimental studies and quantitative methods of observation 
and data collection (Bryman, 2008; Ulin, Robinson, & Tolley, 2005). From the 
ontological perspective, a positivist approaches research to either nullify a 
hypothesis or prove it. There are established facts or laws that are believed to 
be present. From the epistemological perspective, empirical information exists 
independent of human construction. Therefore, the appropriate methodology 
for this paradigm would be experimental and focused on verification of a 
hypothesis. As this current research study is not hypothesis-driven, and 
understands the relationship between the research and knowledge to be a 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































for a positivist paradigm. Post-positivists do not agree that knowledge is 
absolute and only external and data-driven (Gibson, 2017). They begin to 
consider the qualitative aspect of understanding the relationship between the 
researcher and knowledge. What makes them different than the 
interpretivist/constructivist approach is they do not agree with co-construction 
of knowledge with others or the significance of context (Gibson, 2017).  
The critical theories paradigm is focused on oppression or power struggles 
that may shape the reality of a situation from a social, political, cultural, 
economic, ethnic, or gender perspective (Lincoln et al., 2011). As this 
research is not value-based, seeking to understand the overall value or 
meaning is not congruent with the aim of this study. 
A constructivist or interpretivist approach focuses on symbolic interactionism 
and places significance on the context of the participant as well as the 
researcher in understanding the meaning of the researched phenomenon 
(Altheide & Johnson, 2011). It includes co-constructed realities contextually 
and subjectively interpreted to describe the phenomenon. This tenet is 
congruent with the aim of this research. Moreover, it is a methodology that 
allows the flexibility and depth of the participants’ voices to be explored in 
order to understand the meaning of their experience. 
And finally, the participatory paradigm is an approach that understands 
knowledge is the product of an active human mind, engaged with the world. 
This paradigm approaches inquiry with the intent of changing the world. As 
such, the process of gathering information includes a constructivist 
understanding of how knowledge is understood, but the outcome of the 
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participatory paradigm has a social advocacy element to it. It seeks to place a 
meaning of the experience relative to the larger world. This element extends 
beyond the aim of this study, which is focused on understanding the 
experience of a specific phenomenon from the participant’s point of view, and 
not in relationship to the broader experience as it interfaces with society or the 
world (Lincoln et al., 2011).  
Having selected a constructivist focus, choosing a research design that allows 
a co-construction of the experience under study in order to explore this 
phenomenon from the participant’s words was necessary (Charmaz, 2006; 
Mills, Bonner, & Francis, 2006). Co-construction is a process that allows the 
researcher to be involved in the exploration of a phenomenon and 
conceptualise an abstract understanding of the phenomenon from the 
participant’s words (Charmaz, 2014; Holton, 2007). Developing knowledge 
requires an active process of hearing, understanding of information, and co-
constructing the meaning of the phenomenon as exchanged between the 
researcher and the participant’s words (M. M. Braungart & Braungart, 2018; 
Mills et al., 2006). 
2.4 Choosing an Appropriate Research Design 
Based on the above descriptions and my understanding of the constructivist 
impact on knowledge development, a qualitative methodology that provided 
for the participant’s experience to be deeply understood was selected. The 
interactive co-construction of the participants’ understanding is an important 
aspect of this research, and supports the aim to explore and understand this 
defined period during the cancer trajectory by collecting information from the 
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participants through open-ended dialogue. A qualitative approach allows an 
understanding of this complex human experience and provides the ability to 
put that into words (Richards & Morse, 2000; Silverman, 2000).  
2.4.1 Qualitative approaches considered. 
As described in Denzin & Lincoln (2011), the reality of qualitative research 
includes multiple interpretive practices. How the researcher sees the 
development of knowledge and the type of data considered to research the 
phenomenon of interest will decide which qualitative method is most 
appropriate. Different qualitative designs were evaluated for their support of 
this research study (Bryman, 2012; Charmaz, 2014; Creswell, 2014; Mason, 
2002). Table 2 considers thematic approaches, ethnography, phenomenology, 
grounded theory, narrative methods and case study in relation to their 
potential utility to the research question.  
As the focus of this research study is to explore this experience for people 
with cancer recurrence at the specific transition from believing themselves to 
be cancer free to advanced cancer recurrence, the interactive process of co-
construction allowed the participants’ words to provide meaning for their 
experience. All of the qualitative methods described above include the same 
interpretive design focus but vary in terms of how the phenomena are 
described, how the meaning is understood by the researcher, and whether 
there is a theoretical framework identified from the outset of the research. 
Grounded theory, which demonstrates the greatest congruence with the 
research question, allows meaning to develop as theoretical sampling and 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a theoretical framework but seeks to inductively develop one from the data 
(Charmaz, 2014). 
2.5 Grounded Theory 
As noted above, the planning of this study’s method involved two distinct but 
related steps: (a) The ability to allow the participants’ voices to be heard in 
relation to their experience of having believed they were cancer free and 
subsequently having advanced cancer recurrence, and; (b) to be able to 
develop a conceptual model describing the participants’ meaning of this 
experience. So while grounded theory, as Charmaz (2014) has pointed out, 
‘has had a long history of raising and answering analytic “why?” questions in 
addition to “what?” and “how?”’ (p. 228), in this study my intent is to explore 
specifically the ‘what?’ and ‘how?’ questions, rather than moving into an 
exploration of analytic ‘why?’ questions. As such, by asking participants to 
voice what they are experiencing and then proceeding by constructing a 
conceptual model that reflects how the participants’ experiences interrelate 
and are shared, my study constructs a broader conceptual understanding that 
rests on the interrelationship between the categories of the experiences 
voiced by the participants.  
Grounded theory is an approach to qualitative research that provides a 
framework for social research based on symbolic interactionism (Glaser & 
Strauss, 1967). Symbolic interactionism provides a theoretical perspective 
whereby people construct themselves, reality, and society through interactions 
(Altheide & Johnson, 2011). It is an active, dynamic process where people 
develop and modify meaning through constant comparative analysis and 
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theoretical sampling (Charmaz, 2014; McCann & Clark, 2003). By categorizing 
the experiences of the participants and then conceptualizing how these 
categories of experience interrelate, this study follows the inquiry model set up 
by grounded theory. Grounded theory seeks to provide a description of a 
situation that conceptualizes the participants’ perspective through the 
inductive organization of the data provided and co-construction by the 
researcher (Morse, 2001; Timmermans & Tavory, 2012). As noted by 
Charmaz (2012) the grounded theory method, ‘begins but does not end with 
inductive inquiry, it is a comparative, iterative, and interactive method’ (p. 2). 
This method provides a framework that allows both the methodology and 
methods of the research study to work together.  
According to Glaser & Strauss (1967), traditional grounded theory’s goal is to 
understand the meaning behind human behaviour. Where ethnography is the 
observation of interactions, grounded theory methodology provides empirical 
insight as described directly by the participant (Charmaz, 2012; Timmermans 
& Tavory, 2012).  
Grounded theory allows the researcher to consider a relationship between 
various categories to conceptualise the experience and provide a conceptual 
model related to the phenomenon (Burns & Grove, 2001; Charmaz, 2014)   
2.5.1 Different perspectives of grounded theory. 
Grounded theory has broadly developed into three approaches: traditional, 
evolved, and constructivist grounded theory (Mills et al., 2006). Traditional 
grounded theory was developed by Glaser & Strauss (1967). Strauss & Corbin 
(1997) developed the evolved version and, most recently, Charmaz delineated 
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constructivist grounded theory (Charmaz, 2006; Glaser & Strauss, 1967; Mills 
et al., 2006; A. Strauss & Corbin, 1997). Table 3 provides a comparison of the 
three approaches to grounded theory and a description of the epistemology, 
ontology, sampling, and coding processes for each.  
Table 3 
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There are methods used that are essential for a study to be called a grounded 
theory study (Birks & Mills, 2011). Glaser & Strauss maintain that the data 
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inductively guide the research (Glaser, 1978, 1992; Glaser & Strauss, 1967). 
Strauss & Corbin (1997), however, maintain that the researcher applies 
deductive verification to create themes and categories that arise from patterns 
in the data. Using induction, deduction, and verification as part of the research 
process, the researcher continuously refines the categories based on each 
participant’s data (Glaser & Strauss, 1967; Heath & Cowley, 2003; A. Strauss 
& Corbin, 1990).   
A. Strauss & Corbin (1997) propose that Glaser’s process may not allow new 
information to emerge. In contrast, Glaser argues that Strauss’s & Corbin’s 
use of guiding questions may force the data in a specific direction (Glaser, 
2001). Table 3 provides a comparison of these methods with some detail into 
the coding components. An essential piece of this review was to clarify the 
epistemology and ontology of the approaches. This research aims to 
understand in depth the meaning of the experience of advanced cancer 
recurrence from the participant’s words and co-construction with the 
researcher. The interpretive process of conceptualisation used in the 
constructivist grounded theory (CGT) method as co-construction of the 
meaning provides a methodology that allows a verification of concepts through 
theoretical sampling and memoing that goes beyond the classic method of 
Glaser & Strauss (1967) or Strauss & Corbin (1997). Therefore, using classic 
Glasarian grounded theory (Glaser & Strauss, 1967) or Strauss & Corbin’s 
(1997) evolved grounded theory methods were not congruent because they 
did not allow the co-constructive element and flexible format to explore the 
conceptual development of the experience. 
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2.5.2 Constructivist grounded theory. 
Charmaz (2006) further evolved grounded theory to allow more flexibility and 
synergy with other qualitative analysis methods. This Charmazian grounded 
theory approach is less mechanical and allows the researcher to become a 
participant in the construction process to describe a phenomenon (Charmaz, 
2014, p. 13). Taking the epistemological understanding of knowledge within 
grounded theory, Charmaz (2006) delineates both a constructivist grounded 
theory and an objectivist grounded theory. A constructivist grounded theory 
approach ‘looks at the phenomena of study and sees both data and analysis 
as co-created from shared experiences and relationships’ (p. 130). In this, the 
researcher’s perspective is relevant to the final conceptual model (Charmaz, 
2006; Mills et al., 2006). Constructivist grounded theory shares the necessary 
components of any grounded theory research including the following areas: 
theoretical sensitivity, theoretical sampling, constant comparative analysis, 
coding and categorizing the data, literature as a source of data, and memo 
writing, which is described in greater detail in Section 2.9. It also includes the 
co-construction process for the development of a conceptual model (Charmaz, 
2014; McCann & Clark, 2003). 
The objectivist grounded theory as described by Charmaz (2014) is focused 
on the positivist epistemology, which sees data as real but is not focused on 
the process of how those data are known. Therefore the conceptual model is 
discovered from data that are already in the world and the researcher provides 
the discovered model from a neutral perspective without the inclusion of social 
context (Charmaz, 2014).  
 33 
Constructivist grounded theory (CGT) is particularly appropriate to examine 
the experience of advanced cancer recurrence in people with cancer who 
have perceived themselves as cancer free. By placing the researcher into the 
participant’s story, CGT permits the co-creation of a conceptual model within 
the context of the experience, while retaining the participant’s voice. The 
researcher’s ontological view of constructionism and epistemological stance 
on interpretivism logically leads to the constructivist grounded theory 
approach. This approach guides how knowledge in a growing area of 
research, such as the experience of advanced cancer recurrence within the 
changing context of new treatments that include immunotherapy and focused 
treatment options, becomes known. Through the use of in-depth interviews 
within CGT, insight is gained into the human experience being studied, which 
supports the generation of new knowledge (Crouch & McKenzie, 2006). The 
constructivist grounded theory method provides the conceptual model 
necessary to answer the research question. The newly developed conceptual 
model will allow others to understand the patient phenomena (Mills et al., 
2006). These particular features illustrate why this method of qualitative 
research was selected for this research study. 
2.6 Research Methods 
2.6.1 Research question. 
As stated at the beginning of this chapter, the research question for this study 
is as follows: What is the experience of people with cancer when they are 
diagnosed with advanced cancer recurrence after a period of time where they 
considered themselves to be cancer free? 
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2.6.2 Participant selection. 
2.6.2.1 Population. 
The population of interest for this study are those who have experienced an 
advanced cancer recurrence, following a period where they considered 
themselves cancer free. As noted in Chapter 1, advanced cancer recurrence 
for this study refers to an advanced recurrence of the primary disease at stage 
III or IV.  
The population for this study is unique in that, unlike the population of people 
with cancer who do not experience a recurrence but live with a fear of cancer 
recurrence, the participants in this study have experienced advanced cancer 
recurrence after believing they were cancer free (Simonelli, Siegel, & Duffy, 
2017). Secondly, for the participants in this study, the transition to advanced 
cancer recurrence was not contiguous to the original diagnosis. Thirdly, the 
context within which these participants experience cancer recurrence is 
unique in that within this last decade current advances in advanced cancer 
care presents participants with a number of treatment options. As noted by 
Couzin-Frankel (2013), the year 2013 ‘marks a turning point in cancer, as 
long-sought efforts to unleash the immune system against tumours are paying 
off’ (Couzin-Frankel, 2013, p. 1432). In her article, Couzin-Frankel refers to 
the development of this new age of cancer immunotherapy as a ‘sense of 
paradigm shifting’ (p. 1432). 
Filling the gap in knowledge about what the experience of transitioning out of 
a state of believing to be cancer free into advanced cancer recurrence 
consists of providing insight into what motivates these people with advanced 
 35 
cancer recurrence for future research. It is appropriate, therefore, to refine the 
population to those who have experienced a gap between the end of active 
treatment and the diagnosis of their advanced cancer recurrence after at least 
2 years to capture this transition.  
Solid tumours, breast, colorectal, lung, prostate, cervical, and ovary cancers 
are primarily the types of cancer with a typical trajectory which manifests with 
recurrence of advanced disease after a period where the person may have 
perceived themselves to be cancer free (American Cancer Society, 2016b; 
Simard et al., 2013). For that reason, the initial population focus for this study 
was on those with lung, colorectal, breast, or ovarian cancers. This criteria 
was later extended (following Internal Review Board approvals) to include 
head and neck cancers in order to increase recruitment and attempt to have 
different tumour types included.  
2.6.2.2 Inclusion and exclusion criteria. 
The inclusion and exclusion criteria that were operationalized to identify 
people from this population of interest are detailed in Table 4.  
2.6.3 Setting. 
The City of Hope Medical Center is a National Cancer Institute (NCI)-
designated, free-standing cancer hospital in Southern California in the U.S. 
City of Hope is one of eight comprehensive cancer centres in California and, 
as a free-standing cancer hospital, is engaged only in cancer research. Given 





Criteria Included Excluded 
Cancer 
status 
People with solid tumour cancers 
(lung, colorectal, ovarian, breast, 
and head & neck) who have been 
cancer free for 2 or more years and 
recur with stage III or IV cancer 
without potential for cure (verified 
by treating physician and 
documented in the medical record) 
People with haematological 
cancers or tumours other than 
lung, colorectal, ovarian, breast, 





Able to complete a 1-2 hour, in-
depth interview 
People who are not able to 
comply with the requirements of 
the study due to cognitive deficits 
or distress caused by the 
interview process as assessed 
by the treating physician who 
initially introduced the study 
Age Age 18 or older Younger than age 18 
Language English-speaking  Non-English speaking 
 
research, the patient population is comprised of a high number of advanced 
cancer patients, and patients experiencing recurrence. These patients are 
seeking access to what they perceive as state-of-the-science cancer 
treatment.  
This setting provides care to nearly 6,000 new cancer patients per year per 
cancer registry September 2016. As this study was conducted by a single 
researcher employed in this setting, the sample size and access to 
participants was believed to be appropriate and achievable. As a senior 
research specialist in the Department of Nursing Research and Education, my 
role has been to recruit and manage data for two major survivorship grants 
over the last 10 years. I did not work in the clinical setting and therefore did 
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not have relationships with potential participants for this study. Additional 
aspects of reflexivity are discussed in Section 2.11. 
2.6.4 Sampling. 
Sampling began with a purposive approach of choosing participants who met 
the inclusion criteria and therefore had experienced the phenomenon being 
studied (Charmaz, 2014; Patton, 1990). This process is congruent with a CGT 
approach to sampling. In line with CGT, theoretical sampling occurred as 
dictated by the analysis as theoretical concepts developed. As theoretical 
concepts were compared through constant comparison analysis (detailed 
below), new themes were developed and defined until saturation of themes 
occurred (Baker & Edwards, 2012; Bryman, 2012; Charmaz, 2014; Crouch & 
McKenzie, 2006). This process allowed verification of the developing 
concepts. 
The sample size estimated for the Internal Review Board was between 12 to 
20 participants, reflecting that CGT is not focused on a generalisable sample 
size but seeks to provide in-depth data to describe the studied phenomenon 
and achieve saturation of themes (Charmaz, 2006; Glaser & Strauss, 1967; 
Hallberg, 2006). A sample size of 15 participants was achieved and is 
described in Chapter 3. 
2.6.5 Theoretical sampling. 
Theoretical sampling is a method of data collection used in grounded theory 
that describes the process of sampling based on theoretical development 
(Draucker, Martsolf, Ross, & Rusk, 2007). Charmaz (2014, p. 212) describes 
theoretical sampling as a process that ‘advanced your analysis’ (p. 212) and 
 38 
allows the researcher to follow an ‘emergent’ (p. 212) process to evaluate 
categories and clarify relationships. It permits the checking and refining of 
categories in order to evaluate the emerging concepts of the developing 
conceptual model and interrelationships of the categories that lead to the 
substantiation of the developing conceptual model (Breckenridge & Jones, 
2009; Charmaz, 2014; Coyne, 1997; Hallberg, 2006). This type of sampling is 
not intended to provide a representative sample of the population, but rather 
to develop a conceptual model that is grounded in the information provided by 
the participants who have been living for an extended period of time cancer 
free and recur with advanced cancer.  
Integrating memos throughout the process permitted theoretical concepts to 
be built which were refined using theoretical sampling to assess specific new 
categories and themes and identify gaps in the categories (Charmaz, 2006). 
Theoretical sampling substantiated the developing conceptual model and 
ended with the saturation of concepts identified by the participants and 
affirmed in the interview process.  
2.6.6 Recruitment. 
Medical oncologists and their advanced practice nurses were approached 
through the disease teams in breast, lung, colorectal, gynaecological, and 
head and neck cancer during their weekly disease team meetings and by 
email to introduce the study and request their assistance in identifying 
appropriate patients. These disease teams see high numbers of recurrent 
cancer patients and were believed to have the potential to provide participants 
that would meet the inclusion criteria.  
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The medical oncologists and nurse, treating physician, or nurse practitioner 
identified potential participants based on the inclusion and exclusion criteria 
and provided the patient’s medical record number to the researcher. The 
patient’s medical record was reviewed for verification of ‘time since treatment’, 
and whether there had been an actual remission or ‘perceived cured’ 
statement documented in the records. This recruitment procedure was 
approved by the Institutional Review Board at the research setting. 
The potential participants were introduced to the researcher during their clinic 
visit or their treating physician asked if the researcher could contact them by 
phone to introduce the study. For those interested in participating, the 
researcher met and discussed the study and took written consent. A copy of 
the consent form (Appendix A), the patient bill of rights included in the consent 
form were provided to the participant. The research protocol (Appendix B) 
described the purpose of this research—to understand the experience of 
advanced recurrence—the method of in-depth interviews to be used to collect 
the data, and the fact that this was a PhD student conducting the research. As 
a PhD student the recruitment and consent was obtained directly by me. I 
clearly explained to the participants their right to refuse to participate at any 
time without concern for prejudice or impact on their treatment or relationship 
with their health care team. 
2.6.7 Ethics approval. 
The research protocol related to this study was approved through the City of 
Hope Institutional Review Board and through the Faculty of Health and 
Medicine Research Ethics Committee (FHMREC) at Lancaster University. The 
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appendices to this dissertation include copies of the submitted U.S. protocol 
(Appendix B), and FHMREC protocol (Appendix C), letters of approval 
(Appendix D, E, F), renewal (Appendix G), and closure (Appendix H). 
2.7 Data Collection 
2.7.1 Interviews. 
After consenting to participate in this study, semi-structured, face-to-face 
interviews were scheduled at a mutually convenient time at the City of Hope 
Medical Center. In constructivist grounded theory, intensive interviewing 
facilitates the gathering of in-depth information to explore the desired 
phenomenon in an unrestricted manner (Charmaz, 2014). Most participants 
chose to arrange the interview for their next clinic appointment, which was 
usually within one week of signing the consent. If participants asked to be 
interviewed on the day of consent, an office designated for participant 
interviews was reserved and the interview was completed.  
The interviews were digitally audio-recorded. The interviews consisted of initial 
open-ended questions. An interview guide was followed to help consistently 
focus on areas of interest related to this study’s research question. (Appendix 
I) As theoretical sampling occurred, the questions were altered to provide 
insight into newly developing concepts relating to the emerging conceptual 
model. The questions were developed consistent with grounded theory to elicit 
the participants’ experiences. Therefore, according to a grounded theory 
approach, interview questions changed as codes were categorised within 
each interview.  
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In constructivist grounded theory, the role of the researcher is to discover the 
concepts as related in the interview. The interview data and the analysis are a 
process of interpretation, and a contextual understanding is essential to 
identify the meaning of the experience for the patient at the time of the 
interview (Birks & Mills, 2011; Charmaz, 2006). Through careful listening 
during the interviews and the use of probes to elicit more information, the 
developing concepts were further understood. A copy of the interview guide 
can be found in Appendix I.  
2.7.2 Data management. 
Interviews were digitally recorded and transcribed using a professional 
transcription service where anonymity was maintained. Participants were 
numbered prior to the interview and recordings were transferred through 
secure password-required methods. The interviews were than reviewed and 
the audio and written transcripts were compared for accuracy. Any identifying 
information in the written transcript was anonymised immediately. This 
process is described in the protocol and FHMREC application (Appendix B & 
C). 
2.7.3 Data analysis. 
Transcripts were read numerous times so I could become familiar with the 
words and narratives. The recordings were also reviewed to hear the 
participants’ voices and emotions. Grounded theory requires that data 
collection and analysis be conducted simultaneously (A. Strauss & Corbin, 
1997). Constant comparative analysis is essential within grounded theory to 
process the data and immediately start inductively synthesising to understand 
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and begin development of subcategories and categories for theoretical 
sampling and building a conceptual model (Birks & Mills, 2011; Charmaz, 
2014; Holton, 2007).  
Constant comparative analysis provides a method of comparing data between 
participants, and codes with codes, subcategories to subcategories, to 
ultimately compare categories with categories, in a continuous process 
beginning with participant 1 to participant 2, then participant 1, 2, and 3, and 
so on, adding with each new data set. This process allows the development of 
abstract concepts as I move through the data to inductively evaluate individual 
data and compare iteratively as the categories continue to build until 
saturation of themes is achieved (Charmaz, 2014). From the interview 
transcripts, initial codes, and theoretical memos focused codes were 
developed into detailed subcategories, and categories led to the concepts. 
The concurrent data collection and analysis within a constant comparative 
approach involved moving from participant codes to detailed subcategories 
and categories; using theoretical sampling and refining of the interview 
questions to investigate and support the categories and development of the 
final concepts. Theoretical memos helped to focus theoretical sampling and 
guided the development of the emerging conceptual model (see Box 1, with 
detailed examples of the category to concept development described in 
Chapter 3, Tables 6, 7, and 8). 
  
 43 
Participant 2: ‘You are a little tireder, you are six years older too. It took a 
little longer to get back to fighting mode as far as we’re going to still beat 
this thing’. 
Theoretical Memo: Does older age impact response to advance 
cancer recurrence and accepting of the incurable status? 
Box 1. Using theoretical memos in practice.  
2.8 Coding and Sampling Lead to Conceptualisation  
Using constant comparative analysis, interview transcripts were evaluated and 
initially coded using a line-by-line process. The interviews were iteratively 
compared as the initial codes were coded into focused codes using action 
words that would illustrate their meanings as developed through co-
construction between the researcher and the participant. A sample of coded 
transcript can be found in Appendix J. Gerunds are recommended for coding 
in grounded theory as they provide an action-focused understanding of the 
meanings, which help the researcher co-construct the conceptual model and 
maintain the meaning from the participant (Charmaz, 2014). As pointed out by 
Charmaz (2012), ‘Gerunds build action right into codes, Hence, coding in 
gerunds allows us to see processes that otherwise might remain invisible’ (p. 
5). Codes were discussed with supervisors to verify agreement with coding 
decisions. These processes required extensive time to conceptualize 
categories and begin to apply focused coding and develop theoretical 
categories and define possible relationships between categories. 
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As depicted in Figure 1, initial codes were grouped related to similar meanings 
and focused codes emerged. These focused codes were developed into 
subcategories that were than reflected as categories that were co-constructed 
and conceptualized into the final meanings. In order to verify that these 
categories accurately reflected the participants meaning I used theoretical 
sampling and analysis. This constructivist grounded theory approach of 
theoretical sampling and analysis led to emerging themes to inform 
interpretation by comparing patterns between participants and identifying 
connections. Focused codes were combined and used to develop 
subcategories which reflected patterns and identifying connections between 
participants. These patterns that developed through the subcategories to 
categories became the final concepts that were then used to explain the 
experience of people with cancer who had perceived themselves to be cancer 
free for two or more years who then recur with advanced cancer. As Charmaz 
(2014) proclaims, the strength of this process lies in the ‘focus and flexibility’ 
(p. 320) followed to engage this method of constructivist grounded theory 
development. These categories described the overall meaning of the actions 
of the participants related to the researched phenomenon. 
Box 2 below shows coding in practice as it developed from participant words 
to Memo to code to category. 
2.9 Memo-Writing  
An important part of the grounded theory process is theoretically guided 
memo-writing. Memo-writing is concerned with making comparisons and 




Figure 1. Coding process, constructivist grounded theory.  
Participant 2: 'You are a little tireder, you are six years older too. It took a 
little longer to get back to fighting mode as far as we’re going to still beat 
this thing.’  
Theoretical Memo: Does older age impact response to advance 
cancer recurrence and accepting of the incurable status? 
1. Initial code: feeling tireder, age related to disease. 
2. Focused code: age impact on cancer 
3. Subcategory: Age-developmental and temporal 
4. Category: Behaviour and Attitude Toward Recurrence 
5. Concept: Reluctant Acceptance 
Box 2. Coding in practice.  
Apply Initial Codes as each interview is completed 
Constant Comparative Analysis after each transcript is 
initially coded 
Group similar codes together, then using theoretical 
sampling verify and apply Focused Codes 
Group into Subcategories 
Co-Constructed Analysis 
Develop Categories around meaning 
Conceptualize Final 
meaning 
Describe final conceptual 
framework 
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theoretical focus, and refine categories for co-construction of the final 
concepts (Charmaz, 2006). This began the process of identifying the concepts 
emerging within the data. Advanced memo-writing builds upon the initial 
memos to describe how the category emerges and to make comparisons 
(Birks & Mills, 2011; Charmaz, 2006). Advanced memos reflect on the 
analysis of the data and help maintain the rigour of the study. Memo-writing 
provided an area where coding rationale was documented. By keeping 
memos, I was able to write thoughts or potential codes after each participant 
interview. This process aided the constant comparative reviews. Additionally, 
it allowed for potential categories to be written down and considered between 
each interview. Memos relating to the initial code about ageing, for instance, 
allowed the code to be considered, and subsequent theoretical interviews 
examined participants’ meanings about age and how it related to recurrence. 
Comments were used within the initial analysis section as an opportunity to 
capture thoughts about the specific interview and consider the nuances of 
what was said. In grounded theory, comments may be descriptive, and include 
personal observations and reactions during the interview. In this research, the 
comments were tied to specific sections of patient interviews while memos 
were related to the overall project. Memos and comments were integrated into 
the analysis process using Atlas-Ti (described in the following section) and 
handwritten comments on transcripts were therefore part of the project 
documentation. 
2.10 Atlas-Ti Qualitative Analysis Tool 
Atlas-Ti qualitative data analysis tool was used to support coding and the 
development of concepts (Friese, 2014). Atlas-Ti training tools and resources 
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are listed in Appendix K. This software allows memos to be used while coding 
as well as provides a space for specific memos related to concept 
development and the researcher’s field notes to be documented and filed 
within the program for convenience and accuracy (Friese, 2014). 
2.11 Reflexivity  
Reflexivity pertains to the awareness of the researcher’s own knowledge of 
the area being researched, and how biases, values, and presence impact the 
researcher’s findings (Bryman, 2012). Providing a reflexive piece to one’s 
analysis as part of memo-writing is necessary to prevent insertion of the 
researcher’s personal beliefs into the patient’s story (Birks & Mills, 2011). As a 
Senior Research Specialist in this setting I participate primarily in nursing 
education-focused grants. I do not provide direct patient care or work directly 
with any of the medical staff other than to introduce research protocols and 
recently to recruit for this study.  
In constructivist grounded theory, it is necessary to focus on reflexivity to 
actively document the researcher’s input into the meaningful links between the 
patient’s story and the researcher’s analysis. Providing a transparent process 
from the time of patient interview through coding, theming, and the 
development of a conceptual model is an essential part of cocreation in 
constructivist grounded theory research (McGhee, Marland, & Atkinson, 
2007). Glaser (2001) cautions that reflexivity, as a part of analysis, can lead to 
‘reflexivity paralysis’ (p. 47) if the researchers’ attempts to identify their 
theoretical concepts are done in such a way that they lose sight of their 
analysis. 
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Reflexivity in constructivist grounded theory is meant to provide an opportunity 
to expand the memo-writing to document the reasoning for coding in a 
particular way and help to provide a distinction between patient description 
and the researcher’s own personal thoughts (Glaser, 1978). As noted above, 
comments and theoretical memo-writing were used to document the 
researchers thoughts related to codes or patient remarks (see Box 1). 
Within constructivist grounded theory, the researcher is more than an 
observer of the data but actually meant to co-construct the meaning from the 
participants’ words (Charmaz, 2014). Therefore, maintaining constant 
awareness of what the participants say and what the researcher hears 
requires diligent thinking about the co-constructed meaning and assuring that 
the final concepts are in fact from the participants’ meanings and not the 
researcher’s alone. As I have experience with this population in general, as 
people who have cancer, careful attention was paid to theoretical memos and 
researcher comments as the conceptual model of advanced cancer 
recurrence was developed.   
2.12 Ethical Concerns in Qualitative Research 
Providing safeguards when planning a research study is important regardless 
of the methodology being used. In relation to qualitative research, protecting 
participants is essential, especially when dealing with people with advanced 
cancer experiencing incurable disease, as in this research REF). Issues 
related to recruiting within this population and the effects this type of 
questioning may have on participants must be considered (Clarke, 2006; Orb, 
Eisenhauer, & Wynaden, 2001).  
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Principles essential to the ethical conduct of a study include autonomy, 
beneficence, nonmaleficence, and justice. Autonomy is related to treating 
participants with respect protecting their right to act independently and with full 
consent. In research, this included supporting a recruitment process that was 
free from coercion. Because the setting was a research-focused cancer 
centre, there was concern that participants might feel obligated to participate 
in research studies. Participants were assured through the consenting process 
of their right to refuse to participate at any time without concern for prejudice 
or impact on their treatment or relationship with their health care team. I was 
the only person available to obtain consent in this study.  
The principle of beneficence and nonmaleficence, preventing harm and doing 
well for others, requires the researcher to be very clear about how the 
research was conducted. During the research process, privacy and 
confidentiality was maintained. Preventing harm to the participants because of 
the very sensitive focus of the interviews was important. During the interviews 
I was careful to observe the participant for stress or anxiety. The consent 
included a statement providing access to a social worker should they feel they 
needed to discuss issues raised during the interview. There was an ethical 
obligation to maintain anonymity. Participants were assigned numbers and 
interviews were immediately de-identified to maintain anonymity.  
Finally, the principle of justice requires that participants be treated equally and 
fairly. As a grounded theory study, the participant’s words are the focus of the 
coding process and co-construction of the conceptual model using the words 
to describe concepts was done carefully and thoughtfully. 
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2.13 Summary of Methods and Methodology  
This chapter has defined how constructivist grounded theory informed the 
methodology chosen for this study. The qualitative research designs were 
described and the rationale for this methodological choice was made related 
to the aims of this research. As described earlier, because this is a 
constructivist grounded theory study, the literature review is provided in 
Chapter 4 to further substantiate the constructivist grounded theory analysis 
and conceptual model. Chapter 3 (Findings) describes the codes and 
categories that were conceptualised from the participant data and uses these 
to develop a conceptual model.   
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Chapter 3: Core Findings 
3.1 Introduction 
The constructivist grounded theory approach described in Chapter 2 details 
the analytic approach including the development of the coding plan, 
subcategories, categories, and concepts. The concepts, their intersections, 
and the cross-cutting subcategories allow the diagramming of the 
development of the subcategories and categories into the model to be 
described, as appropriate to constructivist grounded theory (Charmaz, 2014).   
This chapter first presents participant demographics, describes the coding 
process leading to concept development, and introduces the developed 
concepts. Second, the findings are presented along with descriptions of the 
co-constructed meaning of the participants’ own words and my interpretation 
of those words. Finally, the patterns and intersections between the categories, 
subcategories, and the developed concepts are identified and discussed.  
3.2 Participant Demographics 
Fifteen participants (13 women and two men) participated in the study. The 
participants ranged in age from 44 to 77 years old. Initial diagnoses included 
breast cancer (n = 12), lung cancer (n = 1), ovarian cancer (n = 1), and 
ovarian and breast cancer (n = 1). At the time of the study, eight participants 
were receiving standard chemotherapy treatment, two were receiving 
biological treatment, and five were receiving bisphosphonates as supportive 
treatment. The time between their initial diagnoses with cancer to advanced 
cancer recurrence ranged from two years to 20 years. All 15 participants had 
lived two years or more cancer free prior to their diagnosis of advanced 
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cancer recurrence; 3 lived two years cancer free, 12 lived four or more years 
cancer free, and seven of the 12 lived a period of 10 years or more cancer 
free. Table 5 provides an overview of the demographic details of all 
participants. 
Table 5 






Mean age yrs. 
(Female 67.5 / Male 75) 
40 – 50 years 1 
51 – 60 years 0 
61 – 70 years 11 
71 – 80 years 3 
Cancer diagnosis  
Breast cancer 12 
Ovarian cancer 1 
Lung cancer 1 
Breast and ovarian cancer 1 
Time since diagnosis to 
identification of advanced 
disease 
Mean time to recurrence in years 
(Female 9.5 years / Male 3 years) 
2 years 3 
3 years  
4 years 1 
5 years  
6 years 2 
7 years 1 
8 years  
9 years  
10 years 3 
11 years 1 
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Characteristic n 
12 years 2 
13 years  
14 years 1 
> 15 years 1 (diagnosed twice with advanced 
disease); 20 years since second diagnosis 
of advanced cancer 





3.2.1 Participant confidentiality. 
To protect participants’ confidentiality, participants are referred to as “P” and 
identified by their participant number. For participant quotations, in-text citation 
includes participant number and transcript line number.   
3.3 Coding Process Leading to Concept Development 
The initial coding provided 235 codes that were described in action terms, 
consistent with grounded theory methodology (Charmaz, 2014). Examples of 
gerund type action codes developed using the constructivist grounded theory 
method include acknowledging, being, believing, coping, describing, fearing, 
feeling, fighting, focusing, ignoring, living, maintaining, pursuing, recognising, 
refusing, uncertainty, and working (Charmaz, 2014; Glaser & Strauss, 1967). 
Initial codes evidenced below in Box 3 therefore include direct quotes from the 
participants. For instance, as illustrated below in Box 4, pursuing 
‘chemotherapy treatments again’, recognizing ‘cancer is no longer curable’, 
acknowledging ‘never once did I think this wasn’t going to work out’. 
Subcategories included the sense of ‘again’, which was categorised for 
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Behaviour and Attitude Toward Recurrence, as in cancer occurring again. 
Positive-accepting described codes applied to the category of Coping–














Box 3. Exemplar initial codes 
Pursuing “chemotherapy treatments again” 
Recognizing “cancer is no longer curable”,  
Acknowledging – positive outlook “never once did I think this wasn’t going to 
work out” 
Hoping “I feel fortunate, I’m hoping to have a few more years” 
Box 4. Exemplar initial coding with associated quotes  
Appendix L presents the complete list of initial and focused codes to 
subcategories and categories and finally developed concepts. The following 
19 subcategories were developed: minimising gravity of disease, focusing on 
treatment, established treatment plan, positive attitude, seeking knowledge, 
age-temporal and developmental, meaning of illness, anger and sadness, 
family support, spiritual faith, pursuing healthy living (self-advocacy), ‘not 
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curable but treatable’, faith in physician, humour and laughter to minimise 
disease, future orientation, focusing on others, uncertain future, realisation 
incurable cancer, and hope. These subcategories represented the building 
blocks that led to the following categories: Behaviour and Attitude Toward 
Recurrence, Treatment Focused, and Coping–Working and Existential.  
3.4 Introduction to Developed Concepts 
Following the analytic process explained in Chapter 2, the three categories 
(Behaviour and Attitude Toward Recurrence, Treatment Focused, and 
Coping–Working and Existential) were co-constructed and conceptualised into 
three concepts: Reluctant Acceptance, Seeking Life Through Continuous 
Treatment, and Hope in the Face of an Uncertain Future. These three 
concepts comprise the conceptual model of this constructivist grounded theory 
study. While ‘why’ questions lead to explanatory findings, this study is focused 
on describing the ‘what’ and ‘how,’ as in, ‘what’ the experience of advanced 
recurrence consists of for people diagnosed with advanced recurrence after 
believing themselves to be cancer free, and ‘how’ this experience motivates 
them through this experience (Charmaz, 2014, p. 228). This research is not 
introducing a theoretical analysis of the relationships described in this 
experience.  
Results from this study’s ‘what’ and ‘how’ questions led to the subcategories 
that, through co-construction, led to the categories. The description of what 
that experience was for them formed the basis for these subcategories. Using 
the inductive process of reasoning, I combined these subcategories into 
distinct categories. These distinct categories and the relationships between 
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these categories’ subcategories led to the development of the three concepts 
mentioned above. These three concepts—Reluctant Acceptance, Seeking Life 
Through Continuous Treatment, and Hope in the Face of an Uncertain Future 
—represent ‘how’ the participants see their experience. The resulting 
conceptual model consists of these three concepts and their interrelated and 
co-constructed categories and subcategories. 
Following Charmaz (2014), I used diagramming as a way to represent this 
study’s categories, subcategories, and concepts and their relationships (p. 
218). Diagrams provide a concrete visual of the dynamic relationships 
between a study’s categories, subcategories, and resulting concepts, thereby 
providing a conceptual map guiding the analysis for this study’s findings 
(Burns & Grove, 2001; Charmaz, 2014). As detailed below, the Venn diagram 
(Figure 2) provides a diagram and conceptual map for this study.  
In the next sections, each concept is presented, along with its categories and 
related subcategories.  
3.4.1 The concept of Reluctant Acceptance. 
The concept of Reluctant Acceptance was conceptualised from the category 
of Behaviour and Attitude Toward Recurrence and is distinctly underpinned by 
the subcategories of age-temporal and developmental; anger and sadness; 
uncertain future; and realisation incurable cancer. Each of these is discussed 
in the following sections. Figure 3 highlights this portion of the overall Venn 
diagram. A table at the end of this section summarises, with examples, how 
empirical data were used to construct this concept. 


























































































































































































































































































































































































































































































































































































































































































































































3.4.1.1 Age-temporal and developmental. 
The passing of time since their initial cancer diagnosis meant that participants 
often acknowledged that they were at a different life stage. The recurrence 
was experienced in the context of their current life stage, encompassing the 
time that had passed since their initial cancer diagnosis. Inevitably, they 
understood that they were closer to death. Age impacts the concept of 
Reluctant Acceptance in two ways: the developmental changes associated 
with growing older, and as the temporal concept of passing of time. Although 
mortality, as related to being older and the advanced disease stage, was 
apparent, there was not a focus on personal mortality. Instead the focus was 
on implications in terms of age and mortality in general, with an acceptance of 
the possibility of death. Participant 1 represented this idea, stating: 
Um, I don’t know, maybe as you get older you accept mortality, start 
looking into your mortality more, as you get older. (P1:61) 
. . . and it’s like waking up and its cancer. I really have cancer and it 
could take my life, you know, this time, you know, I’m older and it’s 
harder to fight it each time. It’s hard like . . . it’s just become more 
serious to me now as I’m older. I think that’s what it is. (P1:483–485)  
Even though death was understood in relation to age and cancer, it wasn’t 
until diagnosed with advanced cancer recurrence that death was implicitly 
recognised as a possible result of cancer. There was a temporal component 
as well as an underlying acceptance of morbidity with aging:  
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. . . having the chemo and saying, ‘You have no cancer in your body. 
And you are good to go’. And then to have that change, it was—I wish I 
was better at explaining that because it was definitely an entirely—and 
you are a little tireder from—and you are six years older, too. [Laughs] 
You are a little tireder. It took a little longer to get back to fighting mode 
as far as, ‘we're going to still beat this thing’. (P2:110–111) 
Accepting the diagnosis was important for these participants, as their attitude 
and behaviours described how their age and life experiences framed the 
meaning of this recurrence. Recognition of the time spent cancer free and the 
development of an advanced recurrence signalled a new phase in the 
trajectory between diagnosis, believing cured, and recurrence at an older age. 
The statement below expresses how age impacts the diagnosis of an 
incurable advanced cancer recurrence relates to the initial diagnosis. 
I lived 10 years cancer-free, enjoyed watching my grandson grow up. 
He’s gone off to college now, and if I was to go now, at least I’ve had a 
good life, you know, and done just about everything I want to do, but 
we’re all gonna die eventually, I mean really. We’re all terminal, you 
know? (P12:30–31)  
For the purpose of this study, aging is understood in relation to recurrence. So 
even though the reality of the relationship between aging and the incidence of 
cancer is understood by these participants, reflecting on their age and their 
recurrence revealed a greater sense of reluctant acceptance: 
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The only negative factor I think I have at the moment is the fact that I’m 
10 years older. So I realize that, but the fact that I’ve been through 
chemo before I kind of know what to anticipate. (P9:66) 
Participants described how accepting death is a part of aging and yet they are 
reluctant to give up on life and they seek treatment to continue living. The 
contribution of age to the appreciation of the reality of their situation (with 
increased risk of cancer in older people and the length of time they already 
had to experience life) led to expressed feelings that younger participants 
might be more distressed to be diagnosed with recurrent cancer than people 
who had lived a full life before cancer was diagnosed, as described by this 
participant: 
You’re younger so you think you haven’t had the time to do what, what 
you want to do when you’re older then you feel okay; it’s also an age-
related disease. (P14:224) 
The impact of age on the diagnosis of recurrent cancer provided a background 
for the sadness or anger described by the participants about how they had 
been here before and were now uncertain about their future. 
3.4.1.2 Anger and sadness. 
Anger and sadness, a subcategory of the category of Attitude and Behaviour 
Toward Recurrence, was initially expressed as anger, with a focus on the 
cancer recurring despite their efforts to live a healthy lifestyle; participants 
expressed feeling defeated by the recurrence of cancer:  
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That’s the anger for me for reoccurrence is that I did everything right. 
[Laughs] I can’t sit on that and feel sorry for myself and let that be the 
life I lead. I have to stand up. (P2:66–79)  
Anger also arose from the recognition that cancer is unpredictable:  
Cancer’s wicked. It goes where it wants. (P12:256) 
Yet even with this recognition, there was a movement beyond the emotion of 
anger, to shift focus on what could be done to continue living with this 
recurrence. They then moved beyond the anger to action, and focused on 
treatment options. Participants described the experience of recurrence from 
initial anger and sadness to focusing on a plan of care: 
I had my 2 or 3 days of like, you know sadness and like, you know, not 
feeling good about it, but that was it really. To be honest with you, that 
was it. Then it was like, ‘Ok, now what are we going to do?’ (P10:49)  
Accepting the uncertainty of a future with advanced cancer that is no longer 
curable was a choice made to minimise anger, depression, or negative 
emotions that could immobilise them if they allowed it to, and prohibit moving 
forward. Therefore, although this was still a very difficult time, participants 
were determined to manage their emotions rather than dwell in a negative 
emotional state, and responded to the recurrence by actively seeking 
information, considering options, and planning for life changes to 
accommodate treatment.  
That way you’re gonna be sad or you’re gonna be depressed or you’re 
gonna be whatever, you know, it is. And who would choose to be like 
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that? You know, unless it was a real mental illness or something, you 
can’t . . . you don’t have a choice, but I think you just have to, you 
know, you just have to get past it and think, ‘I have a choice. I can 
wallow in this or I cannot’. (P10:60)  
Accepting anger and sadness in response to advanced cancer recurrence 
was an active choice that allowed participants to move forward and accept 
their uncertain future. 
3.4.1.3 Uncertain future. 
The subcategory of uncertain future that surrounded this period of recurrence 
with advanced cancer was clear to the participants that it was different from 
the first diagnosis, where treatment was done with curable intent. Noted along 
with this sense of uncertainty was an attempt to face it with a positive attitude 
and hope for continued life: 
Well, I kind of think what’s going to happen down the road, you know? 
How much time do I have? I mean, they don’t tell you. They just say, 
‘Well, some people can go another 10 to 15 years’, you know? . . . So I 
kind of grabbed on to that thinking, well that’s good [laughs]. (P12:132–
134) 
Approaching the advanced recurrence by embracing the uncertain future with 
a positive attitude and a focus on good things is described by these three 
participants. 
Just the news, the tragedies that happen occur, and just when you 
think they can’t top themselves 9/11 comes along. It’s like, 
 64 
unbelievable. The things that I have I feel fortunate. I’m hoping to have 
a few more years, I don’t know, and make the best of them. (P5:50–51) 
Well I just think that I don’t think I’m gonna, you know, I don’t know 
what my years are . . . that I have left. But you know, I mean, I kind of 
have to face reality about it too. (P12:360–362) 
Like, maybe I won’t get more than five years or 10 years or whatever, 
but I’ve just got to deal with it day by day. I don’t think you can really 
look into the future and get all crazy about it. I think that obstructs the 
purpose of trying to stay healthy. (P12:364) 
Participants describe the importance of staying positive to support their coping 
with this new advanced cancer recurrence. Allowing the uncertainty to remain 
there as well as a loose look at reality maintains their hope and support of 
living with this cancer recurrence. ‘Maybe I won’t get more than 5 or 10 years’ 
acknowledges the unknown reality of prognosis in people with advanced-
stage cancers but also, I believe, displays an ignorance regarding what is 
known about advanced-stage cancers. Living five to 10 more years would be 
too many people unthinkable with advanced-stage cancer, at least in the past. 
This new environment where treatment is an option may be changing those 
perceptions. 
3.4.1.4 Realisation of incurable cancer. 
The need to move forward was significant in making decisions to seek 
treatment. Despite a history of two cancers, treatment, and an 11-year period 
cancer free, one participant expressed anger but was focused on ‘living with 
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it’: ‘It’s like, you know, what have I done that I’m going through this a third 
time? And this time it won’t be cured. I just have to live with it’ (P13:90).   
The realisation of incurable cancer was not always seen as absolute. Some 
were cautiously hopeful that there would be more time:  
I don’t think I am ever going to be cured of this, but I think that if it 
[treatment] buys me more time, I’m willing to, you know, try and make 
the best of it because I have 12 grandkids. I don’t want to, you 
know . . . (P12:142) 
Participants were open about the effect of the devastating news of recurrence 
and their anger and sadness, but they believed that when dwelling in this 
emotion they were not in control of their actions. Instead, they actively moved 
forward with hope for treatment and a positive attitude. The choice between 
anger and sadness or accepting the diagnosis of advanced cancer recurrence 
was made to allow them to regain control and pursue treatment. They pursued 
this plan believing they could have a similar outcome as they previously had 
and achieve a successful remission again: 
 I would say that the best thing is just to keep positive, you know, 
because it, it’s hard to go through it the second time because you 
already know how bad it was the first time. . . . It just kind of a bad 
battle, but you have to go through it again. But you gotta stay positive 
because it’s so hard if you’re not. You get up and you’re depressed and 
you’re anxious and you just have to talk and work through it and if they 
can do it, it’s worth it to try and beat it you know? Get more years on 
your life. (P12:261–264) 
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Table 6 describes the development of the concept of Reluctant Acceptance 
from the participants’ words to the final concept. 
3.4.1.5 Summary of the concept of Reluctant Acceptance. 
I lived it and I enjoyed it and I shared it [life after cancer] and when it 
got bad again I just said, “I’ll deal with it”. (P3:114) 
Together, the category of Behaviour and Attitude Toward Recurrence and its 
subcategories (age-temporal and developmental, anger and sadness, 
uncertain future, and realisation of incurable cancer) were developed into the 
concept of Reluctant Acceptance. These subcategories represented the initial 
response to the diagnosis of advanced recurrence and help to describe the 
feelings that motivated participants to make decisions about their next steps. 
The acceptance of this diagnosis was necessary for participants experiencing 
advanced recurrence to move forward with what to do next. Having 
experienced cancer before, the participants moved immediately into coping 
strategies to reduce their distress and find a personal equilibrium between 
advanced cancer and continuing to live with incurable cancer. This state of 
Reluctant Acceptance motivated the participants to cope with this new stage 
of dealing with cancer and coming to terms with no longer having a curable 
disease. This concept describes the overall understanding of what behaviours 
and attitudes toward advanced recurrence are and the stimulus those 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.4.2 The concept of Hope in the Face of an Uncertain Future 
The concept of Hope in the Face of an Uncertain Future developed from the 
category of Coping–Working and Existential, which in turn consisted of two 
subcategories: focusing on others and pursuing healthy living. The 
subcategories were developed from codes that focused on coping with an 
uncertain future and methods allowing participants to be less afraid of their 
new advanced cancer recurrence. The category of Coping–Working and 
Existential was underpinned by the subcategories of focusing on others and 
pursuing healthy living/self-advocacy, which are described below. Figure 4 
highlights this portion of the Venn diagram. 
3.4.2.1 Focusing on others. 
Focusing on others provided a method of coping by reducing anxiety. It may 
have also contributed to finding meaning in this experience of advanced 
cancer recurrence, as described by this participant: 
I pray every day, but I don’t pray for me, I pray for others. I find caring 
about others first helps me. (P10:69–70) 
The need to focus on others allowed participants to concentrate on something 
outside of their diagnosis and concerns and provided a means of coping that 
also helped them consider the meaning of this experience. 
It’s especially [needed] now because cancer is very prevalent, it’s time 
that we wake up to the reality. I’m really, really committed myself to 
doing that [sharing my story to improve cultural response to cancer in 
 








































































































































































































































































































































































Africa]. I encourage people on what we women need to help us through 
this kind of process. So I find myself thinking God has really used me 
as a vessel. And I’m very humbled by it. . . . I have work to do [helping 
others with breast cancer]. (P7:203–239) 
3.4.2.2 Seeking healthy living/self-advocacy. 
Healthy living strategies provided a sense of control and self-advocacy to 
cope with advanced cancer recurrence. Participants strongly believed in their 
own body’s ability to fight the recurrent disease. They expressed the view that 
by actively pursuing healthy living activities, they would support their body in 
protecting itself and fighting the cancer. Pursuing healthy living was believed 
to positively impact their immune system and support living life. Even if it was 
acknowledged that such practices had not prevented the cancer from 
recurring, there was still an effort to follow those practices. There was also an 
acknowledgment that not maintaining optimal health may have contributed to 
recurrence.  
The other part is that, when after I had the cancer and I did all the 
reading and I really felt if I kept my immune system really, really healthy 
that it would um, help protect me from—from cancer again and that if I 
kept my stress under control. I did not keep my stress under control; 
however healthy, I became a vegetarian. I ate well. I exercised. I ran. I 
did everything to keep my body in a position where it could fight off 
anything. (P2:116–123)  
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The change in activities and lifestyle after their initial recurrence and previous 
cancer treatment and subsequently during the time they believed themselves 
to be cured was a common focus for participants. 
Also I changed my diet, you know, I ate a lot of red meat before that, 
and so I’d change the diet with less red meat, uh, and more fish and 
chicken, you know, and um, also ate lots of vegetables, you know, and 
uh. . . . Just originally I did that to uh, prevent cancer, thinking it would 
help to give me antibodies, you know. (P11:34–40) 
The participants had pursued a healthy living strategy after their initial 
diagnosis as a means to take control of their bodies, so they could continue to 
live and fight their cancer. After their successful treatment, they experienced 
years of what they perceived as healthy living free of cancer. Once their 
cancer recurred, they pursued whatever means they could to continue to live 
now with the new reality of advanced cancer.  
I have lost 30 pounds, I’m so happy about that. I didn’t lose much 
weight in the first one. . . . I think the reason is my son’s got me on 
organics and he’s making me shakes and alkaline water. I’m eating 
healthy and I haven’t been eating healthy. That’s contributing to my 
weight loss. This time I am doing it [become more healthy] for myself. 
(P5:192) 
Table 7 provides details related to the transcripts, codes, subcategories, and 
categories associated with the category of Coping–Working and Existential 
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3.4.2.3 Summary of the concept of Hope in the Face of an 
Uncertain Future. 
Coping strategies provided the momentum for moving away from anger and 
toward seeking treatment and living with cancer recurrence. These strategies 
provided a source of hope that the participants could live longer with cancer. 
The categories of Coping–Working and Existential and Treatment Focused 
revolve around hope, amidst an uncertain future. Multiple subcategories 
contributed to the concept of hope in uncertainty which overlapped with the 
concept of seeking treatment, including the following: family support, spiritual 
support, and faith in their physician.  
Hope existed with the ability to receive treatment, as the two seemed to 
reinforce each other. The participants focused on being positive and hoping 
for a future, while recognising their disease was no longer curable. They 
chose to move forward with treatment and be hopeful.   
So that’s good. I’m always looking at that positive part of it, you know. 
It’s not curable, ok that’s a bummer, you know, ok I have my 3 or 4 
days of this is really awful, but you have options, you know. You can 
continue to feel sorry for yourself and whatever or you can put your big 
girl panties on and you move forward. And, you know, that’s . . . what 
you have to do. You know, because I feel you still have an option. I 
mean why, why wouldn’t you choose to do that? Because your life will 
be better. (P10:20–23) 
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The category and the developed concept of Hope in the Face of Uncertainty 
supported the maintenance of hope as participants faced the new recurrence 
diagnosis and remained positive throughout treatment. The acceptance of the 
new disease status allowed them to be hopeful and proceed with treatment.   
There were multiple subcategories associated with coping that worked 
together to reinforce the concept of Reluctant Acceptance. These overlapping 
subcategories contributed to the development of the concepts and the 
dynamic movement described between the diagnosis of advanced cancer 
recurrence and how participants proceeded to manage this new experience. 
These shared subcategories are discussed in Section 3.7 below. 
3.4.3 The concept of Seeking Life Through Continuous 
Treatment 
The concept of Seeking Life Through Continuous Treatment developed from 
the category of Treatment Focused, which was underpinned by the 
subcategories of focusing on treatment and the importance of an established 
treatment plan. During the transitioning phase between believing they had 
been cancer free survivors to finding they had recurred with advanced 
incurable cancer, participants were focused on the availability of treatments 
and coping strategies that provided hope and reassurance that treatment was 
available and a long-term remission was possible. This was captured in the 
words of one participant: 
It’s not curable but treatable. (P10:141) 
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The meaning of this recurrence was transcendent for many and allowed them 
to regroup and have hope for their uncertain future. Participants 
acknowledged that this advanced recurrence was incurable and therefore 
different than the initial diagnosis of cancer. All of the participants chose to 
seek treatment and believed that having treatment options symbolized hope 
that they could live, albeit live with cancer. Figure 5 highlights the portion of 
the Venn diagram related to this concept. 
In the following section the subcategories of focusing on treatment and the 
importance of an established treatment plan are discussed.  
3.4.3.1 Focusing on treatment. 
As noted above, participants expressed a desire to keep moving forward, and 
as part of this did not want to discuss the possibility of dying from their 
disease. Instead their focus was on continuing to live with cancer. There was 
confidence in their ability to successfully live with recurrent disease, believing 
that remission was possible because they had achieved that in the past. 
How did it feel? Gosh. I guess obviously upset, but I knew that there 
were so many treatments available that it wasn’t like I thought, ‘Oh my 
God, you’re gonna die’ or something. I just ploughed right ahead. 
(P6:24).  
Believing that there were ‘so many treatments available’ allowed hope for a 
future and contributed to believing there was life through treatment.  
 









































































































































































































































































































































































I have oral chemo . . . but if I have to do it, I’ll do it; I’m not, you know, 
ready to throw in the towel because I’ll hear people say, ‘I have heard 
of people saying “No, I don’t want to do this anymore”’. I definitely am 
not at that point. I just can’t imagine . . . (P5:108–111) 
Participants sought new treatments for their recurrent disease in order to live 
and were willing to remain on treatments continuously. Even as participants 
described their initial response to be of anger and sadness to the advanced 
cancer recurrence, they uniformly shifted to a focus on treatment after 
acceptance rather than on the possibility of death. Having completed 
chemotherapy treatment as part of their initial cancer, seeking treatment again 
sustained a belief in the possibility of treatment leading to remission again, as 
described by this participant: 
I’m considered in remission, however, I have to continue my therapy 
indefinitely because of the kind of cancer I do have. (P7:50) 
Participants described the benefits of planned treatments and their overall 
beliefs for treatment outcomes.  
They wanted me to start on this pill that can attack this mutated type of 
thing. So I started it now going on 4 weeks. I have been through this. I 
figured if I did it once I could do it again. (P3:24–28) 
The concept of Seeking Life through Continuous Treatment is shared with the 
other concepts of Hope in the Face of an Uncertain Future and Reluctant 
Acceptance, and therefore contains the subcategories that are seen within 
these respective concepts. These subcategories were shared as they 
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overlapped with how participants responded to the acceptance of advanced 
cancer recurrence and were involved in seeking treatment. 
3.4.3.2 Established treatment plan. 
The significance of having an option for treatment was important. The 
willingness to participate in treatments and follow the doctor’s 
recommendations was apparent. Knowing the doctor had a plan for 
treatments gave participants focus and energy to seek survival. 
I just make the best of it. Do what you have to do. You know, and that’s 
how I feel, I’ll just do what I need to do and when I talked to the doctor I 
should have asked her if there’s anything extra I should be doing. 
(P5:202–203)  
Believing in the doctor’s recommendations even when acknowledging it was 
not a cure was important. There was hope in this comment as well. Also 
maintaining the uncertainty allowed the participant to stay hopeful and cope 
with the knowledge that this treatment is not focused on a cure: ‘I was told it’s 
not a cure, but it’s something that might help, to shrink the tumour’ (P1:129–
130). 
This focus on treatment to keep living was a driving force that gave hope for a 
future. The acceptance of ‘it’s not curable but treatable’ as described by 
participants included the different subcategories, such as focusing on 
treatment and the meaning behind having an established treatment plan. It 
was the hope for remission and continued life and also displayed the positive 
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attitude that was described by participants as well, looking for the positive 
side.  
Table 8 provides details related to the transcripts, codes, subcategories, and 
categories associated with the category of Treatment Focused and the 
construction of the concept of Seeking Life Through Continuous Treatment.  
3.4.3.3 Summary of the concept of Seeking Life Through 
Continuous Treatment. 
The concept of Seeking Life Through Continuous Treatment is underpinned 
by the understanding that this cancer recurrence is not curable, but treatable. 
Unlike with participants’ initial cancer treatments, where the goal was to cure, 
there was understanding that a cure was no longer a realistic goal. Having a 
treatment plan signified hope for a future and reinforced the belief that their 
disease was treatable. They described a concern that treatment might now be 
harder than for their initial cancer experience because they were older, and 
uncertainty about whether they would have more difficulty with the illness, but 
they still chose to be treated. The subcategory of focusing on treatment 
provided insight into what the participants believed about their disease 
prognosis and goals for care.  
This category, Treatment Focused, and the subcategories described above 
were the ones that provided the overall meaning of advanced recurrence and 
the interrelated concepts with the primary desire of those experiencing it as 
seeking treatment to continue living. While I present the findings individually 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































shared subcategories and helps to provide a rationale for the conceptual 
model that shows the interactive feedback loop action taken by participants in 
this moment of time. The shared subcategories are seen within each concept 
but maintained a separateness that was encompassed by the reactions as a 
whole. Therefore, the model was not seen as a single circle surrounding all of 
these categories the concepts Reluctant Acceptance, Seeking Life Through 
Continuous Treatment, and Hope in the Face of an Uncertain Future provides 
the framework that holds the experience together. 
3.5 Intersections of the Three Concepts 
Understanding the interrelationships between concepts is critical to 
understanding the iterative and temporal nature of the model presented in 
Chapter 5. Figure 2 provides the overall description of how the intersections 
are related to the three concepts; Figure 6 highlights just the areas where all 
concepts overlap. As described above, these shared subcategories are seen 
in all of the concepts and were constructed from the categories of Behaviour 
and Attitude toward Recurrence, Treatment Focused, and Coping–Working 
and Existential. These are a motivation to find personal equilibrium and 
support seeking life. 
The overlapping subcategories demonstrate a relationship between two or all 
of the categories of Behaviour and Attitude toward Recurrence, Coping–
Working and Existential, and Treatment Focused, and serve to support or 
increase the impact on the concepts as they provide coping strategies and 
hope for the participant. These shared subcategories included seeking 
knowledge, positive attitude, minimising gravity of disease, humour/laughter,  
 













































































































































































































































































































































































































meaning of illness, future orientation, ‘not curable but treatable’, family 
support, spiritual faith, faith in physician, and hope. The non-overlapping areas 
display subcategories for the respective categories.  
The degree to which the concepts and their related categories and 
subcategories intersected varied between the individual participants and 
depended on the context and significance they placed on each category. The 
shared concepts of Hope in the Face of an Uncertain Future and Seeking Life 
through Continuous Treatment seemed to happen simultaneously after the 
concept of Reluctant Acceptance. Reluctant acceptance was the catalyst that 
allowed the transition to treatment and hope, as described in the following 
participant quotations.  
I’m going to give it my best shot and what happens is going to happen. 
But I’m going to make the best of it. I’m still planning . . . I’m getting 
things done . . . I’m also making plans for next month to go out of town 
for a few days. (P3:309–315) 
Hey, this is not too bad, you know, attitude-wise I wasn’t too bad. I have 
been through this. I figured if I did it once I could do it again. (P3:110–
112) 
The overlap of subcategories and concepts can be seen in this transcript: 
So I had to kind of pray and deal with it. Faith is a big support. And I 
have my kids. They are really supportive that way too. So I have all this 
family that can help out . . . and they give me a lot of positive 
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accolades. It is really positive and it helped me stay positive. (P12:88–
92) 
This comment illustrates how subcategories of positive attitude, spiritual faith, 
and family support together developed into the concepts of Hope in the Face 
of an Uncertain Future and Seeking Life through Continuous Treatment. Each 
of the subcategories can be isolated but they are not mutually exclusive and 
are instead all constantly present. 
Participants described their experience and the interrelationship of the 
concepts as they supported their pursuit for continued life. The following 
section describes the shared subcategories among the three concepts.  
3.5.1 Seeking knowledge. 
The participants’ words as related to the meaning of seeking knowledge 
describe a way to understand their previous treatment, and why the cancer 
recurred. They also relate to Reluctant Acceptance as they begin seeking 
knowledge about the diagnosis of advanced recurrence, which in turn 
promotes treatment-seeking behaviour. Seeking information was linked to a 
sense of control. It was important to participants to research ways to treat their 
recurrent disease and know of all treatment options to enhance the likelihood 
and hope that they could achieve stable disease with acceptable quality of life. 
Receiving the diagnosis of recurrent disease often caused participants to 
review their prior treatments and compare their treatment history to other 
cancer patients, and treatment guidelines they found in publically available 
literature or on the Internet. For some participants, seeking knowledge was 
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not only about what might help in the future but also about what went wrong in 
the past that contributed to them now being diagnosed with recurrence. 
Describing the stage of breast cancer at initial diagnosis, one participant said, 
I wasn't really worried about the breast because breast was 2B, at least 
that's the way they staged it. (P2:30–31) 
This participant expressed that she may have been undertreated initially 
related to possibly being mis-staged, and therefore recurred:  
But looking back on it, I mean, they could have mis-staged this whole 
thing because I was at—for my original, who knows. (P2:240–241) 
Concerns about misdiagnoses speak to the importance of knowledge and 
information about treatment plans. 
I knew it had to be a mistake because no one in my family on either 
side had ever had breast cancer. It had to be a mistake. I then I was 
very angry about my care at [cancer treatment centre]. I saw [oncology 
physicians], they were supposed to be the best but I did not get the 
right care. [First diagnosis oncology physician] doesn’t know anything 
about aftercare and [first diagnosis oncology physician] never offered 
me hormone therapy. All the big shots. So I was the first person from 
[cancer treatment centre] to go to [first diagnosis physician]. He told me 
I did not have an infection in my breast. I did not have mastitis. I had all 
of it. He did not take care of me. I was very mad at him. (P4:14–24) 
By voicing their treatment concerns, participants questioned whether they had 
received the right treatments with their initial cancer. They wondered if their 
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initial treatment had been different, perhaps they might not have experienced 
recurrence. They described information they had found on the Internet or 
recommendations they had read about that would help them understand why 
their cancer recurred. It was as if seeking and finding information about their 
previous treatments would help them understand why the disease recurred 
and also what could be done differently in the next phase of treatment to avoid 
future recurrence:  
So I just knew that it was something that I just had to accept and then, 
you know, educate myself, educate my family and just figure out how 
we were going to get through this. (P7:19–20) 
This theme of seeking information was a means of moving from reluctant 
acceptance and avoiding a trajectory toward death to regaining control. Their 
years of being identified as survivors, people who successfully defeated 
cancer, had prepared them to respond to this recurrence and continue to live, 
even if it meant living with cancer.  
3.5.2 Positive attitude. 
The overlap of Reluctant Acceptance, Hope in the Face of an Uncertain 
Future, and Seeking Life through Continuous Treatment is seen through the 
positive accepting attitude that participants describe as they plan to do 
whatever is needed. This attitude continued to be present in the three 
concepts and provided a means of coping and acceptance. It promoted 
energy and acceptance and hope for a future. 
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I’m working through all that and I continue to try to be positive about 
everything. . . . It’s just a competition. I’m going to . . . I’m going to live. 
I’m going to do everything once again that I need to do to take care of 
my body and see how long we can keep this thing back. (P2:284–289) 
This positive attitude saturates all the concepts by allowing acceptance of the 
disease and focus on treatment. One participant said,  
And from the moment I came in the door and from the very first doctor I 
saw, everybody continued with this positive attitude and never once did 
I think this wasn’t going to work out. (P09:8) 
This subcategory was seen between all three concepts as it impacts Reluctant 
Acceptance, Hope in the Face of an Uncertain Future, and Seeking Life 
through Continuous Treatment.  
3.5.3 Minimising the gravity of disease. 
As participants faced their recurrence and began to accept the new reality, 
they often concluded that the situation could be worse. The attitude that ‘it 
could be worse’ was identified through theoretical sampling as a minimisation 
strategy used by participants that contributed to their sense of Reluctant 
Acceptance and overlapped with their Hope in the Face of an Uncertain 
Future and their Seeking Life Through Continuous Treatment. Minimising was 
a coping strategy that allowed participants to believe that their disease, 
although incurable, could be worse. Therefore, there was hope for another 
remission or stabilisation of disease that would allow them to continue living 
with cancer. Participants were focused on the extent of the recurrence, 
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involvement of lymph nodes, or the extent of metastasis as a means of 
gathering information to plan their best treatment. In cases where diagnostic 
tests had revealed less extensive disease than they had first feared, 
participants saw this news as an indicator that they would live longer:  
When I had the PET scan the news was good that it was only in the 
three lymph nodes. (P8:176) 
This is an example of how participants minimised the gravity of their disease. 
Another participant stated: 
But I could see in the uh, when they did the CT scan—the bone scan 
rather, I could see um, in a little computer image above—it was very 
small, but I could see little spots that were highlighted. So I’m thinking 
okay, those are the tumours in the bones, but at least it wasn’t the 
whole bone system. (P11:24) 
Minimising the gravity of their cancer allowed participants to believe they could 
continue living with incurable disease for many years. Having fewer lymph 
nodes or bone metastases was perceived as meaning the disease was 
controllable. They did not deny that they had advanced cancer but chose not 
to dwell on the gravity associated with advanced cancer but focused instead 
on treatment and stabilisation of their disease. To survive meant to minimise 
the gravity of the disease, to accept their disease and sustain hope that 
treatment would prolong their life.  
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3.5.4 Humour and laughter. 
Participants used humour and laughter to cope with the emotions of their 
advanced disease and maintain Hope in the Face of an Uncertain Future. At 
times, participants also used humour to face the possibility of death. Humour 
softened the intense reaction to the reality that they could die from this 
recurrence. 
Oh, my husband and I sat up there and cried when we first got home 
from the diagnosis. And yet eventually there was a humour because I 
was all ticked off because I worked all my life and I'm not going to get 
to draw Social Security [laughs]. (P2:355–358)   
When describing their advanced disease, other participants used humour and 
laughter to reduce anxiety and fear and maintain a feeling that treatment could 
work again. 
Interviewer: So do you ever think about what would happen if it didn’t 
go away?  
Participant: No. 
Interviewer: Stay positive? 
Participant: I don’t really address that. [Laughs] I mean I know that 
could happen, you know, and if it does well, you know, that’s the way it 
is, but, uh, I’m not going to do anything to discourage myself, you know. 
And I don’t like to think things like that cause I think, ‘Ok, let’s don’t go 
there. We don’t know that’s a possibility, you know. Just take today, 
98 
you know. That’s what we got.’ [Participant laughing throughout 
conversation] (P9:79–82) 
Participants also used humour and laughter to negotiate their identity as 
cancer patients. 
I would come here, you know, for my regular check-ups. Which I never 
missed. I always, you know, came here and I’d think all these poor sick 
people. And [laughs] and I guess I was one of them too, but I just didn’t, 
you know, I didn’t think like that. (P11:30–31) 
Humour and laughter was used to minimise the fear around the recurrence 
and what it meant. It allowed them to avoid the seriousness of this recurrence 
at this time as they focused towards future treatment.  
Participant: I just, you know, every situation I’ve ever been in, I’ve tried 
to make the best of it. It doesn’t, I try to find humour in it, I try to . . . 
Interviewer: And so knowing its stage 4 and your, your attitude is? 
Participant: ‘Here we go. What’s this new adventure? Let’s see what 
happens,’ you know. (P5:190) 
There was an attempt to keep the conversation light and move the 
conversation toward hope and positive remarks about their future. Humour 
and laughter were used for Reluctant Acceptance of their diagnosis, Seeking 
Life Through Continuous Treatment, and sustaining Hope in the Face of an 
Uncertain Future. 
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3.5.5 Meaning of illness. 
The meaning of illness drove much of the participants’ reflection on their 
experience with advanced cancer recurrence. These reflections extended 
throughout their entire cancer experience, from the time of their initial 
diagnosis and treatment, through the time of remission and now with disease 
recurrence.   
But what I’m saying is, disease changing you, changes you. And 
although you don’t think about it, you have a new wisdom about life. 
And, you know, cancer survivors always say, ‘Oh, you know, I survived 
and I bless this disease because it taught me how to live. It taught me 
how to appreciate everything. Everything looks new to me. I appreciate 
things I look at, which I took for granted. I appreciate the people around 
me which I never noticed before.’ It’s true. It gives you an awareness of 
what’s important. Really, sharp awareness. And that is a blessing. Now, 
I don’t want this awareness to go. I don’t want my body, [to die—but did 
not say the words] now I found this new wisdom I want to use it, you 
know? (P14:186–190) 
In reflecting on the meaning of the illness, some of the participants expressed 
how their lives were significantly changed and others described the faith in 
living day to day.  
I want to be strong and just what I'm saying is that I want to do 
everything I can to live a quality life for as long as I can. I would want 
that for anyone. I understand that in the very beginning, you are 
disseminating a whole bunch of information and looking at your life 
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being shortened. But as long as we're here and we can do everything 
that we can to make that a quality life, I'm all about that. That's probably 
what I would share with them is it's every day one foot in front of the 
other and just—you know, I still get up every single morning and go 
open my window and look at the sun just starting to peak up and gather 
light. It's the most beautiful sight in the world. It's my new day. I got a 
new day. I can stand there and applaud. (P2:15–28) 
The meaning of the illness includes both the initial cancer diagnosis and 
making sense of this advanced cancer recurrence and pervaded the three 
concepts. Initially with the diagnosis of advanced cancer participants 
questioned why, and sought a meaning for this recurrence. The meaning they 
attributed to the experience permeated their rationale for why treatment would 
work and supported hope for treatment. Establishing meaning gave them a 
purpose for seeking living.  
3.5.6 Future orientation. 
It was necessary for participants to focus on their future and that idea is what 
supports all three concepts. Initially with Reluctant Acceptance, to believe they 
had a future was necessary and provided them with Hope in the Face of an 
Uncertain Future and supported focusing on treatment to Seek Life Through 
Continuous Treatment:  
I don’t think you have any option other than to move forward [have 
treatment] and be positive about whatever outcome there is. I still feel 
positive about it. It’s not a great result but it’s treatable. (P10:64–66) 
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Future orientation included maintaining a positive attitude. It allowed a belief 
that life could go on: 
I feel I can keep my attitude positive, I can keep going . . . I’ll buy some 
time. I’ll get through this thing. I’ll have some more good years. 
(P3:234–237) 
This is also an example of maintaining a positive attitude as described in Hope 
in the Face of an Uncertain Future, and although it is uncertain, believing 
there is a chance. As participants all chose to seek treatment and describe 
hope they have for continued life, their belief in a future was clearly in place. 
The overlapping concepts are seen throughout this experience of advanced 
cancer recurrence. This particular subcategory clearly relates as seeking 
treatment gives hope and knowing treatment is possible allows acceptance.  
Participants in this study were early in the time of recurrence and remained 
focused on the hope for extended survival. While there was some mention of 
potential death in the interviews, the participants remained largely concerned 
with continued living and they did not speak about hope for a peaceful death 
as described in the literature. As in the participant comment below, treatment 
would keep the disease ‘in control’: 
She [the physician] told me that I would probably never be cancer free 
at this point but what I, but what they could do, it would be like a fire. 
And it would be . . . the medications they would give me and everything 
would keep it down to like a low little ember burning, so they could keep 
it under control so that I could have a longer, more enjoyable life, you 
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know, and not let it get out of control to consume me, you know? And 
so that’s what I’m believing is . . . is the plan. (P11:81–84)  
A treatment plan provided hope for continued life for the participants. 
Achieving a response did not necessarily mean that treatment would end, but 
rather that all participants assumed that treatment would continue indefinitely. 
Remaining under treatment and having a long-term treatment plan supported 
the goal of living with cancer, not dying from cancer.  
I’m considered in remission; however, I have to continue my therapy 
indefinitely because of that, you know, the kind of cancer I do have . . . 
disease that it is, you know, he doesn’t want to put to chance that if we 
stop therapy. That, you know, there might be a chance that it comes 
back and we don’t want that. So that’s why I’m here today. (P7:50–54) 
Confidence in cancer treatment and believing that their treatment options were 
more advanced today and more effective than what they had received with 
their initial cancer diagnosis promoted acceptance, hope, and treatment. They 
felt that this current era of cancer treatment options offered greater hope and 
would yield better responses. 
Participant: Well, yeah. I know that I’m getting state-of-the-art, up-to-
the-minute medical benefits from [cancer treatment centre] which 
instead of antiquated systems, you know, like now for instance. Instead 
of giving me radiation for my bone cancer, and causing other problems 
and other horrible side effects from that, they give you a shot, you 
know? A shot in the arm, or a shot in the butt, and it does this 
wonderful work on you. 
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Interviewer: Building your bones. 
Participant: Yeah, so it really addresses the problem and takes care of 
it. So the quality of life is still good. (P11:189–193) 
The belief in the availability of treatments that promised living longer impacted 
the attitudes of these participants and their decisions. They reluctantly 
accepted the diagnosis of advanced recurrence and moved forward in a new 
reality of living with cancer. Participants reflected on treatment options when 
first diagnosed and how the many new advances in recent years are a source 
of hope.  
3.5.7 ‘Not curable but treatable’. 
The concepts of Reluctant Acceptance and Hope in the Face of an Uncertain 
Future revolved around the belief that even though the recurrent disease was 
different than their initial cancer experience, the cancer was still treatable. 
They accepted the fact that this recurrence was not curable and turned their 
hope to it being treatable hence the subcategory ‘not curable but treatable’.   
Well, I . . . I know the cancer I have now is not curable. I know it’s 
treatable. How long it will be treatable? I don’t know, you know, we’ll 
see. I got my attitude is like I am doing the most aggressive treatment 
that I can handle. And I think I can handle a lot. And so, you know, 
there are times I think, ‘Ok what am I going to do? What’s going to be 
the treatment when I’m done with this?’ But I don’t go forward with that, 
you know, I just say, ‘When I get there I’ll get there’, and, you know 
what I mean? I don’t go beyond that and saying one I’m not going to be 
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able to have this treatment, I am going to have to have something else. 
You know, I don’t think like that. I just think this is my treatment. I know, 
I’m intelligent. I know that someday that’s not going to work and I’m 
going to have to do something else, but I don’t bother thinking about 
that is the point. There’s no point until that happens, and who knows? 
(P10:141–150)  
Participants described the belief that there would always be another treatment 
available should their current treatment not achieve remission. They described 
the treatment, remission, recurrence, and return to treatment cycle for the 
recurrence that would maintain their life. Remaining on treatment was also 
based on hope that new treatments or cures might be discovered if the 
participants could just stay alive until that time. Participants described this 
need for continuous cancer treatment and compared cancer treatments to 
chronic disease management.   
I don’t know. I think, I think a friend of mine just said to me, she did not 
know I had this recurrence. And we were . . . see, she has rheumatoid 
arthritis. And she said, ‘Bad news is we have this disease. The good 
news is there is treatment for it.’ And I look at it that way. Bad news is, 
you know, it’s there and we have it. The good news is there’s treatment 
and we’re treating it. (P8:28)  
This comparison to rheumatoid arthritis allowed this participant to accept 
continuous treatment as something she shared with other people with chronic 
disease who were also living with their illness. Participants described being 
hopeful because the new treatment options available for their recurrent cancer 
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were better than earlier chemotherapy or radiation therapy used for their initial 
diagnosis. They were able to accept a new life that would include ongoing 
treatment if that would allow them to remain alive. Participants with advanced 
recurrence now had an understanding that treatment would be life-long, and 
they would manage their disease as others manage chronic illness. 
Participants described their goal as living for as long as they can, as well as 
they can. If living required chemotherapy continuously to maintain remission, 
they were willing to have continuous chemotherapy treatments.   
And I was on those for December, January, and February. Then I 
repeated the CAT scans and all of that and not only had the tumours 
not receded, but they had grown and I had new ones. So that was 
probably, that was one of the more difficult times because, you know, 3 
months of infusions and the concurrent side-effects and then somebody 
just, and then you’re just like they’ve done . . . not only has it not gotten 
better, it’s gotten worse. So then at the beginning of [month] I started 
on treatment number 3, which is the oral, um, chemotherapy, uh, 
[treatment name]. (P6:27–33) 
There was an acceptance of doing whatever it takes including treatment after 
treatment to maintain life with stable disease. 
My friends, some of them want to know I’m done with this. And they 
don’t understand I’m gonna be in treatment for the rest of my life. I have 
to keep saying that. They said, ‘You’re going to [cancer treatment 
centre] for what?’ I said, ‘For my monthly treatment’. ‘You still have to 
go there? Well I thought you were in remission.’ ‘Yes I am, but this . . . I 
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will have this for the rest of my life’. And it’s having to explain that. And 
you say it over and over again and finally you internalize it. (P8:144–
145) 
Participants described that at the time of their initial diagnosis they were seen 
by their families or themselves as either a patient with cancer or a person 
whose cancer was ‘in remission’ or ‘cured’. Now, they view the cancer as not 
ever being in remission, rather in a stable situation due to treatment and 
assume their life is now a life similar to other chronic illnesses. Continuing 
treatment and viewing cancer as a chronic disease was related to the concept 
of hope, as continuous treatment signified the potential to live with recurrent 
disease.  
3.5.8 Family support. 
The subcategory of family support was described by all of the participants as a 
source of strength in dealing with their cancer recurrence. Family support was 
critical, allowing them to have Hope in the Face of an Uncertain Future and to 
continue to live with cancer. Participants described the importance of their 
families’ support at recurrence and through seeking a treatment plan and 
receiving treatment. Caregivers and family were not interviewed as part of this 
study. Family support provided optimism and helped them deal with their 
disease and added to their sense of hope.  
So you play the best possible hand you can gather. And I’m very, very, 
very lucky, because okay, I, I’ve got this one bad card, but I’ve got a 
fantastic doctor, got fantastic husband, my family’s wonderful. They all 
came to . . . from [describing where they came from to visit] one after 
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the other to visit. My sister is here, my brother was here last month, my 
mother was there the month before. So, I mean, I am so lucky to have 
these huge things in life. Some people don’t have this. (P14:292) 
Thirteen of the 15 participants came to the interview appointment with their 
significant others or a family member. Family members were described by the 
participant as helping them remain focused on the future, as reflected by 
these participants. 
Support of your family is the most important. (P1: 399) 
Focusing on family motivated participants to keep moving forward.  
When I was feeling really bad, I would just go out there and sit and 
watch [grandchildren playing in the pool] with a huge smile on my face. 
This last week we’ve been able to do a few things together. So it’s 
been—it’s just been great. (P2:323–326) 
3.5.9 Spiritual faith. 
Spiritual faith was identified as an important subcategory in supporting their 
feelings of hope and seeking treatment. Spiritual faith ranged from strong 
religious identification, such as believing their diagnosis and treatment was an 
act of God, to a Jungian belief that promoted a transcendent aspect of coping 
without a belief in a God.  
Interviewer: So you actually do think about the future and think and kind 
of draw a line, it could be this or it could be that?  
Participant: Yes. You know, and I do have religion, I am spiritual. 
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Interviewer: Spiritual?  
Participant: Spiritual. I just had to go back to the mantra of ‘your only 
problem is today’. No matter what any doctor says, they are not going 
to put an expiration date on you. That's between you and God. And it's 
today. (P2:177–184)  
Placing faith in God provided hope and a sense that there was something 
else, a greater power that guided their path.  
But see, who knew then now that I was going to deal with this and be in 
a place where, you know what I mean? I think God just is divine and 
puts things in order for me, ‘Okay, you know what’, and then you look 
back and you’re like, ‘Oh that’s why you did this’. [Laughs] (P7:254) 
Believing in God or other spiritual forces created a sense of hope, described 
as a hope that God would see them through this crisis. Faith provided a 
shared experience of not only hope for a future, but supported a positive 
attitude and future orientation. Family support and spiritual faith contributed to 
support for seeking treatment and living with the cancer recurrence.  
3.5.10 Faith in physician. 
The subcategory of faith in physician speaks to trust in physicians and 
treatment. Trusting in their physicians and believing that their physician cared 
about them and shared their desire for survival allowed participants to cope 
with recurrence and hope for a future through treatment. The belief that the 
physician had the knowledge and the ability to provide the treatment to keep 
them alive was important. Participant 9 described her feelings about treatment 
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for this recurrence and seeking a second opinion in which staff were more 
positive: 
Then I went on from there to [from one hospital to another] [and it] was 
a complete opposite viewpoints. ‘You definitely will survive. You do 
exactly what we tell you, you will survive’. And from the moment I came 
in, the door of [the second hospital] and the very first doctor I saw, 
everybody continued with this positive attitude and never once did I 
think this wasn’t going to work out. (P9:10) 
Participants described the faith they had in their physicians and the impact it 
had on their hope for continued life. Participants believed physicians 
communicated hope by providing reassurance about their treatment options 
and ability to live with cancer. 
I told my sister, you look at him you know right away what he’s thinking, 
what he’s feeling. Like the day that I went and the colour drained from 
his face. I mean you can see and she said, ‘You’re right’. She goes, ‘He 
was practically doing cartwheels because your test came back so 
good’. (P8:214–215) 
This faith in their physician was interrelated with coping and seeking 
treatment, as participants reported that when their physician was hopeful, and 
treatment was offered, they were hopeful for a future. 
3.5.11 Hope. 
As a subcategory, hope speaks to seeking treatment for continued survival in 
uncertain future and resulting acceptance. Hope is how they coped with the 
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distress of the diagnosis of advanced cancer recurrence, and provided 
support to seeking treatment. Participant 7 commented:  
Accept it and figure out how to deal with it and be open about it. (P7:29) 
Hope did influence their actions to seek treatment for survival and allowed 
participants to cope with recurrence by providing them a plan with which to 
focus their actions and influence positive coping in an uncertain future. 
Participant 1 stated:  
I know I was told it’s not a cure, but it’s something that might help, you 
know, to shrink the tumour. (P1:169–170) 
Hope for a treatment was evident as participants sought to have a response to 
treatment in light of their incurable stage of disease. Positive relationships and 
family were cited in the interviews as key supports at this time of recurrence, 
and family members provided hope by strongly encouraging the participants to 
seek treatment for their advanced disease. For one participant, her child 
played a pivotal role in her deciding to seek treatment. 
She had a lot to do with it ‘cause she didn’t want me to give up. She 
says, ‘I want to look into this. I want to talk to so and so’. She was more 
involved this time, I would say, in my treatment procedures. (P1:495–
496) 
These participants again describe the energy that is used to keep them 
moving forward and seeking life in light of the uncertainty experienced with 
advanced cancer recurrence and knowing it is incurable. One participant said, 
‘I learned to fight better than I ever have in my life’, clearly recognising the 
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seriousness of this diagnosis yet maintaining a positive hope for a future and 
describing no other choice: 
My own personal philosophy is to be positive. Every day be positive, 
because I learned to fight better than I ever have in my life. . . . I’m 
gonna be a survivor. I’m a survivor I have to fight every day. I have to 
think positive. (P9:56–57) 
As participants considered how they would live now with recurrent cancer, 
they sought ways to actively cope by pursuing strategies they believed would 
help them control their health and future.  
I feel I can keep my attitude positive, I can keep going. And I can get 
myself physically built back up strength-wise and mentally-wise, 
physically I’ll be alright. I’ll buy some time. I’ll get through this thing. I’ll 
have some more good years. And that’s my attitude. It’s the way I’m 
looking at it. (P3:9–14) 
This participant clearly describes the importance of a positive attitude to ‘keep 
going’ and the importance of feeling physically and mentally strong. 
Participant 3 illustrates the meaning of these concepts as they relate to 
continued life. 
As a force that motions participants forward, hope underlies their ability to 
seek treatment in the face of the uncertain future. The positive attitude 
reflected feeling hopeful, even when at times it came from a place of sadness. 
For instance, 
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Participant: Well, it, it is sad. But I don’t want to dwell on it, uh, I just 
can’t. What good does it do? And I have a hope. 
Interviewer: You have hope? 
Participant: I have hope. I just make the best of it. Do what you have to 
do. You know, and that’s how I feel, I’ll just, I’m doing what I need to do. 
(P5:207) 
The following section presents a summary of the intersections of the three 
concepts.  
3.5.12 Summary of the intersections of the three concepts. 
As illustrated in Figure 2, the concepts developed from the subcategories and 
categories constantly interrelate to support the concept of participants seeking 
life. Seeking knowledge and minimizing gravity of their disease as coping 
strategies help participants find acceptance and allow them to cope with the 
uncertainty of this new phase of their cancer trajectory. 
This section has described the subcategories that were evident in each of the 
constructed concepts. Participants described how these subcategories 
impacted their reluctant acceptance of their advanced recurrence and chose 
to seek treatment as family support and hope for a remission influenced how 
they sought their future. As people remain biological, psychological, social, 
and spiritual beings, no one moves through decisions—especially life 
threatening decisions—without being influenced by multiple factors as 
illustrated by these subcategories. 
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The reality is that the dynamic interplay between these subcategories in the 
conceptual overlap between the concepts provides an abstract understanding 
of these relationships. The interrelationship of the concepts provides a 
baseline for a deeper study of the relationships capturing this particular 
moment of time of advanced cancer recurrence for theory development in the 
future. 
3.6 Summary of the Core Findings 
This grounded theory approach has led to the identification of three concepts: 
Reluctant Acceptance, Seeking Life Through Continuous Treatment, and 
Hope in the Face of an Uncertain Future. The next chapter examines literature 
related to these three concepts and how these concepts relate to previous 
research. Significantly, for the most part, the context in which the studies 
occurred does not reflect the evolving treatment options available to the 
population for my study.  
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Chapter 4: Literature Review 
4.1 Objective of the Literature Review 
As described in Chapter 1, although the number of people achieving cure is 
growing in the U.S., many will recur with advanced disease years after 
completing treatment (American Cancer Society, 2016a; Ng &Travis, 2008). 
This research seeks to understand the experience of advanced cancer 
recurrence using a constructivist grounded theory methodology (Charmaz, 
2014). The objective of this literature review then is to examine relevant 
literature to further support and substantiate the newly developed conceptual 
model describing this experience, of Reluctant Acceptance of Living with 
Advanced Cancer Recurrence and how the model fits into the broader 
relevant literature. The literature review allows refinement of the newly 
developed model related to the findings in the reviewed literature and 
positions the newly developed model to answer the research question 
(Charmaz, 2014). This newly developed model will be discussed in detail in 
chapter 5. 
4.2 Rationale for Positioning of the Literature Review 
This literature review was conducted after analysis of the data. This design is 
guided by grounded theorists’ recommendations for the literature review to be 
delayed until after data analysis and theoretical findings are completed as a 
means to improve rigour of the developed findings (Charmaz, 2014; Chiovitti & 
Piran, 2003; Dunne, 2011; Giles, King, & de Lacey, 2013; Glaser & Strauss, 
1967). There are multiple reasons described by grounded theorists to support 
a delayed literature review:   
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1. A delayed literature review avoids biasing of the outcomes by 
incorporating preconceived knowledge into the theoretical findings 
(Charmaz, 2014; Chiovitti & Piran, 2003; Dunne, 2011; Giles et al., 
2013). By reviewing literature prior to conducting research, there is 
the risk of unconsciously testing a hypothesis rather than observing 
a phenomenon (Andersen, 1993, p. 635; Suddaby, 2006).   
2. Charmaz (2014) acknowledges that investigators begin their 
research with some background and thoughts related to relevant 
literature. The challenge is to maintain a ‘theoretical agnosticism’ 
(Henwood & Pidgeon, 2003, p. 138). By ignoring knowledge on a 
related theory, the researcher is less likely to subconsciously 
integrate or force the developing findings around an established 
theory. Therefore delaying the literature review reduces the risk of 
incorporating other established theories into the new findings. 
3. The qualitative literature review is done after analysis of the data to 
further support the trustworthiness of the newly developed findings 
(Chiovitti & Piran, 2003; Glaser & Strauss, 1967; Seale, 1999). The 
investigator can compare the findings of the grounded theory 
findings to other quantitative and qualitative studies with similar or 
diverse populations to understand the concepts of interest across 
studies and how they relate to the newly developed model. 
4.3 Methods of the Literature Review 
4.3.1 Aim of literature review. 
The aim of this literature review is to support or substantiate the newly 
developed conceptual model describing the experiences of people with cancer 
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who have been cancer free for two or more years of time and recur with a 
diagnosis of advanced cancer in literature relevant to the conceptual model 
and key concepts.  
This review describes the concepts within the newly developed model through 
focused literature related to this population with advanced-stage cancer. 
4.3.2 The narrative synthesis review design. 
4.3.2.1 Introduction of elements of narrative synthesis review. 
To allow the literature review to achieve the aims of supporting or refuting the 
key concepts described in the theoretical model, a narrative synthesis was 
selected. Although a narrative synthesis is often used as part of a systematic 
review, it also allows the related literature to be evaluated and serve to 
provide an understanding of the state of the science to date (Popay et al., 
2006). Furthermore, it also allows for comparison of concepts to support or 
refute the new, inductively developed findings (Britten et al., 2002). In an effort 
to improve the trustworthiness and transparency of this method, a 
systematically constructed, conceptually led approach was undertaken. This 
method provides a transparency process that can be followed clearly for future 
studies as recommended for credibility and transferability of a research study 
(Bryman, 2012; Whittemore et al., 2001).  
A narrative synthesis review provides a framework designed to support a 
‘systematic review and synthesis of findings from multiple studies’ (Popay et 
al., 2006, p. 5), which focuses on the words and text of the included literature 
to build new knowledge. It provides a systematic guide to improve the 
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transparency of the process and support the literature review findings. 
Narrative synthesis is an approach that aims to establish the current state of 
knowledge related to the specific review question, and is not meant to include 
all literature related to the topics in general, only as they relate to my study’s 
conceptual model (Popay et al., 2006).  
The four main elements of the narrative synthesis as recommended by Popay 
et al. (2006) include the following:  
1) Developing a conceptual model that answers the research question 
as to how, why, and for whom; 
2) Developing a preliminary synthesis of findings of included studies; 
3) Exploring the relationships in the data; and 
4) Assessing the robustness of the synthesis (p. 12).  
4.3.2.2 Justification for the narrative synthesis review. 
The narrative synthesis is designed to include literature chosen as it relates to 
the specific concepts of the newly developed model. This review did not 
include all research related to the topic and did not include grey literature, only 
specific peer-reviewed published literature related to the three concepts of the 
newly developed model.  
To meet the requirements of researching literature from the constructivist 
grounded theory approach, after the development of the conceptual model, 
the narrative synthesis method fits the purpose of this review by providing an 
approach that arranges heterogeneous literature into homogenous groups by 
making the context and characteristics of the research study more lucid 
(Barnett-Page & Thomas, 2009; Lucas, Baird, Arai, Law, & Roberts, 2007). A 
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synthesis of the concepts as identified within the included literature is a 
process that allows multiple views to be evaluated in relationship to the 
conceptual model. Grouping based on homogeneity can be helpful to 
synthesize different types of research such as qualitative and quantitative. An 
important consideration of this focused literature review, though, must include 
making careful conclusions, as through homogeneity there may not be much 
diversity of context and therefore if one is looking for specific concepts one 
may find only those specific concepts (Lucas et al., 2007).   
This process is similar to the constructivist grounded theory methodology of 
this research. It allows the reviewed literature to be constantly compared to 
the concepts in the conceptual model and seeks to identify others’ findings 
related to the meaning of advanced recurrence from the participant’s 
perspective. The qualitative literature in this review is looking for broad themes 
and experiences reported in other literature related to people living with 
advanced cancer recurrence and reviewing their designs and contexts related 
to the newly developed conceptual model to compare and contrast the 
findings. This supports the co-construction aspect of the constructivist 
approach of this research. 
This model-driven review is related to the review question and the three 
concepts of the developed model (Reluctant Acceptance, Seeking Life 
Through Continuous Treatment, and Hope in the Face of an Uncertain 
Future); the general guidelines for the narrative synthesis were followed. The 
development of the synthesis process allowed literature that included some or 
all of the three concepts to be included. The literature findings were described 
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as relating to the concepts of the model and the contexts and temporal 
variables of the research (Lucas et al., 2007). The specific population of focus 
in this study of people with advanced cancer recurrence has not been largely 
studied, within the context of newly recognised treatment options for people 
with advanced recurrent cancer, and therefore demanded a broader search of 
literature in an attempt to examine findings that include advanced cancer 
recurrence, treatments received, and data that relate to the concepts of this 
newly developed conceptual model. 
This conceptual model describes the transition phase of cancer free to 
advanced recurrence and incurable disease within a context of time where 
new opportunities for treatment have come available. Therefore, the narrative 
synthesis review allows the comparison of this qualitative data and its 
significance to the convergence and divergence from the theoretical findings 
and the developed conceptual model (Barnett-Page & Thomas, 2009; Dixon-
Woods et al., 2006). By applying a systematic approach to the data search, 
extraction, and analysis of the literature review, transparency and rigour were 
maintained (Bryman, 2012). The convergence or divergence from the relevant 
literature allows the conceptual model to establish a starting point from which 
future research questions may be developed.  
4.4 Literature Review Method 
4.4.1 Method introduction. 
The development of the search strategy required a thoughtful attempt to 
locate literature related to a specific moment in time in the participant’s cancer 
experience, namely, diagnosis with advanced cancer recurrence after a period 
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of time of being cancer free, occurring at a time when treatment opportunities 
for late-stage cancers have improved (American Society of Clinical Oncology 
[ASCO], 2018). This strategy required using a broad set of inclusion and 
exclusion criteria in an effort to find literature that related to advanced cancer 
recurrence, although locating studies where initial treatment led to two or more 
years of cancer free time and the belief in having been cured was minimal. 
Despite broad criteria and a comprehensive search, there were very few 
studies that related to this specific population. A description of the literature 
review strategy and how it was developed follows. 
4.5 Inclusion and Exclusion Criteria 
Table 9 describes the inclusion and exclusion criteria followed for the literature 
review. Two papers believed to reflect similar populations were identified and 
evaluated to examine search strategies for if they were included in the search 
results it helped to verify the search strategy as most likely to provide 
appropriate literature (Nierop-Van Baalen, Grypdonck, Van Hecke, & 
Verhaeghe, 2016; Vivar, Whyte, & Mcqueen, 2010). 
4.6 Literature Review Strategy 
The overall literature review strategy (as shown in Table 10) included 
identifying the participant’s experience of advanced cancer recurrence by 
starting with ‘advanced’; the words used to identify advanced disease included 
palliative care, hospice care, and palliative medicine, as these would gather 
studies focused on late-stage diseases and patients at end of life. Additionally, 




Inclusion and Exclusion Criteria for Literature Review 
Category Inclusion Criteria Exclusion Criteria 
Language English language Grey literature 
Content Qualitative research 
studies reporting 
empirical data related to 
the three concepts of the 
conceptual model: 
Reluctant Acceptance, 
Seeking Life Through 
Continuous Treatment, 
and Hope in the face of 
an Uncertain Future from 
the patient’s perspective 
Theoretical papers and 
publications describing 




Journal type Peer-reviewed journals Non-peer-reviewed 
journals 
Secondary content Secondary analysis of 
qualitative research 
studies reporting 
empirical data from the 
patient’s perspective on 
advanced cancer and 
published in peer 
reviewed journals. 
 
Patient perspective Studies where 
participants describe the 
experience of advanced 
recurrence but this may 
not be the focus of the 
study.  
Studies that do not include 
the patients’ experience 
from their perspective 
 
cancer, carcinoma, oncology, or neoplasms. Identifying meaning was 
searched by including the terms attitude, psychosocial aspects of illness, and 
adaptation. Multiple other words used to capture meaning, including 
experience, feel, view, voice, attitude, perspective, understanding, believe, 
belief, meaning, significance, and hope. And finally to focus the review on 
qualitative studies, search terms included surveys, interviews, narratives, 
focus groups, qualitative research, personal narratives, and ethnography.  
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Table 10 
Brief Overview of Concepts and Search Terms 
Concept Controlled vocabulary terms 
(MeSH or other) 
Text keywords 
Advanced  "palliative care"[mh] OR 
"hospice care"[mh] OR 
"palliative medicine"[mh] 
“Neoplasm metastasis”  
[mh] MW “PA” 
Palliative OR 
Hospice OR 
"end of life" 
stage IV 







Identifying meaning Attitude[mh] OR 
Psychosocial Aspects of 
Illness [mh] 













Qualitative "Surveys and 
Questionnaires"[mh] OR 
"interviews as topic"[mh] OR 
Narration[mh] OR 
"focus groups"[mh] OR 






"focus group" OR 





Note. [mh] refers to mesh headings; * allows all endings applied to that word 
to be included in search.  
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4.7 Search Process 
Searches using the concepts in Table 10 were conducted across four 
databases (CINAHL, PubMed, PsychINFO, and Web of Science) according to 
their particular search terms and architecture. These sources were chosen for 
their breadth of medical, nursing, behavioural, and social science coverage 
where the most relevant literature would be anticipated to be found. Searches 
were conducted up to September 28, 2016. Detailed descriptions of each 
database search are located in Appendixes M, N, O, and P. An additional 
search including neoplasm metastasis and stage IV were conducted in 
PubMed and Web of Science to identify further studies that may have been 
missed by not including those words directly to gather advanced disease 
literature. 
4.8 Study Selection  
The importance of providing a systematic narrative synthesis allows the 
transparency of the selection and synthesis process to support the rigour of 
the study. The goal of this review, in light of the specific population, required 
broad inclusion criteria to attempt to discover literature with related information 
specific to the key concepts of the conceptual model. Therefore, any study 
that met inclusion criteria was included in the literature review. 
The PRISMA figure (Figure 7) describes the screening process with a stop 
date of September 28, 2016. The search yielded 12,505 plus an additional 7 
records identified through reference reviews that were not identified in the 
literature search results. Duplicates were removed and a total of 8,058 articles 
were screened. Based on title and abstract review, 7,957 were excluded, 
leaving 101 articles that were evaluated for inclusion using full text. Of those, 
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51 were excluded and are described with reasons for exclusion in Appendix 
Q. The final number of included studies was 50.  
 
Figure 7. PRISMA flow diagram.  
4.9 Assessment of Quality 
The purpose of a quality assessment of included literature in a review is to 
evaluate the quality of the reported research and the circumstances around 
Records excluded 
(n = 7,957) 
Full-text articles assessed 
for eligibility 
(n = 101) 
Studies included in 
qualitative synthesis 
(n = 50) 
Records identified through 
database searching 
(n = 12,505) 
Additional records identified 
through other sources 
(n = 7) 
Records after duplicates 
removed 
(n = 8,058) 
Records screened 
(n = 8,058) 
Full-text articles excluded 
(n = 51) 
? Focused on unrelated 
concept (n = 13) 
? Not focused on patient 
perceptions of adv. 
recurrence (n = 11) 
? Focused on 
professional or 
caregiver (n = 5) 
? Not qualitative (n = 5) 
? Not interviews (n = 4) 
? Focused on 
intervention (n = 4) 
? Not focused on adult 
population (n = 8) 
? Reprint of earlier 

























which it was carried out, to achieve a trustworthiness as to the validity of the 
data (Maxwell, 1992). Two reasons for completing a quality assessment of 
literature are described as (a) to evaluate the clarity of the researcher’s 
concept and its impact on what it is meant to describe and (b) the rigour of the 
process (Toye et al., 2013). As an additional component of providing rigour to 
a literature review, a clear assessment process is important to establish the 
quality of the research literature being evaluated for its contribution to the 
newly developed conceptual model (Bryman, 2012; Chiovitti & Piran, 2003; 
Dixon-Woods, 2011; Toye et al., 2013). Mishler (1990) adds a relative side to 
the discussion on what the concept of validity means in qualitative research 
and primarily describes the inability to apply a standard model since the 
meaning of validity or trustworthiness in qualitative evaluations is focused on 
meaning and interpretation. Mishler proposes that ‘scientific knowledge is 
socially constructed’ (p. 415), therefore establishing validity as a mutual 
acknowledgement of its value is shown by the researchers’ use of the 
literature in their review. 
Describing validity-related qualitative research includes five considerations as 
described by Maxwell (1992). These provide a philosophical structure to apply 
to qualitative assessment. Maxwell divides the types of validity as follows: (a) 
Descriptive validity: Is the report accurate? (b) Interpretive validity: Are the 
participants’ meanings and experiences accurately understood by the 
researcher? (c) Theoretical validity: Is the theory or theoretical discussion 
about the research accurate and appropriate? (d) Generalizability: Is this 
related to the value and implications of the research for others not directly 
studied? This term is not used in the same way as the term is used in 
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quantitative research appraisal. And finally, (e) Evaluative validity: Has there 
been an evaluative framework used? 
Others have argued there is a problem with quality assessment in qualitative 
research (Carroll, Booth, & Lloyd-Jones, 2012; Dixon-Woods, Shaw, Agarwal, 
& Smith, 2004; Eakin & Mykhalovskiy, 2003; Toye et al., 2013). The criteria 
debate is focused on what criteria are used in qualitative assessment and 
using one standard general set of assessment tools does not take into 
account the epistemological and ontological stance of the researcher (Eakin & 
Mykhalovskiy, 2003). The key argument is that appraising the quality of 
‘insight and interpretation’ (Dixon-Woods et al., 2004, p. 223) is reliant on 
subjective judgement. Therefore, knowing how the reviewer is approaching 
and analysing the content of the research is not an easy or straightforward 
approach (Eakin & Mykhalovskiy, 2003). The problem though still exists that 
within qualitative research there needs to be a process that is identified and 
followed, attempting to establish some assurance that the quality of reviewed 
literature is trustworthy prior to incorporating the findings into, as in this 
instance, a newly developed conceptual model.  
Establishing a framework to evaluate the quality of the included studies is part 
of a narrative synthesis literature review process and is meant to provide 
clarity and a standard of rigour and trustworthiness to the review (Bryman, 
2012; Carroll et al., 2012; Chiovitti & Piran, 2003; Eakin & Mykhalovskiy, 2003; 
Popay et al., 2006; Toye et al., 2013). Therefore, a method was chosen to 
follow that allowed the most opportunity to consider the important 
contributions and methods of the reviewed literature. After examining different 
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quality appraisal frameworks, the Critical Appraisal Skills Programme (CASP) 
model, discussed below, was used, as it has been used with narrative 
synthesis review in other research (CASP, 2013). 
The CASP model provides ten questions for appraising qualitative research 
for inclusion in meta-ethnography reviews (CASP, 2013). Although this review 
is a narrative review, the use of the CASP model is considered applicable and 
allows the process appraisal process to be clearly described. The questions 
focus on reflexivity noted within the research and provide an opportunity to 
describe the value of the research. The CASP questions were used in this 
review to provide a framework for assessing the quality of the included 
literature and believed to be acceptable to the appraisal required by the 
narrative synthesis review (Britten et al., 2002; 2013). Compared to other 
briefer assessment guides, the CASP 10-question tool was believed to be 
more comprehensive by providing more evaluation criteria (Carroll et al., 
2012; Eakin & Mykhalovskiy, 2003; Joanna Briggs Institute). Literature was 
evaluated and graded as defined by Dixon-Woods, Shaw, Agarwal, & Smith 
(2004) as KP (key paper providing rich conceptual insights), SAT (satisfactory 
paper), FF (fatally flawed), and IRR (irrelevant: not meeting inclusion criteria). 
As the literature included had already been evaluated as meeting the inclusion 
criteria, none of the papers in my review were labelled as FF or IRR. One 
paper that is described later was considered SAT but with further review had 
FF components (Kuhl, 2011). It lacked a literature review and the method for 
participant selection was unclear. Participants were referred to as ‘co-
researchers’ but in limitations the author indicates that these ‘co-researchers’ 
had difficulty in describing their experience therefore making developing 
128 
themes difficult. As a result this paper was minimally used for this literature 
review. Five papers were seen as KP and provided rich conceptual insights 
and guidance for the review (Garcia-Rueda, Carvajal Valcarcel, Saracibar-
Razquin, & Arantzamendi Solabarrieta, 2016; Mahon & Casperson, 1997; 
Nierop-Van Baalen et al., 2016; Vivar et al., 2010; Wanat et al., 2016). All 
answers to the CASP questions were ‘yes’ except for a few where direct 
comments identifying contextual understanding were unclear and data were 
not present in the article (e.g., Have relationships between researcher and 
participant been considered?). The papers reviewed are given equal authority 
to describe shared themes related to their context and the concepts of the 
conceptual model. Because this literature review included only peer-reviewed 
journals, it was accepted that the manuscripts had already met professional 
standards required for publication and therefore met the CASP 
recommendations (Bryman, 2012).  
How the data were extracted and managed is discussed next, providing clarity 
to the process to allow transferability of outcomes for future research. 
4.10 Data Extraction Grids 
As part of the narrative synthesis exploring the relationships between the 
studies and comparing information related to the key concepts of the 
conceptual model, a data extraction grid was developed in Excel. It includes 
the authors and article rating, year, research question, title, country, journal, 
design/ methodological orientation, population, setting, and data collection 
method. Additionally, columns were added to include the three key concepts 
of the conceptual model: Reluctant Acceptance, Seeking Life Through 
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Continuous Treatment, and Hope in the Face of an Uncertain Future where 
relationships in the concepts of the findings could be described. Two more 
columns were added: (a) To compare any differences in the data concepts 
that were unrelated to the current developed concepts and (b) A column to 
describe major findings in the article for synthesis focusing on results, 
contexts, and characteristics (Appendix R). 
4.11 Extraction and Synthesis of Literature 
Focusing on the characteristics of the narrative synthesis, the key concepts of 
the conceptual model directed the analysis. Each paper was preliminarily 
reviewed to identify data related to the participant’s experience with advanced 
cancer and any content related to reluctant acceptance, continuous treatment, 
or hope that was described by the participant. Synthesis of the literature 
therefore occurred iteratively as each article was graded, compared, and 
contrasted to the newly developed conceptual model and to the other articles 
to evaluate and compare concepts shared with other research describing the 
experiences of advanced cancer recurrence.  
The contexts of the interviews relating to setting and population as well as 
methodological components of the study were evaluated. Palliative and 
hospice care are accessed differently within the United States in comparison 
to European countries. This is due to U.S. payment systems which provide 
hospice benefits only to patients who are within 6 months of death and are no 
longer receiving chemotherapy or other curative treatments. Palliative care is 
limited in the United States and is not provided consistently across settings 
(Hui & Bruera, 2016). This fact was important to understand the context of the 
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current research setting to compare to the setting where the reviewed study 
took place. This topic is discussed further in Chapter 5: Strengths and 
Limitations. For instance, in studies where participants were interviewed in the 
inpatient hospice care units, there were more feelings of hopelessness related 
to loss of mobility (Davies & Sque, 2002; Kuhl, 2011; Mak, Wood, & Elwyn, 
2005). This perspective would be different for the current researched 
population who were all outpatients in a cancer hospital that does not provide 
inpatient hospice services. Synthesis of the literature with consideration of 
context was then compared and contrasted to the newly developed 
conceptual model for confirmation of applicability.  
4.12 Results 
A total of 50 articles met the inclusion criteria and were included in the 
systematically developed narrative review. The detailed synthesis of the 
reviewed literature related to the three concepts is detailed in Appendix R. The 
CASP results are provided in Appendix S. 
The three primary theoretical concepts as described in detail in Chapter 3 are 
Reluctant Acceptance, Seeking Life Through Continuous Treatment, and 
Hope in the Face of an Uncertain Future. Any findings or concepts that refuted 
the conceptual model are also discussed. The conceptual model was 
developed through a constructivist grounded theory methodology as described 
in Chapter 2, and therefore it is related directly to the participants’ words and 
co-constructed through the researcher; so although the conceptual model 
itself was not expected to change, identifying what others found in similar 
populations would allow refinement of the model concepts if needed.  
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4.13 Reluctant Acceptance 
4.13.1 Concept description.  
Throughout the literature, acceptance is described as a coping mechanism 
that allows patients to accept the disease and move on to seek treatment 
(Brown & de Graaf, 2013; Pineros, Cuartas, & Davalos, 2015; Saeteren, 
Lindstrom, & Naden, 2011). Brown & de Graaf (2013) found that patients with 
advanced-stage cancer experienced high levels of vulnerability and 
uncertainty, but also that the patients redefined it in a positive way, so that 
uncertainty allowed them to compartmentalise negative feelings about their 
future. This allowed patients to experience the risk of death as real, but the 
uncertainty of proximity of death helped them to remain positive (Gibson et al., 
2016). Brown & de Graaf (2013) also found that the uncertainty related to the 
participants’ terminal prognosis and availability of clinical trials led to a ‘wealth 
of uncertainties’ (p. 545). As the treatment options for advanced cancer 
recurrence are growing, more research is needed in this area to understand 
the impact on decision-making and informational needs. Seeking knowledge 
about treatments remains an important strategy for people with advanced 
cancer recurrence to help manage the uncertainty and cope with advanced 
disease. Several studies cite the need to have control through knowledge or 
health promotion, which allowed patients to accept their diagnosis and control 
their future (Volker, Kahn, & Penticuff, 2004; Warmenhoven et al., 2016). 
Wanat, Boulton, & Watson (2016) in their meta-ethnography, stated that 
‘providing information and communication were integral to patients’ 
experience of recurrence’ (p. 248). In Clavarino, Najman, & Beadle (2003), 
although participants were told they had advanced terminal cancer, they were 
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receiving treatment and chose to believe it was incurable but not fatal. In 
Ekwall, Ternestedt, & Sorbe (2007) understanding the extent of their disease 
as being incurable was described as well as focusing on a positive attitude to 
keep living despite despair of disease. The concept of reluctant acceptance 
was the starting point for dealing with the diagnosis of advanced recurrence 
and described similarly in the reviewed literature. This acceptance often 
reflected how participants coped in their initial diagnosis and how they coped 
with the news of recurrence (Saeteren et al., 2011).  
4.13.2 Synthesis of the literature regarding Reluctant Acceptance.  
The concept of Reluctant Acceptance is related to acknowledging the 
transitional meaning of this diagnosis from believing cured to incurable 
disease and moving into a new phase of living with advanced cancer 
recurrence. Studies in the literature reported how patients recognised death 
as a possibility and yet focused on continuing to live (Brown & de Graaf, 2013; 
Chen et al., 2015; Coyle, 2006; Gibson et al., 2016). Patients are reported in 
these studies as describing the need to sensitise themselves to the new reality 
of advanced disease and worked to prolong life (Banning & Tanzeem, 2013; 
McWilliam, Ward-Griffin, Oudshoorn, & Krestick, 2008). Using adaptation and 
acceptance as a coping mechanism, participants integrate the experience into 
their lives, move forward, and live with their disease (Davies & Sque, 2002; 
Krigel, Myers, Befort, Krebill, & Klemp, 2014; Pineros et al., 2015; Saeteren et 
al., 2011). They hope for remission and a longer life with reluctant acceptance, 
which helps them adapt to change and live with new meaning as they 
personally re-evaluate the acceptable parameters of quality of life (Garcia-
Rueda et al., 2016).   
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Previous literature consistently describes a component of this reluctant 
acceptance as related to faith in God or the belief in God’s will (Lin, 2008; 
Mak, 2002; Montoya-Juarez et al., 2013). Studies describe how religious faith 
facilitated this reluctant acceptance as patients described faith as a belief and 
trust in God, who has the power to heal. This faith allowed patients to adapt to 
this advanced disease yet maintain hope and a fighting spirit (Montoya-Juarez 
et al., 2013; Pineros et al., 2015; Saeteren et al., 2011; Svensson, Brandberg, 
Einbeigi, Hatschek, & Ahlberg, 2009).   
4.13.3 Application of literature regarding Reluctant Acceptance 
with the newly developed conceptual model. 
The concept of Reluctant Acceptance is reported in previous literature as 
avoidance of death. In Chinese studies, (Mak, 2002; Mak et al., 2005), ‘letting 
go’ allowed participants to maintain control of dying. This was described as 
not allowing death to direct them, but instead letting go of the fear of death to 
focus on living, which provided participants with hope and reduced their fear 
and suffering (Mak et al., 2005; Mok et al., 2010). Both of these studies 
discussed the concept of acceptance as maintaining control of the situation.   
MacArtney et al. (2015) described how patients accept a change in plans to 
transition to palliative care. The authors described the potential downside of 
resilience and acceptance as disruptive at end of life and negatively affecting 
quality of life. From MacArtney et al.’s perspective, a participant’s reluctant 
acceptance and focus on living longer prevents the transition to palliative care 
or hospice care, as the participant continues to seek more treatments. Gibson 
et al. (2016) also describe how the attitude of seeking treatment and focusing 
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on surviving a cancer recurrence also prevents discussions about mortality 
and planning for end of life. The concept of Reluctant Acceptance includes 
making a decision to seek treatment and choose not to focus on death or 
dying from their advanced cancer recurrence.   
Anger for the study population in this grounded theory analysis was an initial 
response to the realization of their diagnosis of advanced recurrent cancer 
and contributed to the concept of Reluctant Acceptance; it was not identified 
similarly in a literal sense in the literature. This difference may be related to 
the issue of most literature having included participants closer to the end of life 
as compared to this study’s focus on people who had recently received 
unexpected news of advanced recurrence and were receiving outpatient care. 
The participants in this research study experienced anger but then refocused 
their energy to seek knowledge and locate potential treatments to prolong 
their lives. The literature review related to this concept may have had less 
anger described as anger per se, but may have been due to cultural or 
religious beliefs that speaking or acknowledging anger or cancer could attract 
negative feelings or bad results (Banning & Tanzeem, 2013; Chen, 
Komaromy, & Valentine, 2015). Participants who describe feelings of 
alienation, such as ‘living in limbo’ (Ekwall et al., 2007), could have included a 
sense of anger or sadness associated with those feelings. 
4.13.4 Summary. 
Reluctant Acceptance is the catalyst to seek treatment and to move forward. 
Reluctant Acceptance was related to the positive attitude and positive 
approach that participants in this study exhibited with their new diagnosis. 
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Age, minimisation gravity of disease status, and seeking knowledge were 
subcategories that supported the concept of accepting their recurrence and 
working to prolong life while confronting the prospect of death (Chen et al., 
2015; Coyle, 2006; Dale & Johnston, 2011). These factors and concepts were 
supported by the literature (Best, Butow, & Olver, 2014; Brown & de Graaf, 
2013; Montoya-Juarez et al., 2013; Nierop-Van Baalen et al., 2016; Pineros et 
al., 2015). This catalyst motivated participants to seek treatment as they 
gathered energy from the knowledge that treatments were available and the 
hope they felt related to their treatment options (Brown & de Graaf, 2013; 
Chen et al., 2015; Coyle, 2006; Daneault et al., 2016; Garcia-Rueda et al., 
2016; Karlsson, Friberg, Wallengren, & Ohlen, 2014). 
4.14 Seeking Life Through Continuous Treatment 
4.14.1 Concept description. 
The concept of Seeking Life Through Continuous Treatment is related to 
participants’ focus on aggressively fighting the cancer amidst advanced 
recurrence to continue living. The inclusion of this concept in the development 
of the conceptual model was clearly described by participants and reinforced 
through the reviewed literature. 
4.14.2 Synthesis of the reviewed literature regarding Seeking Life 
Through Continuous Treatment in the newly developed 
conceptual model.  
Multiple articles reviewed included participants’ specific comments related to 
treatment and the importance of having treatment options available. Hope for 
a future was related to having treatment options available for their advanced 
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cancer (Banning & Tanzeem, 2013; Brown & de Graaf, 2013; Chen et al., 
2015; Clavarino et al., 2003; Coyle, 2006; Garcia-Rueda et al., 2016; Karlsson 
et al., 2014; Lin, 2008; Mahon & Casperson, 1997; McCarthy & Dowling, 
2009; McTiernan & O'Connell, 2015; Nissim, Rennie, et al., 2012; Pineros et 
al., 2015; Reynolds, 2008; Robinson, 2012; Saeteren et al., 2011; Sarenmalm, 
Thoren-Jonsson, Gaston-Johansson, & Ohlen, 2009; Svensson et al., 2009; 
Weeks et al., 2012). Participants described the opportunity to receive 
treatments to prolong their life as providing hope for a future and the belief 
that because treatment worked for them earlier in their diagnoses, it will work 
again (Brown & de Graaf, 2013; Clavarino et al., 2003; Mahon & Casperson, 
1997; Svensson et al., 2009).  
Karlsson et al. (2014) completed a phenomenological study to understand 
uncertainty in participants receiving palliative treatment with advanced 
gastrointestinal cancer. The ability to receive treatment supported the 
participants’ feelings of existential certainty and contributed to decreasing their 
sense of vulnerability and uncertainty. The option to receive treatment, 
regardless of the disease stage, reinforced a belief related to prognosis as 
incurable, rather than fatal (Clavarino et al., 2003).   
McCarthy & Dowling (2009) completed a phenomenology study of 
participants’ living with non-small cell lung cancer. Their findings were very 
similar to my current study with key themes echoing maintaining normal life 
and continuing treatment. Similar to this current study, the population in 
McCarthy & Dowling (2009) was very focused on the importance of treatment 
to maintain living. The fear of stopping treatment and its consequences were 
137 
also expressed by these participants as not an option and were consistent 
with this study’s findings. McCarthy & Dowling’s study findings of lung cancer 
patients support the concept of continued treatment and the conceptual model 
describing the experience of living with advanced cancer recurrence. 
4.14.3 Differences noted between literature review and current 
research.  
Two studies found that the need to continue treatment was identified as the 
means to prolong life, but the studies also described the downside of 
continuous treatment (MacArtney et al., 2015; McKechnie & MacLeod, 2007). 
These studies both took place in inpatient hospice units, which may account 
for patients’ negative views on continuous treatment. These participants were 
within days to weeks of death, which was unlike this recent grounded theory 
study whose participants were very functional and receiving outpatient 
treatment. In McKechnie & MacLeod’s (2007) study, participants described 
treatment as ‘haphazard’ (p. 258), and reported having a sense of not knowing 
what treatment would or could achieve. MacArtney et al. (2015) recognized 
the downside of uncertain treatment and prolonging life in the face of 
inevitable death. MacArtney et al. described seeking treatment as a ‘toxic 
resilience’ (p. 9) that can be ‘counter-productive’ (p. 9) to the participants’ 
quality of life, as they transition to end of life. The population in the MacArtney 
et al.’s study were inpatient hospice patients and were transitioning to end of 
life, unlike the population with whom this conceptual model was developed: 
those who continued treatment and were not focused on end of life but on 
survival. 
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The key differences rest in the population in this evolving conceptual model as 
more recent experience of recurrence as compared to previous studies whose 
participants were often receiving hospice over a longer length of time and 
closer to death. Studies in the reviewed literature took place in multiple 
settings and in multiple countries, reinforcing the strategy used by participants 
in my research to prolong life through continuous treatment (Garcia-Rueda et 
al., 2016; Gibson et al., 2016; Mahon & Casperson, 1997; Reynolds, 2008; 
Svensson et al., 2009).  
4.14.4 Summary. 
Participants’ response to newly recurrent advanced cancer was a desire to 
seek treatment with the hope of living longer. Reynolds (2008) reinforced the 
findings in this current study. Although the timing of the interviews in relation 
to the time of diagnosis were not clearly specified in many of the studies 
examined, participants living in inpatient hospices without access to further 
treatments were focused on end of life and not anticipating living a longer life 
with continuous treatment (Karlsson et al., 2014; Mak, 2002; Mak et al., 2005; 
Mok et al., 2010). When treatment was available, participants focused on the 
reality that although this disease was not curable, it was treatable (Clavarino 
et al., 2003; Pineros et al., 2015; Weeks et al., 2012).  
The similarity between the reviewed literature and this newly developed model 
were related to continued hope across studies and a focus on maintaining 
quality of life. This focus on the ability to receive treatment and its meaning 
that continued life is possible is a universal belief regardless of stage of 
cancer diagnosis or recurrence. The current treatment options available for 
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people with advanced cancer continue to reinforce the meaning of Seeking 
Life Through Continuous Treatment. 
4.15 Hope in the Face of an Uncertain Future  
4.15.1 Concept description. 
The concept of hope, referred to in my research as the concept of Hope in the 
Face of an Uncertain Future was described in the reviewed literature as 
complex, abstract, and individual, making it difficult to define (Eliott & Olver, 
2007; Johnson, 2007; McClement & Chochinov, 2008). In the articles 
reviewed, participants’ feelings about the concept of hope were related to a 
feeling of expectation and desire for something to happen. Hope was defined 
by Dufault & Martocchio (1985) as the expectation that something important to 
the individual is realistically possible, even if it is uncertain. Hope with 
uncertainty in this current literature review provides the foundation of the 
framework for the newly developed conceptual model. Subcategories as 
described in Chapter 3 that contributed to the concept of Hope in the Face of 
an Uncertain Future, included faith in their physician, family support, spiritual 
faith, meaning of illness, and minimising feelings through humour and 
laughter. Many of these subcategories were reflected in the literature 
synthesis and are described below.   
4.15.2 Synthesis of the literature regarding hope. 
The concept of hope related to advanced cancer, and advanced cancer 
recurrence was described in 40 of the 50 articles. The concepts of hope 
related to the specific articles are included in Table 11.  
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Table 11 displays the papers in the literature review where the concept of 
hope was identified. Additional themes are identified that were within the 
research findings of the included literature.  
Table 11 
Hope-Related Concepts in Reviewed Literature: Author and Year 
Hope concepts and themes included 
in reviewed literature Lead author (year) 




Neirop-Van Baalan (2016) 
Reynolds (2008) 
Vivar (2009) 
Yedida (2001)  
Hope / age Duggleby (2004, 2005) 
Hope / age 20-59 Pineros (2015) 
Hope / psychosocial meaning Schildmann (2013) 
Montoya-Juarez (2013) 
Hope / age / psychosocial meaning Mahon (1997) 
Hope / age / cultural impact Chen (2015) 
Hope / cultural impact Banning (2013) 
Hope / spirituality Best (2014) 
Hope / faith Lin (2008) 
Hope / positive attitude / being strong Lewis (2016) 
Hope / belief in curability / treatment Clavarino (2003) 








Hope concepts and themes included 
in reviewed literature Lead author (year) 
Hope / uncertainty Brown (2013) 
Karlsson (2014) 
Svensson (2009) 
Hope / uncertainty / normalcy Krigel (2014) 
Hope / treatment Sarenmalm (2009) 
Hope / prolonging life w/treatment Wanat (2016) 
Hope / dying Nissim (2012) 
Hope / dying / uncertain future Ekwall (2007) 
McTiernan (2015) 
Eliott (2009) 
Hope / acceptance of dying Mak (2002) 
Hope / meaning in palliative care / 
living with cancer 
Flemming (1997) 
Hope / resilience–transition to 
palliative care at end of life 
MacArtney (2015) 
 
4.15.3 Hope and interconnectedness. 
Hope was expanded by the interconnectedness between the participant, 
family, and friends supporting the desire to live a longer life (Chen et al., 2015; 
McTiernan & O'Connell, 2015). Research describes how, in the Chinese 
culture, the family is very important and participants admitted ‘staying alive for 
their significant others’ (Chen et al., 2015, p. 162). Others described the 
importance of social contact and family and the connectedness within the 
larger community: ‘If it becomes too much for me, I look for someone to talk 
with, for a while. And now I have found someone to talk to through an 
organization of volunteers’ (Warmenhoven et al., 2016, p. 4). 
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4.15.4 Hope as a motivator. 
Hope was described across studies as a feeling supporting self-motivation, a 
positive attitude (Eliott & Olver, 2009; Garcia-Rueda et al., 2016; McCarthy & 
Dowling, 2009). Hope was described as providing courage to deal with the 
future as well as present problems. Lewis, Willis, Yee, & Kilbreath (2016) 
described how positive thinking, hopefulness, and being strong helped with 
anxiety, uncertainty, and fear. Hope was seen as an essential part of being 
human; it was described as necessary for existence (Eliott & Olver, 2009). 
Hope was seen as a buffer against challenges and that maintaining hope 
allowed them to keep going. As Eliot & Olver (2009) reported from a 
participant’s interview, ‘Well, put it this way, without hope, I think there would 
be nothing’. (p. 616). They described a sense of energy included with this 
human need to maintain hope even in dying patients (Eliott & Olver, 2007). 
A participant in Duggleby & Wright’s 2004 study said, ‘I would say if you don’t 
have any hope, I would just slowly wither away. If you don’t have any hope, 
then you have nothing for the future or even for the present’ (p. 355). A 
secondary analysis done by Nierop-Van Baalen et al. (2016) described their 
work on maintaining hope, described as something that gives energy and 
takes energy. The positive aspect of gaining energy allowed them to maintain 
hope and focus on living longer. Hope was described a motivator for life 
(McCarthy & Dowling, 2009; Reynolds, 2008). Chen et al. (2015) explained: 
‘When days cannot be added to life, add life to days’ (p. 161). 
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4.15.5 Hope and living longer. 
Participants in the included studies described their feelings of hope as hoping 
for a cure or remission that would allow a longer life, while at the same time 
recognizing the stage of their disease as being incurable, and hoping for a 
good or peaceful death (Chen et al., 2015; Coyle, 2006; Daneault et al., 2016; 
Eliott & Olver, 2009; Flemming, 1997; McWilliam et al., 2008; Svensson et al., 
2009). Duggleby & Wright (2005) described transforming hope and the 
process of living with hope, and acknowledging ‘life the way it is’ (p. 77). This 
idea was seen in other studies where hope and acceptance of the advanced 
diagnosis of cancer was dealt with by focusing on living day-to-day. Focusing 
on living and keeping going was important (Duggleby & Wright, 2005). 
Maintaining hope for a cure was shown to improve quality of life for 
participants and support resilience (Robinson, 2012). Even in light of terminal 
disease, participants described a hope for healing and life: ‘What is important 
is that there is hope that I can recover’ (Montoya-Juarez, 2013 p 59). This 
motivation to choose life and focus on each day gave them the ability to 
maintain the possibility of living longer.  
4.15.6 Hope and spirituality. 
Spirituality and spiritual well-being contributed to the ability to find strength 
and courage to go forward. Best et al. (2014), in a study with advanced cancer 
patients, found the relationship between self, family, and God was intrinsic to 
quality of life and a sense of wholeness. Duggleby & Wright (2004) described 
the importance of faith in God in their participants and the belief that faith 
supported hope by believing that God would help them and reduce their 
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suffering, ‘I think without God I don’t have any hope at all. He certainly does 
provide a spot or a garden for our thoughts’ (p. 357). As many others did 
describe, faith supported hope and a sense of normalcy (Coyle, 2006; Garcia-
Rueda et al., 2016; Lin, 2008; Mok et al., 2010). Religious faiths facilitated 
eternal life and hope for a future (Mak, 2002; Reynolds, 2008). 
4.15.7 Hope and treatment. 
The concept of hope as increasing from the ability to receive treatment formed 
a key part of the conceptual model of Reluctant Acceptance of Living with 
Advanced Cancer Recurrence. Treatment represented a chance to live and a 
source of hope (Garcia-Rueda et al., 2016; Nierop-Van Baalen et al., 2016; 
Svensson et al., 2009). Although this sense of having an option for treatment 
meant hope, the intent of the treatment was not understood as described in 
Weeks et al. (2012). Those authors studied 1,193 patients within 4 months of 
receiving a diagnosis of metastatic stage IV lung or colorectal cancer who 
opted for chemotherapy for incurable cancer. In this study, 69% of the lung 
cancer patients and 81% of the colorectal cancer patients did not understand 
that receiving chemotherapy was not an option for cure (Weeks et al., 2012, p. 
1616). Treatment gave hope for more time to live, in a study done by Chen et 
al. (2015). Chinese patients, regardless of their cultural traditions or their 
spiritual beliefs in Buddhism or Taoism in which death is a normal expected 
part of life, they were also motivated to seek continued life. Hoping for the best 
helped them find meaning and ‘stay engaged in living while shouldering the 
burden of an uncertain future’ (Chen et al., 2015, p. 161). 
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4.15.8 Summary. 
The concept of hope over the participant’s continuum of the experience of 
cancer recurrence was about prolonging life, but if that was not possible, 
patients transitioned to hoping for a good quality of life (Daneault et al., 2016; 
Pineros et al., 2015). A key finding within this synthesis of literature is the 
understanding of hope as a dynamic concept that changes over the course of 
disease and may be related to symptoms experienced, such as unrelieved 
pain or the realization that death is inevitable (Duggleby & Wright, 2004; 
Robinson, 2012). Brown & de Graaf (2013) referred to this transition as the 
spectrum of uncertainty, as hope moved from active to passive. There was a 
consistent focus in the literature on the future in this dynamic process of 
living—while at the same time dying—with incurable disease (Clayton, Butow, 
Arnold, & Tattersall, 2005a; Coyle, 2006; Ekwall et al., 2007; McTiernan & 
O'Connell, 2015). The concept of the hope continuum appears to transcend 
cultures. Chen et al. (2015) explored the experience of end of life among older 
patients in China. They described the patients’ desire to live longer, even with 
recognition they were dying. Banning & Tanzeem (2013) describe the 
experience of women in Pakistan being treated for advanced breast cancer; 
they had more descriptions of ‘knowing I will die’ (p. 256) and noted cultural 
discrimination and stigma of cancer and lack of support, and yet were still 
positive and hopeful for a future: ‘Life is beautiful and when a person is alive 
she is hopeful’ (p. 257). 
The review of literature above reinforces the concepts of the conceptual model 
of Reluctant Acceptance of Living with Advanced Cancer Recurrence. Hope is 
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an essential element of the experience impacting the lives of these people as 
they make treatment decisions and face the uncertainty of their lives. 
4.15.9 Differences between literature review and conceptual 
model developed from my study’s findings 
In comparing all of the included literature to the results of the current research, 
five studies described a finding of hopelessness in patients with advanced 
disease. These studies described feelings of hopelessness resulting from 
patients’ advanced disease and their realization that they would die (Banning 
& Tanzeem, 2013; Coyle & Sculco, 2004; Davies & Sque, 2002; Kuhl, 2011; 
Mak et al., 2005). These studies describe patients’ social isolation and their 
need to build a new identity within this life experience of advanced cancer 
recurrence. Unrelieved symptoms, fear of loss of dignity, and ‘unendurable’ 
(Coyle & Sculco, 2004, p. 699) suffering are areas where people with 
advanced cancer have described feeling hopeless and a wish to die (Coyle & 
Sculco, 2004; Mak et al., 2005). Additionally, settings where the research took 
place and as described above the severity of suffering they were experiencing 
influenced this response to advanced cancer. The Davies & Sque (2002) 
study took place in an inpatient hospice unit in Hong Kong. This inpatient 
setting and the patients’ advanced disease state influenced the feelings of 
lack of future and social isolation and the changes in how they identified 
themselves. A second study by Kuhl (2011), although it is not highly appraised 
for the quality of its research technique, included patients’ words describing 
similar feelings related to unrelieved symptoms, feelings of isolation, and also 
the spiritual impact on coping during those times. Kuhl’s study participants 
included AIDS patients and those patients may also experience emotions 
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similar to the cultural experiences described by the Chinese and Pakistani 
studies, where isolation and stigma of having a cancer diagnosis or fear of 
communicable disease caused increased suffering for people experiencing 
advanced cancer recurrence (Banning & Tanzeem, 2013; Kuhl, 2011; Mak et 
al., 2005).  
Pineros et al. (2015) described advanced colorectal patients’ feeling less 
hopeful for remission or stable disease based on their symptoms. In this 
population, improved symptoms brought an increase of hope, whereas 
worsened symptoms, such as unrelieved pain, brought feelings of 
hopelessness and a sense of worsening prognosis. Participants in this 
grounded theory study did not discuss symptoms as a major factor in the 
interviews, possibly because their disease had only recently recurred and 
symptoms had not become a major concern. 
These responses were not seen in my study’s model, but this may be due to 
the timing of my study. These participants were within two weeks to one year 
of recurrence, and only one participant was dealing with symptoms that were 
primarily skin changes and fatigue; otherwise they were independent and able 
to live their lives without inconveniences at this time. This allowed them to 
maintain a hopeful and positive attitude.  
4.15.10 Conclusion and influence of hope on the conceptual 
model of Reluctant Acceptance of Living with Advanced 
Cancer Recurrence. 
The concept of hope as described in this conceptual model is reflected in the 
perspectives of the reviewed literature (Eliott & Olver, 2007; MacArtney et al., 
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2015). The perspectives of hope across studies were similar in participants 
who were experiencing advanced cancer nearing end of life and those who 
had been receiving care in inpatient hospices and palliative care units (Mak, 
2002; Pineros et al., 2015). Hope in people experiencing advanced recurrent 
cancer provided resilience and energy to cope with their uncertain future 
(Brown & de Graaf, 2013; Daneault et al., 2016; Duggleby & Wright, 2004; 
Garcia-Rueda et al., 2016). Participants in the reviewed literature were 
disinterested in talking about end of life, especially when treatment options 
were available (Gibson et al., 2016; Lewis, Willis, Yee, & Kilbreath, 2016). The 
meaning of hope remains a complex concept that provides a means of coping 
with advanced recurrent cancer from initial recurrence and focus on seeking 
treatment and supporting the transition to the end of life. Hope becomes 
focused toward a peaceful, symptom-free, good death (Daneault et al., 2016; 
Reynolds, 2008; Robinson, 2012). Hope has been shown to be a complex 
emotion described by participants experiencing advanced cancer recurrence 
and seeking survival.  
4.16 Discussion 
The three concepts constructed through the CGT method and the narrative 
synthesis literature review has shown that these concepts are consistent with 
other research on advanced cancer recurrence. This review substantiates the 
inclusion of the three concepts of Reluctant Acceptance, Seeking Life Through 
Continuous Treatment, and Hope in the Face of an Uncertain Future as they 
pertain to people acknowledging and living with advanced cancer recurrence 
in the context of improved treatment options for advanced-stage cancers. The 
reviewed literature substantiates the relationship between Reluctant 
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Acceptance and treatment providing hope; other research as described above 
has shown the relationship between hope and treatment and the need for 
acceptance of the recurrence as a catalyst to seek living through treatment. 
This newly developed conceptual model captures a moment in the time 
immediately after diagnosis with advanced recurrence, after participants had 
experienced two or more years of cancer free time and considered 
themselves to be cured at a time where improved treatment options are 
changing the paradigm of care for people with advanced-stage cancer. The 
systematically developed narrative synthesis review allowed the concepts to 
be compared to other qualitative literature related to these three concepts in 
people experiencing advanced cancer recurrence. The literature syntheses 
further supported the theoretical development of this research and did not 
alter the conceptual model but did reinforce what this experience of advanced 
cancer recurrence is and the unique experience of these participants 
transitioning from considering themselves as free of cancer to now living with 
cancer at a time when more people are living with advanced-stage cancers.   
4.17 Limitations 
This literature synthesis is limited by having been performed by only one 
reviewer. The lack of multiple reviewers may have limited objectivity and 
provided opportunity for error. Thesis supervisors did provide some level of 
review, but detailed discussions of categories and concepts from the reviewed 
literature were limited.   
The narrative synthesis approach was chosen because it provided a 
framework that closely fit the constant comparison and inductive process of 
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constructivist grounded theory. The literature review was focused on 
evaluating this newly developed conceptual model when there are limited 
numbers of studies that directly relate to the specific population. Therefore, 
the framework of a review aimed at contributing to the interpretation of the 
review findings and flexible enough to allow the iterative approach necessary 
to compare and contrast literature to this point in time was important (Barnett-
Page & Thomas, 2009; Dixon-Woods, Agarwal, Jones, Young, & Sutton, 
2005; Lucas et al., 2007; Popay et al., 2006).  
As per CGT, the purpose of the delayed literature review is to ‘claim, locate 
and evaluate literature to defend the constructed findings’ (Charmaz, 2014, p. 
305). This literature review allows the synthesis of multiple studies to help 
define the experience of people seeking to live with a newly diagnosed 
advanced cancer recurrence. Although the delayed completion of the literature 
review remains controversial, it is a recognized approach for constructivist 
grounded theory. Continually asking the question, ‘what is happening in the 
data?’ was not only part of the original interview analysis, but it was a part of 
the literature review and synthesis, as it pertained to the development of the 
conceptual model (Chiovitti & Piran, 2003, p. 429). My understanding of the 
participants’ perspective contributes to the constructivist results and therefore 
a limitation to the results is in reference to the specific period of time of this 
research study and the meanings developed for this moment in time 
(Charmaz, 2014; Chiovitti & Piran, 2003). This literature synthesis has added 
to the methodological literature in identifying this period of disease recurrence 
as unique and distinct from later stages in recurrence where people have 
increased symptoms, unendurable suffering, and are focused on end of life as 
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was seen in the literature (Chen et al., 2015; Coyle & Sculco, 2004; Mak, 
2002; Mak et al., 2005).  
4.18 Strengths 
The delaying of the literature review was central to performing this study, and 
understanding the participants’ experience with advanced cancer recurrence 
within the context of evolving treatment options. By following this method, I 
was cautious to not be influenced by other theoretical concepts that could 
have altered or biased the results of this study (Charmaz, 2014; Giles et al., 
2013). This literature review synthesis fit well within the CGT, allowing the 
theoretical development to be evaluated and situated within the defined period 
of the cancer trajectory. This narrative synthesis literature review allowed the 
findings to be compared, and substantiated and sustained the inclusion of 
these important concepts of advanced cancer recurrence in my study’s 
conceptual model of Reluctant Acceptance of Living with Advanced Cancer 
Recurrence. The descriptions of the participants describing their experience 
with advanced cancer recurrence were supported by this current research 
study and supported this newly developed conceptual model. It also reinforces 
the transferability or fittingness of the model.  
4.19 Summary 
In summary, this specific approach to the narrative synthesis literature review 
allowed the use of other findings to support the conceptual model generated 
by this research through context and characteristics comparisons (Barnett-
Page & Thomas, 2009; Dixon-Woods et al., 2005; Popay et al., 2006). The 
three main concepts defined in the model stand as (a) Reluctant Acceptance, 
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(b) Seeking Life through Continuous Treatment, and (c) Hope in the Face of 
an Uncertain Future. The context of this conceptual model is based on a 
specific time in the trajectory of the participants’ recurrence of cancer, in those 
participants having lived two or more years without evidence of disease, 
having believed themselves to be cancer free. Within this context of evolving 
treatment options, the phases of survivorship no longer rest at extended 




Discussion: Seeking Life With Advanced Cancer Recurrence 
5.1 Introduction 
The final conceptual model of Reluctant Acceptance of Living With Advanced 
Cancer Recurrence is presented in this chapter. The chapter reflects the 
process of conceptual development of the model, it critically considers my 
study’s findings in reference to the previous literature discussed in Chapter 4 
and, it outlines the key findings and the evidence drawn from the data 
collection. Strengths and limitations of the study, as well as implications and 
recommendations for future research, are included. Final considerations 
related to this study’s contributions to the fields of palliative care and cancer 
survivorship are discussed in the conclusion. 
5.2 Conceptual Model of Reluctant Acceptance of Living With 
Advanced Cancer Recurrence: Process of Development 
A conceptual model provides ‘a set of highly abstract, related constructs that 
broadly explains phenomena of interest, expresses assumptions, and reflects 
a philosophical stance’ (Burns & Grove, 2001, p. 793). The conceptual model, 
Reluctant Acceptance of Living with Advanced Cancer Recurrence is 
empirically grounded in the experience of people with cancer who, for a 
minimum of two years, perceived themselves to be cured of their disease and 
then subsequently experience a recurrence with incurable stage III or IV 
disease. The model depicts the relationship between the theoretical concepts 
that have been constructed from the data describing the experience of living 
with advanced cancer recurrence. The three concepts constructed through the 
grounded theory method are: Reluctant Acceptance, Hope in the Face of an 
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Uncertain Future, and Seeking Survival Through Continuous Treatment. The 
literature review in Chapter 4 substantiates the final constructed concepts of 
the conceptual model and provides the background for this discussion. This 
model describes the interrelationship of the three concepts (Reluctant 
Acceptance, Seeking Survival Through Continuous Treatment, and Hope in 
the Face of an Uncertain Future) to the experience of living with advanced 
cancer recurrence in the changing context of evolving treatment options such 
as immunotherapy and focused treatments. This model of living with 
advanced cancer recurrence is an important contribution to the field of cancer 
survivorship and focuses on a subpopulation of people living with advanced-
stage cancer who now have treatment options that have been specifically 
designed to include people with advanced cancer. The population of this study 
views their advanced cancer recurrence as incurable but not terminal. This is 
a perspective that in the past was different for people diagnosed with stage IV 
advanced cancers who were told there was nothing more that could be done 
(Couzin-Frankel, 2013).  
5.3 The Conceptual Model of Reluctant Acceptance of Living with 
Advanced Cancer Recurrence: Steps in the Development of the 
Model    
The concepts were constructed through the understanding of the abstract 
meanings of the codes conceptualised from the interviews. The model 
illustrates the progression from diagnosis with advanced cancer recurrence to 
treatment. As such it reflects the experience of participants from the moment 
of diagnosis with advanced cancer recurrence and the subsequent infinite 
movement from treatment to remission and back again. Figure 8 illustrates the 
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initial description of the conceptualisation of the experience of advanced 
cancer recurrence as the infinity symbol. 
 
Figure 8. Infinity model.  
This continuous motion was described by participants receiving treatment and 
either had stable disease or sought new treatment with recurrence. Newer 
treatment options require continuous dosing to support stable disease. In an 
effort to illustrate the significance of maintaining stability of the disease, a 
revised model (Figure 9 below) was used to capture the relationship seen 
between treatment and remission to maintain stable disease. The circular 
diagram came closer to clarifying the interrelationship between treatment 
without curable intent and maintaining stable disease. At this point, the 
process was conceptualised as continuous until death and therefore included 
two options that might describe what happens when treatment is either no 
longer available or they return to remission. This model was revised as my 
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research is not longitudinal and therefore it cannot be assumed that this is the 
case without further research (Figure 9). 
	
Figure 9. Circle transition.  
The concepts of Reluctant Acceptance, Seeking Life Through Continuous 
Treatment, and Hope in the Face of an Uncertain Future were constructed 
from the participants’ experience of advanced recurrence as detailed in 
Chapter 3. Figure 10 attempts to describe the interrelationship between the 
three separate concepts and describe the experience of advanced recurrence. 
Treatment is the force that moves participants in this study from reluctant 
acceptance to hope; therefore, the treatment cog was the largest and initial 




Figure 10. Gears model.  
This figure still did not capture the hope for treatment and the treatment 
encouraging hope that were central to the experience of this population. There 
was a clear movement from initial diagnosis of advanced cancer to reluctant 
acceptance and moving into this process of hoping for treatment that was 
mixed with the uncertainty of treatment options and hope for living a longer 
life. Those two concepts—Seeking Life Through Continuous Treatment and 
Hope in the Face of an Uncertain Future—supported one another, depending 
on the ability to receive treatment. Therefore, because all of these participants 
were seeking treatment and receiving treatment, this model captures this 
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looping transition between advanced cancer recurrence and treatment. But it 
was important to establish the point of the cancer trajectory this research is 
describing. Figure 11 illustrates the conceptualisation of these interrelating 
concepts as they circled treatment and hope. Hope increased, as seeking 
treatment and the ability to receive treatment increased hope as participants 
lived this experience of advanced cancer recurrence after believing they had 
been cancer free. But this concept was still not visible in the model. 
	
Figure 11. Developing circle of 3 concepts together.  
Therefore with further review of the models and re-examining the data, Figure 
12 shows how the conceptualisation developed into the final model as the 
interrelationship and impact of the three concepts were constructed.  
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As identified in Figure 12 the emerged conceptual model of Reluctant 
Acceptance of Living with Advanced Cancer Recurrence includes the circle of 
treatment and hope, which remains an important piece of the final model as 
the focus of the experience at that particular time in the trajectory from 
diagnosis. The significance of reluctant acceptance is clearer in this final 
model. The direction of the movement from diagnosis through anger and 
sadness to reluctant acceptance as the catalyst that encourages seeking life 
through continuous treatment and creates hope in the face of an uncertain 
future. 
 
Figure 12. Conceptual model: Reluctant Acceptance of Living with Advanced 
Cancer Recurrence.  
160 
5.4 The Conceptual Model of Reluctant Acceptance of Living with 
Advanced Cancer Recurrence  
Figure 12 presents the final developed conceptual model illustrating the key 
concepts, and capturing their interrelationship and impact during this distinct 
phase of the cancer trajectory, set within the phase of transition. The person 
with advanced cancer recurrence experiences extended disease-free survival 
to advanced cancer recurrence (Miller et al., 2008; Mullan, 1985). The concept 
of Reluctant Acceptance is the coming to terms with the change in disease 
status and the individual’s appraisal of the situation and motivation to move 
forward in an effort to cope with this new phenomenon. Seeking Life Through 
Continuous Treatment is a coping strategy that promotes hope and provides a 
plan to manage this phenomenon that allows the person experiencing 
advanced cancer recurrence to reduce stress by feeling they are in control 
and have a plan to regain their, which in this case is remission of their disease 
(Clayton et al., 2005b).   
The conceptual model of Reluctant Acceptance of Living with Advanced 
Cancer Recurrence illustrates the relationship between the availability of 
treatment and the increase in the level of hope for continued life. This hope–
treatment cycle has a psychological impact on people living with advanced 
recurrent cancer in that it creates an energy that allows them, upon diagnosis 
of recurrence, to choose to think positively, gather knowledge, and reluctantly 
accept their disease status and face it by seeking treatment (Mahon & 
Casperson, 1997; McCarthy & Dowling, 2009; McTiernan, 2013).  
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The model of Reluctant Acceptance of Living with Advanced Cancer 
Recurrence is situated within the cancer survivor trajectory that describes 
individuals who have been living in ‘extended survivorship as cancer free’ 
(Miller et al., 2008, p. 372) but now recur with advanced cancer. In this 
trajectory, the decision to reluctantly accept the diagnosis of cancer 
recurrence and relinquish the belief of having been cured acts as a catalyst 
toward becoming optimistic in the search for treatment to continue living. As 
discussed earlier, the current context of treatment for people with advanced-
stage cancers—particularly people with solid tumour cancers such as breast 
cancer, non-small cell lung cancer, and melanoma cancer—has impacted the 
understanding of palliative care as applied to the end-of-life trajectory (Miller et 
al., 2016). This concept has also been described by Couzin-Frankel (2013) as 
a paradigm shift as treatment options are now available for people with 
advanced cancer. Instead of accepting advanced incurable cancer as 
terminal, this study’s population sought treatment to prolong their life and they 
were offered clinical trials and treatment options that had not been available 
for this population in the past. This current research was able to document this 
experience and newly occurring paradigm shift.  
5.4.1 Reluctant acceptance of advanced recurrent cancer. 
For people recurring with advanced cancer after perceiving themselves to be 
cancer free, the concept of Reluctant Acceptance motivated the action to 
move forward towards treatment. A key component of this conceptualisation 
was how the news of recurrence was understood by the participant and 
opportunities that were offered to the participant for treatment at the diagnosis 
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of advanced cancer recurrence. Unlike what has been described in previous 
literature, this population accepts the illness as incurable but persists in 
hoping for prolonged life despite their advanced cancer diagnosis. Within this 
context of evolving cancer treatment options, this population’s response to the 
diagnosis is different from the populations discussed in the literature prior to 
these immunotherapy and focused treatment options (Brown, Levy, 
Rosberger, & Edgar, 2003; Chen, Haley, Robinson, & Schonwetter, 2003; 
Coyle et al., 2015). Rather than merely accepting the illness as incurable and 
reconciling that death may be soon, this population accepts the diagnosis but 
turns to treatment in the hope of prolonging life with advanced cancer 
recurrence. 
The model of Reluctant Acceptance of Living with Advanced Cancer 
Recurrence describes the experience of adapting to this specific period of 
advanced cancer recurrence. Here it is useful to briefly turn to the work of 
Naus, Ishler, Parrott, & Kovacs (2009) who describe a Cancer Survivor 
Adaptation Model related to a chronic illness model (Figure 13). This 
adaptation model included three general components: (a) personal context, 
(b) adaptation process, and (c) quality of life outcomes. It uses the adaptation 
process as the central mechanism of change that is continual and yet ever-
changing throughout the cancer experience. Although the Naus model does 
not describe the process of adaptation related to recurrence as is instead 
provided in the newly developed conceptual model Reluctant Acceptance of 
Living with Advanced Cancer Recurrence, it provides a basic framework or 
overview of the adaptation of cancer survivors. 
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Figure 13. Cancer survivor adaptation model. Adapted from ‘Cancer Survivor 
Adaptation Model: Conceptualizing Cancer as a Chronic Illness’, by M. J. 
Naus, M. D. Ishler, C. E. Parrott, & S. A. Kovacs, 2009, Journal of Clinical 
Psychology, 65(12), 1350-1359, https://onlinelibrary.wiley.com/loi/10974679. 
Reproduced with permission. 
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Naus’ et al.’s (2009) Cancer Survivor Adaptation Model reveals adaptation in 
the cancer survivor and includes the phases of cancer survivorship and the 
personal context that leads to cognitive appraisal and the adaptation process 
as a combined model that is dynamic but does not isolate the specifics of 
advanced cancer recurrence. My research addressed one section of the 
cancer survivorship trajectory, mainly the section that illustrates recurrence 
within the ‘chapters of cancer survivorship’ as shown in the Naus’ model. My 
research, as described in Chapter 2, aims to answer the questions of how and 
what the participants’ experience of advanced cancer recurrence is. Although 
the model speaks to adaptation process and quality of life outcomes my study 
did not focus on the why, and therefore these sections did not apply. As such, 
seeking treatment could be understood as a form of adaptation, given my 
study’s focus on how and what the participants’ experience, appraisal and 
outcome of this experience is not of relevance to this study.  
The timing of this research captured this experience at a time of evolving 
treatment options for people with advanced cancer recurrence. This study’s 
conceptual model can be situated within an area described in the Miller, 
Merry, & Miller (2008) model following ‘Extended survivorship cancer free’ (p. 
xx) to ‘Permanent survivorship second cancers’ and ‘secondary cancers’ 
(Figure 14). This research provides an empirical understanding of what the 
experience is for this specific population as they reluctantly accept advanced 
cancer recurrence. 













































































































































































































































































































































Even though both Naus et al.’s (2009) and Miller et al.’s (2008) models 
provided for greater insight into the development of my model, neither model 
provides a framework for advanced cancer recurrence in light of this new 
paradigm shift of evolving treatment options. 
5.4.2 Seeking Life Through Continuous Treatment motivated by 
hope in an uncertain future. 
As reluctant acceptance was seen as the catalyst to seek treatment, hope 
revealed itself to be the driver towards seeking treatment as well as a buffer or 
insulator from worry (Dufault & Martocchio, 1985; Hicks & Conner, 2014; 
McClement & Chochinov, 2008; Nierop-Van Baalen et al., 2016; Rowland & 
Baker, 2005). As Eliott & Olver (2007) note, treatment is sought after when 
there is hope in for the successful outcome of the treatment. Similarly, the 
population of my study revealed a commitment to seeking and completing 
treatment because of their hope for a successful outcome. As the model 
shows, this population is willing to stay in this state of treatment for as long as 
possible, as this period allowed participants to believe that life could continue, 
and that their quality of life could be maintained in this ‘normal’ state. As 
indicated in the depiction of concepts in the model, advanced cancer 
participants in this circle of treatment and hope are able to maintain an 
acceptable quality of life. This study found in an effort to maintain a personal 
equilibrium people with advanced cancer recurrence are willing to stay in 
treatment for as long as it is effective. The model of Reluctant Acceptance of 
Living with Advanced Cancer Recurrence is not about a linear progression 
from diagnosis to treatment to end-of-life as Miller et al. (2008) and Mullan 
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(1985) described earlier in the field of cancer survivorship. This study’s newly 
developed conceptual model provides a better understanding of this evolving 
population where treatment is available. The motivation to regain a personal 
equilibrium and control of advanced cancer recurrence influences this 
population into seeking survival through continuous treatment which then 
creates hope as described in this conceptual model of Reluctant Acceptance 
of Living with Advanced Cancer Recurrence. Sanders, Seda, & Kardinal 
(2012) describe the ‘hope trajectory’ (p. 241) that patients move through with 
advanced cancer. The phases of hope change throughout the course of 
disease, from diagnosis and a hope for cure, and fluctuate around the stages 
of the disease. This is the dynamic meaning of hope. Hope in the Face of an 
Uncertain Future is also conceptualised through Herth & Cutcliffe’s (2002) 
work and also described in Wonghongkul, Moore, Musil, Schneider, & 
Deimling (2000). The definition of hope related to the concepts of this model is 
a multidimensional belief that a positive result can occur. Hope is both a 
connection between an individual and others and between self and the 
spiritual or existential. Hope is ever-changing depending on the object of what 
is being hoped for (Dufault & Martocchio, 1985; Herth & Cutcliffe, 2002; 
Wonghongkul et al., 2000, p. 423).  
The availability of treatment provides hope for extended life (Eliott & Olver, 
2007). Within today’s context of increased treatment options, options which 
were previously not available to people with advanced recurrent cancer, 
acceptance of the disease manifests itself in the pursuit of Seeking Live 
Through Continuous Treatment (Brown et al., 2003; Karlsson et al., 2014; 
McCarthy, Jenn, Leng, & Hamzah, 2016).  
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Figure 12 portrays the circular action for which Reluctant Acceptance of the 
diagnosis is the catalyst that influences the need to seek treatment and 
creates hope in an uncertain future. Working to prolong life through treatment 
gave these participants something to work for while at the same time 
reconciling the reality that death was possible (Chen et al., 2015; Coyle et al., 
2015). 
Studies have shown that hope can positively impact physical and mental well-
being in patients, and a positive attitude and belief in a future (Brown & de 
Graaf, 2013; Farran, Herth, & Popovich, 1995; Gottschalk, Fronczek, & 
Buchsbaum, 1993). These constructed concepts work together to maintain 
hope but when treatment is no longer an option; the person with cancer will re-
evaluate their future and the meaning of hope. This becomes a 
multidimensional and dynamic process of hope (Clayton et al., 2005b; 
Daneault et al., 2016; Penson et al., 2007; Robinson, 2012).  
5.5 Similarities and Differences Between Previous Literatures on 
Recurrence 
As discussed above, this conceptual model illustrates the experience of 
advanced recurrence within the context of treatments now available to this 
population of people with advanced recurrent cancer.  
A number of previous studies have focused on the topic of cancer recurrence 
(Andersen, Shapiro, Farrar, Crespin, & Wells-Digregorio, 2005; Brown & de 
Graaf, 2013; Cella, Mahon, & Donovan, 1990; Lobb et al., 2015; Mahon & 
Casperson, 1997; Northouse, Laten, & Reddy, 1995). Research on the 
relationship of hope and cancer recurrence has also been examined (Brown & 
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de Graaf, 2013; Duggleby, Holtslander, Steeves, Duggleby-Wenzel, & 
Cunningham, 2010; Sanders, Seda, & Kardinal, 2012). However, unlike these 
prior studies, this particular study developed within a context of much greater 
access to different treatment options (Couzin-Frankel, 2013; Early Breast 
Cancer Trialists' Collaborative Group, 2005; Lobb et al., 2015; Welch, 
Schwartz, & Woloshin, 2000). Therefore, this changing paradigm has shaped 
the relationship between hope, treatment, and cancer recurrence. In other 
words, the context of the prior studies differed from this study’s context in that, 
for the most part, treatment options at the time of these earlier studies were 
not available to people with advanced-stage cancer recurrence other than in 
palliative or end of life care as discussed in Chapter 4: Literature Review. 
Anderson, Shapiro, Farrar, Crespin, & Wells-Digregorio (2005), Brown & de 
Graaf (2013), and Lobb et al. (2015) emphasised the impact of newly 
available treatments for participants dealing with advanced cancer recurrence.  
In an effort to put the changing paradigm of advanced cancer recurrence into 
perspective, literature is examined in chronologic order to illustrate the impact 
of evolving treatment options on recurrence research (Couzin-Frankel, 2013). 
Cella et al. (1990) described cancer recurrence as a traumatic event and 
found there was more adjustment needed for recurrence than for initial 
disease diagnosis. Their participants were all diagnosed with incurable 
disease and they described the importance of not including participants with a 
life expectancy of 6 months or less as it may ‘contaminate the issues related 
to a traumatic event versus issues related to terminal illness’ (p. 16).  
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Prior to 2013, research looked at the question of cancer recurrence from a 
particular point of view, one that does not include the access to more 
treatment options for people with advanced cancer. This was likely because 
the context and the outlook for survival were different. The availability of 
treatment options has an impact on the type of questions examined by 
research. Cella et al. (1990) identified concerns about dying and a higher level 
of distress with recurrence over the initial diagnosis (Cella et al., 1990; 
Donovan & Glackin, 2012; Mahon & Casperson, 1997). Northouse et al. 
(1995) compared the response to recurrence of breast cancer between 
spouses. She found that the women had more emotional distress and more 
symptom distress with recurrence. Using the conceptual framework of Lazarus 
& Folkman’s (1984) theory of stress, appraisal and coping, the Mahon & 
Casperson (1997) study evaluated two areas of how a person experiences a 
phenomenon to understand cognitive appraisal and coping related to the 
meaning of recurrence of cancer and whether the person perceived the initial 
diagnosis to be different then recurrence (Mahon & Casperson, 1997).  
Mahon, Cella, & Donovan’s (1990) study described avoidant coping strategies 
that decreased their overall response to recurrence. They suggested that 
longer periods of remission may have supported their avoidant coping and 
temporal uncertainty relating to forgoing follow-up with medical tests as 
recommended. This response was somewhat different in my study as 
participants had followed up as recommended, but they shared the concept of 
hope in the face of uncertainty. Having experienced cancer before and 
maintaining a longer remission, they believed that they could achieve 
remission again, ‘I did it once, I can do it again’ (P3:27). Mahon & Casperson 
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(1997) described their participants as discussing death and dying easily, 
unlike within my population. My study population did not consider forgoing 
treatment; this may be a limitation of the study and is discussed in Section 5.9 
Limitations.  
Andersen et al. (2005) found the psychological response to a recurrent cancer 
caused more stress than what was found in this population. Their study 
describes how stress from the cancer is compartmentalized to decrease 
emotional distress and the resilience patients exhibit when dealing with 
recurrence. This perception of resilience was also described in Rowland & 
Baker (2005) related to diagnosis of cancer and experiencing ‘catastrophic 
events’ (p. 2543). Through compartmentalising the distress of cancer 
recurrence, people in this phase of advanced cancer recurrence display 
resilience in coping during the early weeks after diagnosis (Andersen et al., 
2005). Choosing to accept the situation and maintain a positive outlook with a 
plan for treatment promotes hope and the illusion of having control over 
cancer (Rowland & Baker, 2005; Taylor & Armor, 1996). This finding was 
similar in my study as well, as participants responded to their diagnosis and 
moved into seeking treatment as they had done before with initial diagnosis. 
Unlike Anderson et al. my study did not measure stress which arguably may 
have been offset by increased availability of treatment options. Receiving 
treatment was interrelated with supporting hope, and acceptance of a new 
normal of continuous treatment to continue living. For patients with an 
advanced cancer recurrence after perceiving themselves to be cancer free, 
beginning treatment is the first step toward regaining a sense of control after 
the advanced cancer recurrence diagnosis. This population, as seen in others’ 
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work (e.g., Brown & de Graaf, 2013), is eager to participate in clinical trials 
and hopeful that they will provide benefit to others and prolong their lives.  
This research and resulting conceptual model describes the response to 
recurrence as the context of treatment and improvements in outcomes is 
growing. When compared to early research on recurrence, the concepts of 
hope, acceptance, and treatment remain important concepts in this 
population. The response to recurrence seems universal regardless of 
treatment options or stage of disease at recurrence. Andersen et al. (2005) 
and others recognized the different findings related to stress reactions to 
recurrence being seen as greater than at initial diagnosis (Cella et al., 1990; 
Mahon & Casperson, 1997). Vivar, Whyte, & Mcqueen (2010) work found 
people with recurrent cancer were less hopeful, although participants were in 
hospital or in palliative care settings in their work. Possibly the context of 
where they were influenced this response.  
My research has identified differences in response to recurrence in 
comparison to recurrence before immunotherapy and genomics medicine. 
This study was the first step toward understanding how this population 
describes their experiences to develop future research directions.   
5.6 Elements of the Conceptual Model Reluctant Acceptance of Living 
with Advanced Cancer Recurrence 
As described above, this phase of advanced cancer recurrence has seen 
improved survival and quality of life related to improved detection and targeted 
treatment options (Brown & de Graaf, 2013; Lobb et al., 2015; Maher, 
Velikova, & Betteley, 2015). Although multiple studies have addressed living 
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with advanced disease, these have often focused on people who have 
discontinued disease-focused therapies and who are receiving palliative care 
only, or those living at the end of life (Chen et al., 2015; Garcia-Rueda et al., 
2016; Mak, 2002). In this study, participants had options for continued disease 
focused treatment despite advanced recurrent cancer as found in other 
studies (Brown & de Graaf, 2013).   
Although the evolving treatment options available such as genomics and 
focused therapy are mostly life prolonging, with most patients dying as a result 
of their cancer, some will live and die of other causes. I describe this new 
group as ‘not curable but treatable’ (P10:66), and focused on the options of 
treatment for as long as remission can be possible (Maher et al., 2015). They 
recognise their disease status as incurable but do not see themselves as 
terminal. 
This population is ambulatory, experiencing minimal symptoms and living with 
a sense of normalcy (Garcia-Rueda et al., 2016). This concept of seeking 
normalcy has been described in the literature related to post-treatment 
survivors of cancer who are working toward returning to a new ‘normal’ 
(Walker, Szanton, & Wenzel, 2015), but not in people with advanced cancer 
who are seeking survival through continuous treatment. Since new treatments 
such as oral agents often consist of targeted therapies and are less invasive, 
this population may experience minimal symptoms and are not limited in their 
daily lives (Lobb et al., 2015; Payne et al., 2007). This higher level of quality of 
life may make it easier to believe their lives can reach a level of normalcy 
even with advanced cancer (Marker, 2015; Payne et al., 2007). Their 
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prognosis, although incurable and unpredictable, may range from months to 
years (Lobb et al., 2015). These factors explain their perceptions of seeing 
their lives as ‘normal’ and being ‘otherwise healthy’ (McCarthy & Dowling, 
2009; Nissim, Freeman, et al., 2012). Feeling well, despite their diagnosis, 
adds to their hope and to the cyclical nature of the model of Reluctant 
Acceptance of Living with Advanced Cancer Recurrence. This new population 
has been given treatment options; they are focused on continuing to live and 
maintaining their quality of life for as long as possible and they remain hopeful. 
These study findings are an important contribution that add to the 
understanding of the experience of this specific population who have an 
opportunity to live a longer life with advanced recurrent cancer in ways that 
was not possible for this population of people with cancer in the past (Brown & 
de Graaf, 2013). 
5.6.1 Focusing on survival. 
The need to survive is an inherent goal for any group of human beings 
(Bauman, 1992). As a social construct, human survival has been discussed as 
the human inability to reconcile the power of the mind and reason with the 
‘time-bound fleshy casing’ (p. 1). The constant struggle for survival and 
avoidance of serious illness or death is experienced by all human beings. The 
desire to adapt to the transitions experienced between the diagnosis of 
cancer, stable disease, and recurrence to end of life are described above. 
Facing the reality that death is inevitable, and yet the desire is to delay it, this 
current study suggests that stabilising the cancer remains the constant goal. 
This desire to maintain life at the highest quality possible for as long as 
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possible is seen as allowing the participant to live until a possible cure is found 
or allowing them to ignore the inevitable (Clavarino et al., 2003; Karlsson et 
al., 2014; McCarthy & Dowling, 2009). Participants in this research study were 
not in a state of denial; they understood that their cancer had not only 
recurred, but that it was also advanced. They did express an understanding 
that this recurrence would lead to the end of their life. They maintained a belief 
in the possibility of stable disease, even if a cure was not possible. Seeking to 
live with cancer through access to continuous treatment in this population was 
the goal, despite the realisation that their initial treatment did not cure them. 
5.6.2 Avoidance of death. 
This population, described in my study as ‘not curable but treatable’ avoids 
consciously or unconsciously the possibility of dying from this disease. As 
other studies examined advanced recurrence and describe the experience 
related to palliative care and hospice, this population is not focused on end of 
life. These participants were receiving tumour-directed therapies and the 
benefit of supportive drugs that build bone, decrease side effects, and 
decrease discomfort. They also have access to multiple clinical trials aimed at 
stage IV advanced disease participants, unlike in past clinical trials where 
advanced disease participants were specifically excluded (Brown & de Graaf, 
2013; Couzin-Frankel, 2013; Lobb et al., 2015). 
In 1996, an editorial by Sledge titled ‘Should We Dream the Impossible 
Dream?’ discussed the future of long-term survival in metastatic breast cancer 
patients. This was the beginning of the understanding of hormone receptor 
importance in breast cancer disease management, and the idea that possible 
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changes in treatment could lead to longer survival. Twenty-one years later, 
targeted therapies have grown beyond hormone receptors to genetic 
indicators and provide focused treatments that are extending survival of 
cancer. Unlike the chemotherapy treatments of the past, new therapies have 
reduced toxicity profiles, making them more tolerable. Yet as the future of 
cancer care is rapidly changing, patients still live with the liminal reality of 
having cancer and the reality that it can recur (Little, Jordens, Paul, 
Montgomery, & Philipson, 1998; McKenzie & Crouch, 2004). 
Other studies related to initial recurrence with advanced cancer have also 
noted the lack of willingness to discuss death and dying in advanced cancer 
patients (Lobb et al., 2015). It is important to note that all of the participants in 
this thesis study were receiving a treatment regimen post diagnosis of their 
advanced cancer recurrence.  
This avoidance of death described in this research relates to the pertinent 
context of increased hope, even in an uncertain future as this population has 
opportunities for treatment to stabilise disease (Brown & de Graaf, 2013). This 
allows them to focus on living and maintaining a sense of a normal life (Lobb 
et al., 2015; Periyakoil, Neri, & Kraemer, 2016). Despite social and 
professional advances through hospice and palliative care over the past 30 
years, it is not normal in Western society to talk about death and dying and 
there is sometimes a sense that talking or thinking about death can make it 
happen (Periyakoil et al., 2016).  
In many cultures, there are superstitions or culturally-based beliefs about 
discussing death and dying, as well as religious beliefs influencing perceptions 
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of illness and death (Periyakoil et al., 2016). Additionally for this population 
receiving treatment and experiencing good quality of life, their focus was on 
remission and therefore, they believed it was not necessary to talk about end 
of life at this time. The participants remained hopeful about the prospect of 
new treatments in the future that could lead to stable disease. As long as their 
cancer and symptoms are controlled, they maintain hope for a future. Others 
have also described this sense of living until they die or have unacceptable 
quality of life (Ryan, 2005). The lack of symptoms or side effects from newer 
treatments and oral agents reinforced their sense of wellness and normalcy as 
well as the ability to avoid thinking about the possibility of death. The ability to 
maintain quality of life within the conceptual model of treatment and hope 
allows avoidance of the possibility of dying soon from advanced cancer and 
maintains their desire to live and hope for continual response to treatment. 
5.7 Liminality in Cancer Survivors  
Liminality as a process of being in a life transition that early literature referred 
to as a ‘rite of passage’ has been described in cancer survivors and people 
with chronic disease (Blows, Bird, Seymour, & Cox, 2012; Froggatt, 1997; 
Hockey, 2002; Little et al., 1998; Thompson, 2007). A cancer diagnosis labels 
the person with cancer for life (Little et al., 1998; Thompson, 2007). People 
with cancer have a sense of always being a ‘cancer patient’ with or without 
active disease or in liminality terms, always being on the threshold of cancer 
(Little et al., 1998).  
Secondly, people with cancer often had an inability to communicate the 
meaning of the experience of cancer and its treatment and a sense of life 
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related to the boundaries of cancer and the awareness of the loss of time, loss 
of control, and uncertainty for their future (Little et al., 1998). This concept of 
liminality for this population who are no longer cancer survivors but have 
crossed a threshold and are now people living with advanced cancer 
recurrence remains a reality, but how this concept is imagined in light of 
improved survival rates with recent advanced treatment options is yet to be 
understood. These participants have transitioned from someone who had 
been cured of cancer to having advanced recurrent cancer.  
Thus the concept of liminality is applied to the cancer survivor as being a 
person with cancer, but now advanced cancer that is incurable but treatable. 
Froggatt (1997) described the concept of liminality related to a person 
transitioning to hospice and eventual death. This provides for a culture in 
which the transition will lead to death, in light of the context of advanced 
cancer and the hope to continue living overrides the willingness to transition 
towards death or dying in this new population.  
Hockey (2002) describes the pattern identified by Van Gennep as a tripartite 
structure where the rites of passage are aggregated to ‘1) passage out of a 
previous phase or social status; 2) an ambiguous time and space betwixt and 
between fixed positions; and 3) re-entry into a new social position or period’ 
(p. 212). People living in a liminal stage of this ‘in-between’ re-enter society at 
a higher social status or different place (p. 212). This newly growing 
population who go from no cancer to advanced cancer are in a place that in 
the past had meant transitioning to end of life. This population is in a new 
phase of life, living longer after an advanced cancer recurrence with new 
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treatments that prolong survival beyond days to months or years (Brown & de 
Graaf, 2013; Miller et al., 2016).  
From the sociological sense of avoiding death and the realisation of the limited 
life they now face, these participants sought continued life through treatment 
and have a greater opportunity to actually have a prolonged life. Seeking to 
maintain autonomy and normality in their lives was the primary concern for 
this emerging population in a way that has never before been an option. This 
changing reality has prolonged survival; therefore the realisation of the 
potential for improved survival has also impacted participants’ responses to 
advanced cancer. Despite treatment options, the outcomes remain uncertain 
and patients seek hope and believe in a future (Little et al., 1998; Maher et al., 
2015; Thompson, 2007). The liminality was very much a part of this study due 
to the context and methodology. By restricting the study inclusion to people 
who had recently been diagnosed with advanced recurrent cancer, the study 
captured this liminal experience of being at the threshold of a new phase of 
life.  
5.8 Summary of the Conceptual Model of Reluctant Acceptance of 
Living with Advanced Cancer Recurrence  
This final chapter has described the process of conceptual development of the 
final model, Reluctant Acceptance of Living with Advanced Cancer 
Recurrence, and discussed this process of development in relation to the 
evidence drawn on from the qualitative data collected. Using constructivist 
grounded theory the process of development was illustrated through the 
different model conceptions as the final model concepts were constructed and 
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meanings were developed. What is demonstrated in this conceptual model of 
Reluctant Acceptance of Living with Advanced Cancer Recurrence is that after 
the initial shock of diagnosis for participants recurring with cancer after 
perceiving themselves to be cancer free, there is a shift to a state of reluctant 
acceptance which than as a result of new treatment options moves 
participants to seeking survival through treatment in the hope of an uncertain 
future. 
Reluctant Acceptance as the initial concept motivated the action to move 
forward toward treatment. The conceptualisation of the appraisal of the 
transition from cancer free to advanced cancer recurrence identified that 
personal context and characteristics of the person experiencing recurrence 
were important indicators to how a person accepts and chooses treatments. 
This was compared to the Naus et al. (2009) CSA model and the Miller et al. 
(2008) model to illustrate this specific population and how this new information 
can contribute to the explanation of their experience. My study differs from 
Naus et al. and Miller et al. in that their respective models do not isolate 
recurrence as separate from survivorship. 
Hope in the Face of an Uncertain Future as defined for this population 
includes the multidimensional aspect of hoping for treatment, hoping for a 
future, and recognizing the significance hope provides toward seeking 
treatment even in this era of uncertainty. Mullan (1985) described an area of 
‘uncharted middle ground’ (p. 273) resulting from the rapid growth of survivors 
seen from 1965, where the 5-year survivorship had been 25% and in 1985 
rose to almost 50% (p. 273). This is where this population of people with 
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advanced cancer recurrence stand today, within this gap of understanding 
what the future holds. In the absence of available treatment options in the 
past, this population was considered untreatable. Research focused on people 
who have been diagnosed with advanced cancer recurrence may include a 
whole new experience. Benefits and long-term outcomes of new treatment 
regiments are uncharted and additional research is needed to understand the 
patient experience. 
It is difficult to identify where the changing paradigm begins. Literature usually 
includes data collected one to two years before publication. The American 
Society of Clinical Oncology [ASCO] (2012) provides yearly annual reports on 
clinical cancer advances that started in 2011. Record numbers of survivors 
were documented in 2010 and the U.S. Food and Drug Administration began 
to approve multiple anticancer agents between 2011 and 2012. With notable 
advances in immunotherapy treatment of cancers such as for lung and 
melanoma with Anti PD-1 and Car-T therapies, this trend of improving 
survivorship is continuing (Couzin-Frankel, 2013). 
The boundaries of this research as described above are not entirely clear. 
Comparing the understanding of treatment advances for people with 
advanced cancer recurrence to recurrence literature in the past will provide 
meaningful information to improve our understanding of this paradigm and 
whether it is different and in what ways. Death avoidance and the concept of 
liminality appear to be described by people with cancer or advanced cancer 
recurrence, but again what this means for this new era of cancer treatment is 
just now beginning to evolve. 
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5.9 Strengths and Limitations of the Study  
There are both limitations and strengths in this study of advanced cancer 
recurrence in this growing population. Participants in this study were 
predominately Caucasian and were primarily women. Future research should 
broaden the sample and include more men and greater representation of 
various ethnicities, as these factors could influence the response to advanced 
cancer recurrence and therefore the model. Although the sampling approach 
attempted to include more solid tumour types, the participants were primarily 
breast cancer patients. This population has been researched heavily and also 
has benefited from great success in current treatment opportunities (DeSantis, 
Ma, Goding Sauer, Newman, & Jemal, 2017).  
As the site of this study is a free-standing cancer research and treatment 
centre it must be noted that participants may have been biased to seek 
treatment and therefore may not have been willing to consider options that 
may have included no treatment or seeking hospice care. As one of 49 
comprehensive cancer centres in the U.S. (as designated by the U.S. Cancer 
Institute) it has a focus on treatment as well as research and care. It is 
possible that the population from which the sample was recruited had 
particular expectations about treatment. As such future research with the 
conceptual model should encompass a variety of settings to explore beyond 
The City of Hope, with commercial advertising offering ‘The Miracle of Science 
with Soul’.  
The positive attitude surrounding these participants may have contributed to 
their treatment choices and attitudes about treatment. These participants are 
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focused on achieving a response to advanced cancer recurrence after a 
period of believing they were cancer free; therefore the timing of the interviews 
and the fact that the participants were all in active treatment may have 
contributed to the interrelatedness of hope and treatment. Other studies in 
advanced cancer recurrence in different settings and in additional tumour sites 
have also identified similar concepts related to hope and treatment (Brown & 
de Graaf, 2013; Duggleby et al., 2012; Penson et al., 2007).  
The strengths of this research include that this is a new era of cancer 
treatment options in a population who in the past were referred to hospice for 
end-of-life care. Describing this experience of advanced recurrence in a 
person who has been cancer free for two or more years in light of these 
advances, will also provide empirical data to compare with past recurrence 
literature. This new research provides a theoretically based, qualitative 
approach to provide focused information from the participants’ experience.  
The use of constructivist grounded theory as a method allowed me to be part 
of this research and was found to be an acceptable method that allowed the 
participant voices of this newly evolving population to guide the development 
of this model. Constructivist grounded theory allowed the flexible gathering of 
the participants’ experience to be individually described yet compared 
iteratively to build a co-constructed understanding of the experience of 
advanced cancer recurrence in people who perceived themselves to be 
cancer free. Phenomenology would have also been an appropriate method for 
this study and may have shortened the length of time to complete this study 
without the initial focus on theory development (Charmaz, 2014; Hussein, 
Hirst, Salyers, & Osuji, 2014).  
184 
This study has resulted in a conceptual model to describe the experience 
early after the diagnosis of advanced recurrence in cancer survivors in the 
context of available treatments and clinical trials provided for advanced 
cancer, late-stage participants and thus add to a critical new area of 
scholarship. The cancer survivorship movement in the U.S. was a patient 
advocacy effort borne out of experiences of people living with cancer. The 
National Coalition for Cancer Survivorship (NCCS) has advocated for better 
care of this patient population(National Coalition of Cancer Survivorship 
(NCCS), 2013). This study’s findings and new model can be used as a means 
of advocacy to share the experiences of people facing advanced cancer 
recurrence as this paradigm shift is occurring. 
This research will allow the next step comparison to the experience of 
advanced cancer recurrence prior to 2012, where access to clinical trials for 
stage IV cancers—especially in lung, pancreatic and melanoma cancer 
patients—was not an option (Roth et al., 2012). Therefore evaluating the 
conceptual model and concept links described in this model will lead to theory 
development and build the knowledge base needed to manage care in this 
population for the future.  
Constructivist methodology allowed the constructed knowledge of the 
experience within this newly evolving context of improved treatment and 
survival in advanced-stage cancer patients. As CGT is meant to include the 
context of the phenomenon being studied it also includes the timing and 
details of the inquiry; this was the most appropriate method to capture an 
experience that may be different in light of this new context. CGT allows for 
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broad open coding and conceptual development to capture an unknown 
experience. Charmaz (2014) describes a concept-indicator model as ‘a 
method of theory construction in which the researcher constructs concepts 
that account for relationships defined in the empirical data and each concept 
rests on empirical indicators, thus the concept is grounded in data’ (p. 342). 
Therefore this research will direct the next steps in understanding this 
population that will continue to grow. 
5.10 Implications for Clinicians and Policymakers  
The conceptual model of Reluctant Acceptance of Living with Advanced 
Cancer Recurrence has important implications for clinicians and policymakers. 
Clinicians must understand the priorities of this population of long-term cancer 
survivors who are now living with advanced cancer with treatment options and 
symptom control not seen in the past. Minimal research that describes the 
experience of this population with advanced cancer and treatment options 
needs to be better understood so that clinicians can be prepared to provide a 
realistic treatment plan. Clinicians thus need to be well prepared to discuss 
treatment options while also communicating the reality of progressive disease. 
Communication has become a very important area of research in cancer care, 
as researchers evaluate how communication is occurring between clinicians, 
patients, and family members (Thorne et al., 2014). Communication research 
would be especially important in this population facing recurrent cancer and 
responding to this incurable prognosis. There is a growing body of knowledge 
related to barriers in communication between patients and physicians and the 
impact of poor communication on satisfaction with cancer care, symptom 
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management, lower rates of compliance with medical recommendations, 
reduced trust in physicians, and reduced hope (Brandes, Linn, Smit, & Van 
Weert, 2016; Chawla et al., 2016; Thorne et al., 2014). The inability of 
clinicians and patients to communicate effectively leads to misunderstandings, 
promotes uncertainty, and inhibits patients from making informed decisions 
(Brandes et al., 2016; Chawla et al., 2016; Clayton et al., 2005b; Thorne et al., 
2014). The impact on decision-making would be especially important as these 
participants deal with continuous treatment and the potential for treatment 
failure and transition to hospice and end-of-life care. The limited 
communication noted within this research was an indicator of avoidance of the 
possibility of death from this advanced cancer recurrence either from the 
clinician or participant.  
Palliative care was only discussed by one participant who was dealing with 
side effects related to her multiple treatments, despite the importance of 
palliative care interventions and potential benefits. This is a consideration that 
is important for clinicians and policymakers alike. Research related to the 
benefit of the early introduction of palliative care to advanced-stage cancer 
patients requires this consideration (Temel et al., 2010).   
Advanced cancer patients who are continuing to receive cancer-focused 
treatment may experience multiple comorbidities. The mean age for this 
population was 71 years-of-age, and the age range was between 61 and 80 
years. The older age of this population of advanced recurrence is related to 
cancer incidence increasing with aging. The majority of advanced cancer 
survivors will be older; this is especially true as the population ages (American 
187 
Society of Clinical Oncology [ASCO], 2018). Clinicians will need to also 
consider how older adults are impacted with these newer treatments. 
Coordination of care among multiple disciplines sharing their expertise will be 
important to manage comorbidities. 
A change in definition of palliative care can strengthen the impact for this new 
population. The important factors described in this research as well as 
throughout the literature identify the factors that remain important throughout 
the trajectory of recurrence. These factors include family, spiritual and social 
support, finding meaning, maintaining hope, and positive thinking. Palliative 
care provides support to patients and families who are facing issues related to 
life-threatening illness, yet patients living with cancer have not previously been 
a targeted population for palliative care (Smith et al., 2012). Both the patient 
and family are coping with recurrence, reinitiating cancer treatment, and facing 
an uncertain future. Managing complex psychosocial issues that may arise 
such as anxiety and existential distress is an area where palliative care 
interventions can help improve patient experiences.  
This population of cancer patients with advanced recurrent cancer described 
the importance of family and spiritual support to help them cope with this new 
recurrence. Palliative care research has supported the importance of spiritual 
care and its impact on quality of life, survival, and coping (Puchalski, Ferrell, & 
O'Donnell, 2016). This population of people living with cancer described the 
importance of their spiritual beliefs to help them during this process of 
maintaining hope and seeking meaning in their life and bringing stability to 
their feelings of uncertainty. The importance of family support must also be 
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recognised as an essential part of the care needed by people experiencing 
advanced recurrence.  
This study revealed that the social connectedness and relationships of family 
and friends was an important sub-category of the construct of hope. 
Supporting the family caregiver will improve the quality of care experienced by 
this population (Northouse, Williams, Given, & McCorkle, 2012). Palliative 
care provides resources and understanding for the special needs of these 
family caregivers. This period of advanced recurrence after believing their 
family member was cured is especially stressful for caregivers: Supporting 
their loved one through treatment, with the realisation that cure is not the goal 
of care and the future is uncertain, can cause feelings of anger and suffering 
for loved ones (Borneman & Brown-Saltzman, 2016; Vivar et al., 2010). 
Palliative care involvement provides support for families through these 
emotions or changed plans as well as supporting them through bereavement 
in the future. 
5.10.1 Impact of continued treatment options of cost of care in the 
U.S. 
The population of advanced cancer patients seeking continued treatment will 
have a major impact for health policy in the U.S. Cancer care is known to be 
extremely costly and one study found that 79% of cancer patients experienced 
extreme financial burden (Zafar et al., 2013). An additional study found that 
cancer patients declare bankruptcy 2.7 times more often than people without 
cancer (Ramsey et al., 2013). In the United States, health insurance provides 
support to a majority of the population but these plans include patient co-pays 
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that may be as high as 20% of their health care costs. Even patients covered 
under government-supported Medicare may experience out-of-pocket 
expenses that are as much as 24% of their household income (Narang & 
Nicholas, 2016). Thus, although advanced cancer patients have access to 
new anti-cancer therapies, they are expensive and the long-term benefits are 
often unknown (Goldstein, 2017).  
This model should inform policymakers of the potential impact for the person 
with advanced recurrent cancer seeking expensive treatments, despite 
advancing disease. Financial coverage for healthcare in the United States 
allows for either individual self-payments or insurance coverage that supports 
second- and third-line treatments if desired by the participant; thus, seeking 
continuous treatment is possible (Smith & Medalia, 2014). These opportunities 
are rapidly changing in the United States; it is unclear at this time how long 
this type of insurance coverage will be possible (American Society of Clinical 
Oncology [ASCO], 2018). Regardless of future policy changes, there will 
remain important health policy implications given the more than 14 million 
cancer survivors in the United States (Hewitt et al., 2006).  
The option to participate in clinical trials as described by Brown & de Graaf 
(2013) recognises this changing paradigm for end-of-life treatment. This study 
documented that cancer survivors hope to access clinical trials as new 
treatment options become available. Clinicians and policymakers will need to 
consider the population of people with advanced cancer recurrences who 
continue to seek treatment and the need to coordinate palliative care in an 
effort to provide guidance when needed for end of life care. 
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5.10.2 Palliative care versus hospice care in the U.S. 
An important aspect of palliative care when compared to hospice or end-of-life 
care in the U.S. is the ability for palliative care to be provided to patients 
receiving anti-cancer therapies while dealing with advanced recurrence that is 
allowed by most health insurance coverage. Hospice care in the United States 
is only covered for patients with a prognosis of 6 months or less and does not 
allow anti-cancer therapies to be provided or any other disease-focused 
treatments other than comfort-focused care (Zerzan, Stearns, & Hanson, 
2000). Therefore, this population of cancer survivors—whose priorities as 
described in this research are focused on maintaining survival and promoting 
life at all costs—are not willing to transition their care to hospice. This study 
and the evolving model have captured the unique experiences and 
perspectives of cancer survivors, which have many implications for 
developing, delivering, and reimbursing care. The benefits of palliative care 
interventions will provide physical symptom management, psychosocial and 
spiritual support during this phase of seeking life in an uncertain future. 
Providing access to palliative care will support participants’ goals of care as 
well as support them during future transitions of care providing coordination of 
services for the benefit of both participants and their family caregivers.   
5.11 Implications for Future Research 
The importance of research within this population goes beyond the discussion 
in the section above. Policymakers in the U.S. need information regarding 
expectations of people with advanced cancer recurrence, including defining 
what palliative chemotherapy means, treatment options, and prognosis. 
191 
Evaluating the model of living with advanced cancer recurrence in different 
settings may provide additional insight into this period of advanced cancer 
recurrence that has not been specifically researched in the past. The needs of 
a population that transitions from the status of free of cancer to being a person 
with cancer living with advanced disease with improved treatment options is a 
new area of research. A longitudinal study would allow a better understanding 
of the transition through these experiences. It may also give insights about 
any shift away from treatment and or to end of life care. Applying the newly 
developed model to types other than solid tumours may yield different 
experiences, which will be valuable in extending the model. Different tumour 
types have different options for advanced-stage treatments (Brown & de 
Graaf, 2013).  
Community hospital settings and physician practices may also be providing 
continuous treatment to this population of advanced recurrent cancer patients 
seeking survival. Settings have access to different resources and clinicians in 
each setting should be prepared to support people with advanced cancer in 
comparing treatment options and transitions of care to insure that equitable 
and quality care are provided. Research is needed to evaluate outcomes of 
new care models across settings. 
Applying this conceptual model in different populations would also provide 
additional insight into the application of this model across age groups, 
genders, and disease types and provide a framework for the future 
development of a theory to describe this population. The population of this 
study was primarily women with breast cancer and responses to advanced 
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recurrence by other populations would serve to further inform this model and 
future theory development. Understanding the patient experience through the 
grounded theory approach can inform future theoretical research to insure that 
the interventions reflect true patient needs. 
Based on this growing population of people living with cancer, further 
longitudinal research about newer treatment options for advanced cancer and 
toxicity profiles would help describe long-term effects of these treatments on 
this population living with advanced cancer and continuous treatment. 
Additional qualitative research applying this conceptual model could be 
undertaken concurrently with clinical trials and triangulation methodology 
could include quantitative measures of the concepts in the model such as 
hope and uncertainty. Longitudinal studies that follow participants when 
cancer treatment is no longer tolerable or available would provide much-
needed insight into how to prepare and support this population through that 
transition of care to end of life or how that transition occurs. This study 
consisted of a one-time interview soon after recurrent disease was diagnosed, 
but longitudinal studies could aid in theory development by testing relationship 
between concepts described within this conceptual model. 
This conceptual model provides insight into this specific phase of advanced 
cancer recurrence that has not been described in other models (Miller et al., 
2008; Mullan, 1985). As discussed in Chapter 1, Mullan (1985) and Miller et 
al. (2008) described phases of living with cancer related to diagnosis, 
treatment, and cancer free status but this model describes a specific phase 
that follows the period of being cancer free with a diagnosis of advanced 
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recurrence. This conceptual model extends the knowledge-based 
understanding of what this specific phase of living with advanced cancer 
recurrence means within this new paradigm of available treatment for 
advanced-stage cancer (Brown & de Graaf, 2013; Couzin-Frankel, 2013). 
5.12 Conclusion 
This study and the conceptual model constructed from the findings have made 
an important contribution to the literature addressing a growing population of 
people living with advanced recurrent cancer after a period of being cancer 
free. The conceptual model Reluctant Acceptance of Living with Advanced 
Cancer Recurrence illustrates the key constructed concepts of the experience 
of people living with advanced recurrent cancer: Reluctant Acceptance, 
Seeking Survival Through Continuous Treatment, and Hope in the Face of an 
Uncertain Future. This model puts into context this specific population that has 
moved beyond the stage of Extended Survivorship Cancer-Free described by 
Miller et al. (2008) and now recurs with advanced incurable cancer. Future 
research to study the conceptualised relationships towards theory 
development is needed.   
The term cancer survivor does not adequately describe this group of people 
who experience advanced recurrence. Although the U.S. Institute of Medicine 
definition of a cancer survivor includes all people who are diagnosed with 
cancer from initial diagnosis throughout life, this population is different (Hewitt 
et al., 2006). They have an increased risk of dying from their advanced cancer 
but by living longer, other age-related comorbidities may also lead to death. 
They no longer look at a future in terms of being cancer free but focus on 
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survival, as in living with advanced cancer for as long as possible. These 
people seek cancer treatment and are willing to participate in clinical trials and 
any treatments that will prolong their lives with the hope of reaching remission 
or stable disease (Brown & de Graaf, 2013; Ferrell et al., 2017).  
There are important implications for future health needs of this population as 
they receive multiple treatments and risk multiple co-morbidities associated 
with continued treatment. Cancer risk increases with age and as this 
population includes a significant number of older adults; co-morbidities of 
aging and extensive cancer treatments mean that this population could benefit 
from palliative care support. This study has broad clinical and policy 
implications and should serve as a guide to advancing practice and the focus 
for future research.  
Generic terms such as survivor or survivorship to describe a group of people 
who have experienced a cancer diagnosis limits the understanding of the 
clinical and research needs for this population. This conceptual model 
provides a starting place for future researchers to build knowledge and 
interventions to improve care for this population and describes a newly 
developing population of people with cancer along the continuum of the 
cancer experience who have not been described before. This population is 
growing at a time when improvements in the understanding of the biology and 
treatment of cancer have led to new and innovative treatments that can 
improve and stabilise advanced cancers.  
The growing recognition that people with advanced cancer recurrence can 
hold on to treatment as hope for longer life with acceptable quality, rather than 
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merely treat their disease as incurable or terminal, in invaluable. Within this 
new context of advancing treatment opportunities, this study’s model aims to 
illustrate the experience of this specific population. This model contributes to 
future research which is needed to build evidence based oncology and 
palliative care practice.   
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Appendix A – Research Consent and Patient Bill of Rights 
 
Principal Investigator: Denice Economou RN, MN  
Department/Division: Population Sciences/Department of Nursing Research & 
Education 




INFORMED CONSENT FOR PARTICIPATION IN RESEARCH ACTIVITIES 




I. PURPOSE OF THIS RESEARCH STUDY: You have been asked to 
participate in this research study because you are a long term cancer survivor 
who has recurred. The purpose of this study is to understand better what your 
specific needs are and how best to provide support to you and your family. Your 
participation in this study is expected to last for a one to one and a half hour 
interview. 
 
II. BACKGROUND: As a cancer survivor you have experienced a time of disease 
free survival. Providing efficient coordinated care is important for cancer 
survivors. Understanding what your cancer recurrence means will help us to 
better meet your needs. 
 
III. WHAT WILL BE DONE: This study will require a one-time detailed 
interview that may take up to one and a half hours. This interview will be audio 
taped and information will be used by the researcher to attempt to describe 
specific concerns of long term cancer survivors who recur.  
 
IV. POSSIBLE BENEFITS:  You may benefit from participation in this study by 
describing your thoughts and concerns related to your recurrence after a long 
period of disease free survival.   
 
V. POSSIBLE RISKS: The risks and discomforts of this study are possible 
distress related to discussing your emotions and concerns over cancer 
recurrence. 
 
You may become tired from the amount of time needed to complete the 
interview. The interview will focus on life issues that could cause you to 
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become emotionally upset. If this occurs, you will be referred to your 
physician to determine how best to handle the concerns and issues.  Support 
and counseling will be available from social workers and psychologists as 
needed.   
 
VI. ALTERNATIVES TO PARTICIPATION: Your alternative is to choose not 
to participate in this study. Choosing not to participate will not interfere with 
any future treatment, or any relationship with your physicians or health care 
team here at City of Hope. 
 
VII. CONFIDENTIALITY OF INFORMATION: Any information learned from 
this study in which you might be identified will be confidential and disclosed 
only with your permission. By signing this form, however, you allow the 
researchers to make your information available to City of Hope Institutional 
Review Board (IRB) Office, the Cancer Protocol Review and Monitoring 
Committee (CPRMC) or Protocol Review and Monitoring Committee 
(PRMC)], the Office for Human Research Protections (OHRP), the National 
Cancer Institute (NCI), and the PhD supervisors at Lancaster University, 
Lancaster, England and other regulatory agencies as required by law. If 
information learned from this study is published, you will not be identified by 
name. 
 
VIII. OFFER TO ANSWER QUESTIONS: The principal investigator, Denice 
Economou, has offered to and has answered any and all questions regarding 
your participation in this research study. If you have any further questions, you 
can contact Denice Economou at (626) 256-HOPE (4673) ext. 63477.  
 
IX. COST TO THE RESEARCH PARTICIPANT FOR PARTICIPATION: 
Neither you nor your insurance carrier will be charged for your participation in 
this study. 
 
X. VOLUNTARY PARTICIPATION WITH RIGHT OF REFUSAL: You 
have been informed that your participation in this research study is voluntary. 
You are free to withdraw your consent for participation in this study without any 
loss of benefits, penalty, or interference with any future treatment at, or any 
relationship with, City of Hope.  
 
XI.  IRB REVIEW AND IMPARTIAL THIRD PARTY: This study has been 
reviewed and approved by the Institutional Review Board (IRB). A 
representative of that Board, from the Office of Human Research Subjects 
Protection, is available to discuss the review process or your rights as a research 
subject. The telephone number of the Office of Human Research Subjects 
Protection is (626) 256-HOPE (4673) ext. 62700. 
  INFORMED CONSENT AND 
AUTHORIZATION 




FORM NO 8700-C037                                                                                     





XII.   FINDINGS RELATING TO WILLINGNESS TO CONTINUE 
PARTICIPATION: The person consenting you to this study has explained to 
you that you will be informed of any significant new findings related to this 
study which might affect your willingness to continue to participate.  
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EXPERIMENTAL SUBJECT'S BILL OF RIGHTS 
FOR PSYCHOSOCIAL STUDIES 
 
 
The rights below are the rights of every person who is asked to be in a research study. 
As a research subject in a psychosocial or quality of life study, you have the following 
rights:  
 
1. To be told what the research study is trying to find out,  
 
2. To be told what will happen to you and whether any of the study procedures to 
be used are different from what would be used in standard practice,  
 
3. To be told about the risks, side effects, or discomforts of the things that will 
happen to you as part of the research study,  
 
4. To be told if you can expect any benefit from participating in the research 
study, and, if so, what the benefit might be,  
 
5. To be told of the other choices you have and how they may be better or worse 
than being in the research study,  
 
6. To be allowed to ask any questions concerning the research study, both before 
agreeing to be in the study and during the course of the study,  
 
7. To be told what support or treatment is available if any complications arise,  
 
8. To refuse to participate in the research study or to change your mind about 
participation after the study is started. To be informed that this decision will 
not affect your right to receive the care you would receive if you were not in 
the study,  
 
9. To receive a copy of the signed and dated research study consent form,  
 
10. To be free of pressure when considering whether you wish to agree to be in the 
research study.  
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SIGNATURE FOR CONSENT: By signing this consent form, you are making a 
decision to participate in this research study.  Your signature on this informed consent 
form indicates that you: 
1. Have read and understood the information in this form.   
2. Have had the information in this form explained to you.   
3. Have had a chance to ask questions and these questions were answered to your 
satisfaction.   
4. Have been informed that you will receive a copy of this signed consent form, 
which includes the "Experimental Subject's Bill of Rights."  
 




Research Participant's Signature: ________________________ Date:_________ 
Time ___________  
(date and time must be in research participant’s  handwriting) 
 
Print Research Participant's Name: ___________________________ 
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Exploring the Recurrence with Advanced Disease 
of Long Term Cancer Free Survivors  
 
 
AUTHORIZATION TO USE AND DISCLOSE YOUR PROTECTED  
HEALTH INFORMATION (PHI) FOR PURPOSES OF THIS STUDY 
 
I. Purpose of this Authorization: The information about your health is 
something that is protected by law and cannot, except for certain purposes, be 
disclosed (shared) without your permission. As part of this research, you are 
agreeing to allow City of Hope National Medical Center (City of Hope) to use 
and share with others your personal health information (PHI), as needed for 
the research. If you agree to participate in the study named above (called the 
“Study”), you must sign this consent form in addition to the Study Consent 
Form. 
 
II. The Information About You that is Covered By this Authorization: PHI 
refers to information that we maintain about you that identifies you and 
includes the information contained in your medical record. Your medical 
record consists of information related to your health and the treatment we 
provide to you, such as your medical history, the results of physical exams, 
blood tests, x-rays and other diagnostic and medical procedures. If you sign 
this form, you are allowing City of Hope and the individuals indicated below 
to use and share any PHI we maintain about you that is required for your 
participation in the Study. 
 
III. Purposes for Uses and Sharing of your PHI; Who Will Use, Share and 
Receive your PHI: Your PHI will be used and shared with others for the 
purpose of doing this research as described in the Study Consent Form. Your 
PHI will also be used to keep the research sponsor informed about this Study, 
for reporting to those individuals and authorities responsible for overseeing 
our research activities to make sure that the activities are properly conducted, 
and to report to regulatory agencies as required by the Study.  
 
The people authorized to use and share your PHI for purposes of the Study 
include the Principal Investigator and the research staff supporting the Study; 
your City of Hope physicians and the health care team; and the Health 
Information Management Services Department (Medical Records 
Department). This also includes any agents or contractors used by these 
individuals or groups for purposes of conducting or managing this Study.  At 
City of Hope, the Institutional Review Board (IRB) and other City of Hope 
research regulatory committees will have access to your PHI as necessary to 
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monitor research. In addition, at City of Hope, the Cancer Protocol Review 
and Monitoring Committee (“CPRMC”)   
 
You are also allowing your PHI to be shared with the Office for Human 




[Include as applicable: Also certain other groups and institutions, including, 
insert name of cooperative group; researchers at insert name of collaborating 
institution(s); insert name of CRO, a contract research organization (“CRO”), 
will also have access to your PHI as necessary for research purposes and to 
conduct the Study.] 
 
 
By signing this consent form, you also authorize disclosure of your PHI by 
other health care providers outside City of Hope to be given to City of Hope 
investigator and/or the City of Hope research team for follow-up purposes.  
This follow-up information may include results of laboratory tests, physical 
examination, radiological tests, and other information about you. 
 
This authorization will allow us to use and share your PHI for the Study.  No 
other additional uses and disclosures other than for the purposes of the Study 
are included in this authorization.  City of Hope’s Notice of Privacy Practices 
will continue to protect your non-Study information. If necessary, another 
separate permission will be obtained from you for any non-Study uses or 
sharing of your PHI.   
 
IV. Expiration of this Authorization: This authorization to use and share your 
PHI will expire twenty-five (25) years from the date that you sign this 
authorization.   
 
V. Further Sharing of Your PHI: Your privacy is important, and this is the 
reason for having rules which control who can use or see your PHI. City of 
Hope maintains control over your PHI at present, but once we share this 
information with a third party (for example, an individual or agency outside of 
City of Hope), then it is no longer possible to maintain the same level of 
protection.  The persons outside our control may not be governed by federal or 
state privacy laws, and it is possible that they could share your PHI with others 
for whom you have not given permission.  
 
The information from this Study may be published in scientific journals or 
presented at scientific meetings, but your identity will be kept confidential.  
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VI. Your Rights Under this Authorization: You may cancel this permission to 
use and share your PHI at any time by contacting City of Hope’s Privacy 
Officer at (626) 256-HOPE (4673) ext. 64025. You should ask for the 
Revocation (Cancellation) of Authorization for Use of Protected Health 
Information for Research. Fill this form out and return it as the form 
instructs.  Your cancellation begins when the Health Information Management 
Department of City of Hope receives this form. If you cancel this authorization 
to use and share your PHI, you will no longer be able to participate in the 
Study.  This is because the research under this Study cannot be conducted 
without your PHI.  
 
Once you cancel your permission to use and share your PHI, the researchers 
and others involved in conducting the Study will no longer be able to use or 
share your PHI for this research. PHI already used and shared up to this point 
as part of this Study will continue to be used for purposes of this research. This 
means that any uses of your PHI and any PHI shared about you by City of 
Hope prior to receiving your cancellation (revocation) form cannot be taken 
back. While no further PHI about you will be shared for the Study, your PHI 
already shared will continue to be used in the overall Study.  
 
VII. Signing this Authorization is Your Choice: Your ability to obtain care at 
City of Hope will not be affected by your decision to sign this authorization 
form. You will be able to continue to receive health care at City of Hope if you 
choose not to sign this authorization form or if you sign this form and later 
cancel your permission to use and share your PHI. 
 
If you agree to the use and sharing of your PHI, please sign below. You will be 
given a copy of this authorization form. 
 
 
Research Participant's Signature: ________________________ Date: _______  
Time: _______ 
(date and time must be in research participant’s handwriting) 
 
Print Research Participant's Name: ______________________ 
 
 
Investigator's Signature: _________________________ Date: _______ 
Time:  _______ 
 
 
Print Investigator's Name: _____________________________ 
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Appendix B: Research Protocol U.S.
 Experimental Design Schema 
 
Qualitative Study Design 
To describe the experience of recurrence of advanced cancer in people with  solid tumors who consider 
themselves disease free two or more years post –treatment a qualitative approach guided by Grounded 
Theory will be used.  A qualitative design is appropriate for this type of question and allows for the 
patient experiencing this recurrence with advanced cancer to inform us on the meaning of this experience.  
In-depth interviews will be conducted with people with a diagnosis of cancer recurrence (solid tumors) 
following two or more years post treatment where they had perceived themselves to be disease free. 
Participants will be recruited to the study until saturation of themes is achieved.  The objective is to 
develop a theory of the experience of this transition which will facilitate better care in the future. 
Sample Size 
Estimated sample size is between 12 to 15 people with advanced cancer (each to be interviewed once). 
This is a typical sample size for a grounded theory study. The final sample size will be iteratively 
determined by the saturation of themes.  Interviews will be transcribed and coded after each interview 




 Protocol Synopsis 
Protocol Title: 
EXPLORING THE EXPERIENCE OF ADVANCED RECURRENCE IN SURVIVORS WHO 
PERCEIVED THEMSELVES AS CANCER FREE: A QUALITATIVE STUDY 






Rationale for this Study: 
Although advances in diagnosis and treatment have improved cancer survival, it is anticipated 
that about 1.2 million cancer survivors will have a recurrence of their cancer (1 in 6), and 50 
percent of those will recur with advanced cancer  that leads to death (Jemal et al., 2008, Ng and 
Travis, 2008).  There is limited  research  on the experience of advanced recurrence in patients 
who have been disease free for 2 or more years. (Ferrell, 2011, Burnet and Robinson, 2000).  
Care needs for people who experience this transition from perception of  disease free survival to 
recurrence with advanced cancer may be different from that provided to patients who have never 
experienced extended disease-free survival (Mahon and Casperson, 1997, Vivar et al., 2009).  
There is recognition that long-term social and psychological needs of patients who have a 
recurrence of their disease with advanced cancer have been understudied (Ferrell, 2011, Jarrett et 
al., 2013).  Understanding the impact of recurrence of advanced cancer in someone who 
perceived themselves to be living disease free for 2 or more years since completing treatment will 
add much needed new information (Vivar et al., 2010). 
 
Objectives: 
The objective of this research is to explore the experience of transition from the perception of 
being a disease free cancer survivor to someone with a diagnosis of advanced cancer. A 
grounded-theory approach will be used to gather the meaning of this transition for the cancer 
survivor. A substantive theory will be developed related to the transition from perception of being 
cancer free to that of having advanced cancer. 
Study Design: 
A qualitative approach will be used, based on a Grounded Theory method.  Approximately 12 to 
15 in-depth interviews will be conducted with people experiencing the transition from perceiving 
themselves to be disease free to having advanced cancer. Interviews will be transcribed and 
categorized after each interview using constant comparative analysis (Glaser & Strauss).  
Endpoints: 
N/A 
Sample Size:  
It is anticipated that approximately 12 to 15 people with advanced cancer may be required.  The 
final number will be determined iteratively when themes are saturated. 
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 Estimated Duration of the Study 
24 months 
Summary of Subject Eligibility Criteria: 
Inclusion Criteria 
 People with a diagnosis of lung, colon, rectum, ovarian or breast cancer (solid tumors) 
who have had 2 or more years of perceived disease-free survival and recur with stage III 
or IV advanced cancer without potential for cure. 
 English speaking 
 Age 18 or older 
 Able to complete a 1 to 2 hour in-depth interview 
 Ability to read and/or understand the study protocol requirements and provide written 
informed consent. 
Exclusion Criteria 
 Under age 18 
 Non-English speaking 
Investigational Product Dosage and Administration: 
N/A 





City of Hope 
Case Report Forms 
N/A 
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NCCS National Coalition of Cancer Survivors 
PI Principal Investigator 
 
_____________________________________________________________________________________ 
Definition of Terms    
 
Grounded Theory Qualitative research used to study social situations by creating conceptual 
frameworks or theories through inductive analysis of the data. 
 
Constant Comparative A method of analysis that successively compares concepts or theories 
Analysis                         from inductively gathered data with data, data with category, category with 
category, and category to concept.   
   (Bryant & Charmaz, 2007) 
Saturation of Themes When no new categories or themes are generated from interview data   
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 1.0 Goals and Objectives (Scientific Aims) 
1.1 Goals and Objectives 
The purpose of this study is to describe the experience of the transition from being a person who 
perceives themselves to be cancer free (two or more years post treatment) and experiences a recurrence 
with advanced cancer. This study will adopt a grounded theory approach to gather the meaning of the 
experience of this transition from the person with advanced cancer.  For this study, someone who 
perceives themselves to be cancer free is someone who has lived 2 or more years since completing cancer 
treatment and perceives themselves as disease free. We define recurrence with advanced cancer as 
someone who now has advanced stage III or IV cancer without a possibility of cure. 
Aim: To explore the lived experience of  advanced cancer recurrence in  perceived disease free  
survivors. 
1.1 Introduction/Rationale for Development 
The Institute of Medicine (IOM) in the United States defines an individual as a cancer survivor from 
diagnosis until death and includes caregivers and significant others (Hewitt, 2006). The IOM report, 
“From Cancer Patient to Cancer Survivor-Lost in Transition”, identified the gap in cancer treatment 
between active treatment, and transitioning to cancer survivor (Hewitt, 2006).   
The term survivor was established by the National Coalition of Cancer Survivors (NCCS) in 1986, 
which was meant to support patients in making informed treatment decisions and promote research 
focused on cancer survivors to improve their care and move from cancer victim to cancer survivor  (Clark 
and Stovall, 1996, Khan et al., 2012,  NCCS, 2013).  The term survivor has been accepted by most 
researchers as it has become an identifier for this population of people diagnosed with cancer and 
throughout the trajectory of their life until end of life (Hewitt, 2006).  This final trajectory has been 
referred to as the “final phase of survivorship”, leading to end of life (Ferrell, 2011).  The term 
survivorship includes a patient’s experience from diagnosis through treatment, post treatment, remission 
and recurrence on until death (Mullan, 1985).  In this study, cancer survivors in the final phase of 
survivorship are defined by advanced disease recurrence.   
In the United Kingdom, the number of cancer survivors is growing rapidly as in the United States.  
By 2030 it is anticipated that there will be between 3 million and 18 million people living with cancer in 
both countries (O'Dowd, 2010, American Cancer Society).  The last 20 years have seen improvements 
over survival rates for many diseases (American Society of Clinical Oncology, 2012, Ganz, 2009).  Lung 
cancer, pancreatic cancer, melanoma, breast cancer, and prostate cancer have seen significant 
improvements in survival rates (American Society of Clinical Oncology, 2012, O'Dowd, 2010).  Changes 
in chemotherapy and radiation treatments have reduced side effects and improved survival (American 
Society of Clinical Oncology, 2012, American Cancer Society).  Early stage breast cancer patients have a 
99 percent chance of 5-year survival (American Cancer Society).  Improved use of genomic profiling has 
allowed cell lines to be tested with different chemotherapy treatments in an effort to personalize 
treatments to allow for better response and less side effects (American Society of Clinical Oncology, 
2012).  Further genetic studies have decreased patient morbidity from chemotherapy and have been 
responsible for improved treatment response and survival (American Society of Clinical Oncology, 2012). 
Patients continue to believe that long periods of time without recurrence means cure of their disease.    
Survivors are not a homogeneous group of patients (Feuerstein, 2007).  Advances in cancer diagnosis 
and treatment have been made, but it is anticipated that about 1.2 million patients will have a recurrence 
of their cancer (1 in 6), and 50 percent of those will recur with rapidly progressing disease that leads to 
death (Jemal et al., 2008, Ng and Travis, 2008).  Little research is available to describe the meaning of 
this experience of transitioning from the belief you are cured of your cancer to recurrence with advanced 
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 cancer and probable death (Ferrell, 2011, Burnet and Robinson, 2000).  Care needs in this population of 
those who experience this transition from the expectation that they are cured of their cancer to  advanced 
cancer recurrence may be different from that provided to patients who have never experienced the 
concept of being disease-free (Mahon and Casperson, 1997, Vivar et al., 2009).  There is recognition that 
long-term social and psychological needs of patients who recur have been understudied (Ferrell, 2011, 
Jarrett et al., 2013).  Understanding the impact of recurrence with advanced cancer for those who 
perceived themselves to be cancer free will add much needed new information (Vivar et al., 2010). 
We have learned that barriers still exist to full integration of survivorship care into the cancer care 
trajectory.  Communication and consistent messages related to future risks of recurrence and potential late 
effects of treatment continue.  Programs are focused on survivorship in such a way that patients who recur 
and do not fall into the trajectory of retreatment and cure are outside of the eligibility for most programs 
and therefore may be undertreated or not directed to appropriate palliative care interventions that may 
improve the quality of their life for whatever time they have left.  This will be an opportunity to hear from 
this patient population directly regarding their experience of advanced recurrence. 
 
1.2 Overview of Proposed Study 
This study will require a one-time detailed interview with people with cancer (solid tumor) who perceived 
themselves to be disease free for two or more years post-treatment prior to the diagnosis of advanced cancer. 
Interviews will be conducted and will be digitally audio recorded.  Qualitative data analysis will use 
grounded theory techniques.  Interviews will be transcribed and then themed and categorized using the 
technique of constant comparison. Themes will be inductively identified and through the process of 
comparison will be used to develop a mid-level theory describing the meaning of recurrence with advanced 
cancer for those who perceived themselves to be disease free. A memo-journal will be maintained by the 
researcher for each interview participant to record the insights, feelings or thematic ideas related to the 
research.   
Patient Eligibility 
1.3 Inclusion Criteria  
Eligibility Criteria: 
 Patients with solid tumor (lung, colorectal, ovarian, and breast) cancers who have perceived 2 or 
more years of cancer-free survival and recur with stage III or IV disease without potential for 
cure, 
 English speaking, 
 Age 18 or older, 
 Able to complete a 1 to 2 hour in-depth interview, 
 Ability to read and/or understand the study protocol requirements and provide written informed 
consent. 
 
1.3.1 Disease Status 
Patient has recurrence with stage III or IV disease without potential for cure. 
1.3.2 Age Criteria, Performance Status and Life Expectancy  
Children or adults under 18 years are excluded because occurrence of target cancer types and recurrence 
is rare. 
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 1.3.3 Protocol-Specific Criteria 
The sample will include patients with stage III or IV disease recurrence following 2 or more years of 
perceived cancer-free survival. 
1.4 Exclusion Criteria 
 Patients with active malignancies other than lung, colorectal, ovarian, and breast cancers are 
ineligible for this study. 
1.4.1 Non-Compliance 
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring 
requirements of the study. 
2.0 Grounded Theory strategies 
2.1 Qualitative Sampling 
Gounded Theory research are not focused on a representative sample.  Recruitment is focused on 
patients who meet the eligibility criteria.  Constant Comparative Analysis allows exploration of 
emerging issues from the analysis through theoretical sampling.  Sampling is focused on building 
a theory from the emerging data to explain the meaning of advanced recurrence for long term 
cancer free survivors (Charmaz, 2006).  Minorities will be limited to English speaking since the 
investigator speaks only English and would be unable to interview non English speaking patients.  
No exclusion will be made on the basis of race.  Theoretical sampling will allow for patients who 
meet the inclusion criteria to provide additional information to explore emerging issues from the 
analysis.  An attempt will be made to include non white participants if available.  Grounded 
Theory does not seek to provide a representative sample (Charmaz, 2006).  The goal is to develop 
theoretical categories using the patients words to identify the concepts.Screening and Registration 
Procedures 
2.2 Screening Procedures 
  Patients who have recurred with Stage III or Stage IV disease after 2 or more years of completion of 
their treatment will be referred to the PI by the oncologist team. The PI will discuss the patients 
perspective to their perception of their disease status during the years post treatment.  The research project 
will be introduced and the patient will be consented and the interview will be scheduled at their 
convenience.  Demographic data will be gathered from the medical record to identify disease status and 
time of treatment and completion of treatment.  Clinical documentation will be evaluated for concurrence 
with the patients perspective but patient perception of disease free is the primary inclusive condition.   
2.3 Informed Consent  
The investigational nature and objectives of the trial will be carefully explained by the researcher once the 
physician or nurse practitioner have identified them as potential participants, and a signed informed 
consent will be obtained.  Informed consent will be kept in the PI’s office in locked drawers.  A copy of 
the signed consent will be given to the participant before the interview begins.   
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 3.0 Reporting/Protocol Deviations 
3.1 Data Reporting 
3.1.1 Confidentiality and Storage of Records 
The original hard copy transcriptions will be stored in a locked office in the Population Sciences building 
in the division of Nursing Research and Education office, room 181. Digital audio interviews will be 
coded and identification numbers applied.  All identifiers will be removed. Digital audio data will be 
encrypted and saved onto a Seagate Backup Plus Portable Drive and kept in the PI’s locked office as 
described above and HIPAA requirements. When results of this study are reported in medical journals or 
at meetings, identification of those taking part will not be disclosed.  Medical records of subjects will be 
securely maintained in the strictest confidence, according to current legal requirements.  They will be 
made available for review, as required by the FDA, HHS, or other authorized users such as the NCI, 
under the guidelines established by the Federal Privacy Act and rules for the protection of human 
subjects.  Data may be shared with dissertation supervisors at Lancaster University maintaining 
confidentiality. 
4.0 Statistical Considerations 
4.1 Study Design 
In-depth interviews will be conducted with between 15 and 25 participants but recruitment of participants 
will continue until saturation of themes is achieved. Grounded Theory methods will be used which require 
simultaneous data collection and constant comparative analysis of themes or categories of data. The 
theoretical framework of this study uses Constant Comparative Analysis (CCA) but the word comparative 
has no meaning for statistical comparison.  Memo writing will be part of the analysis process and used to 
analyze ideas related to codes and themes.  The development of a substantive theory will be defined 
related to the transition from the perception of being cancer free to experience of being diagnosed with 
recurrent advanced cancer.   
4.2 Sample Size Accrual Rate 
It is anticipated that 12 to 15 patients will be recruited; however the final sample size is related to when 
theme saturation occurs. The study duration is anticipated to be 24 months.  Purposeful sampling will be 
used at the beginning of the study with theoretical sampling used after initial interview analysis .allows 
refinement of sampling based on emerging concepts that need further investigation. 
4.3 Statistical Analysis Plan 
Interviews will be analyzed using a rigorous process of constant comparative analysis where interviews 
and analysis occur simultaneously. Interviews will be transcribed and themed and results used to select 
future participants until saturation of themes occurs. Atlas Ti data management program will be used. 
 
5.0 Human Subject Issues 
5.1 Institutional Review Board 
In accordance with City of Hope policies, an Institutional Review Board (IRB) that complies with the 
federal regulations at 45 CFR 46 and 21 CFR 50, 56 and State of California Health and Safety code, Title 
17,  must review and approve this protocol and the informed consent form prior to initiation of the study.  
All institutional, NCI, Federal, and State of California regulations must be fulfilled. 
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 5.2 Study location and Performance Sites 
This study will be performed at COH.  
5.3 Confidentiality  
This research will be conducted in compliance with federal and state of California requirements relating 
to protected health information (PHI).  The PHI that will be recorded includes name and medical record 
number and diagnosis date and recurrence date. This information will be contained in a password 
protected Access study database.  
Financial Obligations and Compensation 
5.4 Informed Consent Processes  
The Principal Investigator will explain the nature, duration, purpose of the study, potential risks, 
alternatives and potential benefits, and all other information contained in the informed consent document.  
In addition, they will review the experimental subject’s bill of rights and the HIPAA research 
authorization form.  Research subjects will be informed that they may withdraw from the study at any 
time and for any reason without prejudice, including as applicable, their current or future care or 
employment at City of Hope or any relationship they have with City of Hope.  Research subjects will be 
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There are currently 13.7 million cancer survivors in the United States.  The numbers 
are expected to reach 18 million by 2020 (American Cancer Society). Of those 
survivors, it is anticipated that about 1.2 million will have a recurrence of their cancer 
(1 in 6) and 50% of those will recur with rapidly progressing disease that leads to 
death.  The purpose of this study is to describe what terminal cancer recurrence means 
to long term cancer survivors after 2 or more years of disease free survival. 
Using a grounded theory approach, a qualitative study will be conducted using in-
depth interviews to describe what advanced recurrence means to patients after 2 or 
more years of disease free survival. 
The meaning identified through this study will provide a baseline understanding of the 
concerns of this population of late stage recurrence of disease and will help guide 
palliative care planning and coordination of care. 
 
11. Anticipated project dates  
 
              Start date: _03 March 2014____     End date: 12 December 2015__________ 
 












As a grounded theory qualitative research methodology-anticipate up to 20 interviews but 
will interview until saturation of themes. 
 
 
13. How will participants be recruited and from where?  Be as specific as possible. 
Solid tumor patients will be recruited from lung cancer, colorectal cancer, ovarian 
cancer, and breast cancer who have had 2 or more years of cancer free survival and 
recur with Stage III or IV disease without potential for cure. Physicians and their 
nurse practitioners from each disease specialty will be advised on the criteria for 
eligibility by the PI and contact information shared.  The palliative care team will also 
be informed should they be referred appropriate patients.   
 
14. What procedure is proposed for obtaining consent? 
Recruitment and Informed Consent – Potential subjects will have their first 
contact with the PI through identification by the treating oncologist or their nurse 
practitioner. The PI and oncologists will ascertain patient interest in the study. The PI 
and oncologists will verify eligibility.  The PI will inform the patient about the nature 
of their participation and the duration of the study. The PI will inform patients of all 
data collection methods, the time required, and potential risks. Patients will have the 
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opportunity to ask questions, and are free to withdraw from the study at any time. 
Patients may also refuse to answer any specific questions within the interview. The PI 
will obtain written consent, approved by COH’s CPRMC and IRB, from all subjects.  
 
15. What discomfort (including psychological), inconvenience or danger could be caused by 
participation in the project?  Please indicate plans to address these potential risks. 
 
Potential Risks – All contacts with the patient will be arranged at the patient’s 
convenience and in the setting preferred (face-to-face, telephone or in- home).  The 
potential risk is the possibility of emotional distress by discussing their long-term or 
end-of-life concerns.  The time required for data collection is approximately 60 – 90 
minutes. In any situation where a patient is experiencing uncontrolled symptoms, the 
PI will contact the treating oncologist immediately and referral to social work and the 
Biller Center will be provided per oncologists recommendations.   
 
16.  What potential risks may exist for the researcher(s)?  Please indicate plans to address 
such risks (for example, details of a lone worker plan). 
 
The primary concerns for the researcher are related to discussing palliative and end-
of-life plans with patients.   
In-person in the cancer center or telephone interviews will be the primary sites for 
conducting interviews.  If in-home interviews are needed the time will be coordinated 
and telephone contact with the nursing research & education secretary will occur at 
the start and at completion of the interview.   
 
17.  Whilst we do not generally expect direct benefits to participants as a result of this 
research, please state here any that result from completion of the study. 
 
 Includes recognition of survivorship needs for advanced stage patients 
without potential for cure.   
Importance of the Knowledge to be gained – Knowledge to be gained from 
this study may potentially benefit present and future late stage patients by 
addressing their concerns.  
 
18. Details of any incentives/payments (including out-of-pocket expenses) made to 
participants:  
 
There will be no incentives or payments made to any participants. 
 
19. Briefly describe your data collection and analysis methods, and the rationale for their 
use 
 
Using a grounded theory methodology in depth interviews will be conducted with up 
to 20 participants but will continue until saturation of themes is achieved.  Interviews 
will be transcribed and categorized after each interview using constant comparative 
analysis (Glaser & Strauss).  The development of a substantive theory will be defined 
related to the transition from cancer free to a terminal cancer diagnosis. 




I have had experience with patients diagnosed with advanced recurrence as part of my 
palliative care practice in the past.  I have queried palliative care specialists through 
 253 
personal emails about their experiences with advanced disease recurrence after long 
term disease free survival.  All agreed this is a special population who we as health 
care providers have little information about concerning their needs.  
 
21. What plan is in place for the storage of data (electronic, digital, paper, etc.)?  Please 
ensure that your plans comply with the Data Protection Act 1998. 
– This protocol will be approved by the COH Cancer Protocol Research Monitoring 
Committee (CPRMC), Data Safety and Monitoring Committee (DSMC), and the 
Institutional Review Board (IRB).  Institutional procedures for quality control, data 
management and analysis will be obtained prior to subject accrual. The PI will be 
concerned with protecting the integrity of the interviews, and of the process and 
outcome data for this study.  Interviews will be coded with identification numbers and 
devoid of subject names. The interviews will be themed and verified between the PI 
and internal support Dr. Betty Ferrell.   
22. Will audio or video recording take place?       □ no               Xaudio            □video            
If yes, what arrangements have been made for audio/video data storage? At what point in 
the research will tapes/digital recordings/files be destroyed?   
 
Hard copy transcript data will be stored in a locked cabinet in the researchers locked 
office.  Digital data will be encrypted and saved onto a Seagate Backup Plus Portable 
Drive 1TB .  Transcripts will be electronically stored on the portable drive as well and 
kept in a locked file cabinet in the PI’s office in the Nursing Research and Education 
office.  Once data has been analysed and published the portable hard drive will be 
erased.  All hard copy transcripts will be shredded and disposed of in sensitive data 
bins provided by City of Hope. 
 
23.  What are the plans for dissemination of findings from the research? 
 
The outcome of this research proposal will be submitted for publication in appropriate 
peer reviewed international journals.  Outcomes will be submitted for presentation of 
posters and podium presentations of the data at appropriate health related/cancer 
survivor related professional programs such as the Oncology Nursing Society 
Congress (ONS), The American Psychosocial Oncology Society (APOS), and the 
Biennial Survivorship Meeting, and the Multinational Association of Supportive Care 
in Cancer (MASCC).   
 
 
24. What particular ethical problems, not previously noted on this application, do you think 




Signatures:  Applicant: …Denice Economou .................................. 






Project Supervisor* (if applicable): 
……………………………………................... 










Appendix D – CPRMC Approval Letter 
 
CITY OF HOPE NATIONAL MEDICAL CENTER CANCER PROTOCOL 




TO: Denice Economou, R.N., M.N. 
FROM: MaDonna Johnson     
Manager, Protocol Scientific Review and Monitoring Office 
 
DATE: April 30, 2014 
 
PROTOCOL: 14082 - EXPLORING ADVANCED RECURRENCE IN SURVIVORS WHO 
PERCEIVED THEMSELVES AS CANCER FREE: A QUALITATIVE STUDY 
 
 
The Cancer Protocol Review & Monitoring Committee (CPRMC) took the 
following action on the protocol referenced above: 
 
APPROVED 
The response and revised documents submitted on 04/17/14 for the conditions 
issued on 04/03/14 have been reviewed by the committee. The concerns have 
been adequately addressed and the new protocol (version dated 04/17/14) was 
approved on 04/29/14. 
 
If you have any questions, please contact Gwen Jorgensen at extension 
63034. Thank you. cc: IRB 
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INSTITUTIONAL REVIEW BOARD (IRB) ACTION NOTICE 
 
TO: Betty Ferrell, Ph.D., Principal Investigator 
Denice Economou, R.N., M.N., Co-
Investigator City of Hope - Nursing 
Research MC 
FROM: Christine Hui, MPH, IRB Director  
Office of Human Research 
Subjects Protection 
 
DATE: May 15, 2014 
 
STUDY TITLE: Exploring Advanced Recurrence In Survivors Who 
Perceived Themselves As Cancer Free: A Qualitative 
Study 
 
IRB#/REF#: 14082 / 106791 
 
SUBMISSION: Submission Response for 
Initial Review Submission REVIEW PROCESS: 
Expedite 
Conditions set by the Institutional Review Board for approval of the protocol 
submission referenced above have been met and the following action is in effect: 
 









NOTE: DURING THE PERIOD COVERED BY IRB APPROVAL ANY 
CHANGES IN THE PROTOCOL, OR ANY UNEXPECTED 
PROBLEMS INVOLVING HUMAN SUBJECTS, MUST BE 
SUBMITTED TO THE IRB VIA iRIS FOR REVIEW. NO STUDY 
CHANGES CAN BE INITIATED UNTIL APPROVAL HAS BEEN 
OBTAINED FROM THE IRB. 
 
 
If you have questions or concerns about this submission, please contact Suzanne 
Kelly. 
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Applicant: Denice Economou Supervisor: Dr Sarah Brearley 
Department: OHR 
 
27 June 2014 
 
 
Dear Denice and Sarah, 
 
Re: Exploring the lived experience of advanced recurrence in survivors 
who perceive themselves as cancer free: a qualitative study 
 
Thank you for submitting your research ethics application for the 
above project for review by the Faculty of Health and Medicine 
Research Ethics Committee (FHMREC). The application was 
recommended for approval by FHMREC, and on behalf of the Chair 
of the University Research Ethics Committee (UREC), I can confirm 
that approval has been granted for this research project. 
 
As principal investigator your responsibilities include: 
ensuring that (where applicable) all the necessary legal and 
regulatory requirements in order to conduct the research are 
met, and the necessary licenses and approvals have been 
obtained; 
reporting any ethics-related issues that occur during the course 
of the research or arising from the research to the Research 
Ethics Officer (e.g. unforeseen ethical issues, complaints about 





submitting details of proposed substantive amendments 
to the protocol to the Research Ethics Officer for 
approval. 
 
Please contact the Research Ethics Officer, Debbie Knight (01542 








Secretary, University Research Ethics Committee 
 
Cc Fiona Aiken, University Secretary, (Chair, UREC); Professor Paul Bates (Chair, 
FHMREC) 
 
Research Support Office 
Research and Enterprise Services 
 
Lancaster University Bowland Main 
Lancaster LA1 4YT United Kingdom 
 
Tel: +44   (0) 1524 592002 
Fax: +44   (0) 1524 593229 
Web:   http://www.lancs.ac.uk 
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INSTITUTIONAL REVIEW BOARD (IRB) ACTION 
NOTICE 
 
TO: Betty Ferrell, Ph.D., Principal 
Investigator City of Hope - 
Nursing Research MC 
FROM: Diana Shycoff, BS, IRB Operations 
Manager  Office of 
Human Research Subjects Protection 
 
DATE: April 10, 2015 
 
STUDY TITLE: Exploring Advanced Recurrence In Survivors Who 
Perceived Themselves As Cancer Free: A Qualitative 
Study 
 
IRB#/REF#: 14082 / 115677 
 
SUBMISSION: Continuation REVIEW PROCESS:  Expedite IRB ACTION 
DATE: 04/10/2015 IRB ACTION: 
APPROVAL FROM 04/10/2015 UNTIL 04/09/2016 
 
NOTE: DURING  THE  PERIOD  COVERED  BY  IRB  APPROVAL  
ANY  CHANGES  IN  THE PROTOCOL, OR ANY 
UNEXPECTED PROBLEMS INVOLVING HUMAN SUBJECTS, 
MUST BE SUBMITTED TO THE IRB VIA iRIS FOR REVIEW. 
NO STUDY CHANGES CAN BE INITIATED UNTIL 
APPROVAL HAS BEEN OBTAINED FROM THE IRB. 
 
If you have questions or concerns about this submission, please contact Suzanne 
Kelly. 
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INSTITUTIONAL REVIEW BOARD (IRB) ACTION 
NOTICE 
 
TO: Betty Ferrell, Ph.D., Principal 
Investigator City of Hope - 
Nursing Research MC 
 
FROM: Diana Shycoff, BS, IRB Operations 
Manager  Office of Human 
Research Subjects Protection 
 
DATE: July 11, 2016 
 
STUDY TITLE: Exploring Advanced Recurrence In Survivors Who 
Perceived Themselves As Cancer Free: A Qualitative 
Study 
 




REVIEW PROCESS: Administrative Review 
IRB ACTION DATE: 07/11/2016 
IRB ACTION: 
 
SUBMISSION RECEIVED IN IRB OFFICE ON 05/12/2016 01:26:08 






I. This amendment changes the accrual status of this study at City of Hope and does 
not affect the  protocol versioning. 
 
II. This protocol is open to analysis of previously collected data only. 
 
 
NOTE: DURING THE PERIOD COVERED BY IRB APPROVAL ANY 
CHANGES IN THE PROTOCOL, OR ANY UNEXPECTED 
PROBLEMS INVOLVING HUMAN SUBJECTS, MUST BE 
SUBMITTED TO THE IRB VIA iRIS FOR REVIEW. NO STUDY 
CHANGES CAN BE INITIATED UNTIL APPROVAL HAS BEEN 
OBTAINED FROM THE IRB. 
 
 
If you have questions or concerns about this submission, please contact Suzanne 
Kelly. 
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Appendix I – Interview Guide 
Areas to be examined Rationale for inclusion Example questions 
Introduction General discussion about 
original diagnosis  
Please tell me briefly 
about your initial 
diagnosis and what that 
entailed? 
 
Concept of cure or living 
with “no disease” 
Attempt to verify their 
perception of being cured  
1. How did you end 
your initial 
treatment?  
2. What did you 
understand about 
your prognosis? 
3. What was this time 
of “no disease” like 
for you? 
 
Understanding what this 
recurrence means 
Aim of study is to 
understand what 
recurrence means after 
perceiving self to be 
cured. Need to explore 
those feelings and what 
recurrence means for 
them 
1. What do you 
understand about 
your recurrence? 
2. Did you expect to 
have your cancer 
return? 
3. What does this 
recurrence mean to 
you? 
 
Exploring what the 
participants wishes are now 
that they have recurred 
Opportunity to hear what 
the participant’s plans are 
and what is important to 
them now. 
Using strategies to verify 
meaning and build 
theoretical confirmation of 
newly evolving theory  
1. What are your 
concerns now? 
2. What is most 
important to you 
now? 
3. Explore in depth 
beliefs around theory 




Wrap up Explore any additional 
thoughts the participant 
might like to discuss 
Thank them for their 
participation and provide 
the researchers contact 
information should they 
have any further 
questions. 
1. Are there any other 
thoughts or concerns 
you have about this 
advanced 
recurrence? 
2. Thank you for 
participating 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































terms Text keywords 
Search strategy Web of 
Science 
9-28-2016  N = 4157 
N = 5519 
Advanced   Palliative  
Hospice 




 (Palliative OR Hospice 
OR ‘end of life’) 





(Cancer OR Oncology 

















(Experience* OR feel* 
OR view* OR voice* OR 
attitude* OR perspective* 
OR understand* OR 
believe OR belief* OR 
meaning OR significance 
OR hope) 












Interview* OR ‘focus 
group’ OR ‘case study’ 
OR qualitative OR 
narrative OR ethnology 
OR ethnograph*) 
Note. Copy and paste: (Palliative OR Hospice OR ‘end of life’ OR metastatic 
OR metastasis) AND (Cancer OR Oncology OR Carcinoma OR neoplasms) 
AND (Experience* OR feel* OR view* OR voice* OR attitude* OR perspective* 
OR understand* OR believe OR belief* OR meaning OR significance OR 
hope) AND (Survey* OR Questionnaire* OR Interview* OR ‘focus group’ OR 
‘case study’ OR qualitative OR narrative OR ethnology OR ethnograph*) 
Publish: TS=((Palliative OR Hospice OR ‘end of life’) AND (Cancer OR 
Oncology OR Carcinoma OR neoplasms) AND (Experience* OR feel* OR 
view* OR voice* OR attitude* OR perspective* OR understand* OR believe 
OR belief* OR meaning OR significance OR hope) AND (Survey* OR 
 284 
Questionnaire* OR Interview* OR ‘focus group’ OR ‘case study’ OR qualitative 
OR narrative OR ethnology OR ethnograph*)) 
Key papers:  
27098887 – comes up in search  
20920031 – part of hand search  
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